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ABSTRACT 
 
Protein kinase C (PKC) isoenzymes sit in the crossroad of numerous signaling 
pathways involved in cellular functions such as proliferation, differentiation, migration 
and survival.  The dysregulation of PKCs have been shown to associate with human 
diseases including cancers, cardiovascular diseases and neurodegenerative diseases.  
However, the knowledge of PKC regulation is still limited.  The objective of this 
dissertation is to determine the roles of the PKCα C-terminal tail and the C2 regulatory 
domain in its maturation, activation and down-regulation. 
The C-terminal V5 domain of PKC contains the least conserved sequence among 
the isoenzymes.  In this study, nuclear magnetic resonance (NMR) and circular 
dichroism are used to show that the isolated V5 domain is intrinsically disordered in 
solution.  A detailed characterization is provided for the V5 domain’s secondary 
structural preference, dynamic properties and propensity to interact with a hydrophobic 
environment.   
NMR techniques are used to demonstrate that the PKCα C2 domain interacts 
with the V5 domain.  A structural model for the C2–V5 complex is determined.  In 
addition, NMR-detected binding studies reveal that V5 and calcium interact with C2 
cooperatively.  Mutations that disrupt the C2–V5 interface altered both the conformation 
of full-length PKCα and the kinetics of membrane translocation.  These results indicate 
that C2-V5 interaction plays an essential role in PKC regulation, through its contribution 
to both autoinhibition and activation.  Furthermore, the V5 domain is shown to directly 
 iii 
 
interact with the peptidyl-prolyl isomerase Pin1.  The V5–Pin1 interaction is observed to 
be highly specific, non-catalytic, and is enhanced by the avidity from bivalent binding.  
These data provide insights into a novel mechanism for the Pin1-mediated down-
regulation process of PKCs. 
The metal-dependent membrane interactions of the C2 domain are studied with 
cadmium as structural surrogate and the results compared to other divalent metals.  
Conformational dynamics change induced by calcium binding is detected for regions 
connecting to other PKC domains.  These results reveal specific roles of calcium ion 
during membrane interaction and conformational rearrangement of PKC. 
Together, these data contribute to our understanding of PKC regulation with 
concerted intramolecular contacts and complex intermolecular interactions, which can 
help to develop isoenzyme-specific agents to modulate PKC activity.   
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NOMENCLATURE 
 
ATP adenosine triphosphate 
βME β-mercaptoethanol 
CD circular dichroism 
CFP cyan fluorescent protein 
CM center of mass 
CMBL calcium membrane binding loop 
CN coordination number 
CNBr cyanogen bromide 
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GPCR G-protein coupled receptor 
GST Glutathione S-transferase 
HE Hahn-Echo 
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HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HM hydrophobic motif 
HPLC high-performance liquid chromatography 
HSQC heteronuclear single quantum coherence 
IDP intrinsically disordered protein 
IPTG isopropyl-D-1-thiogalactopyranoside 
KIE kinetic isotope effect 
KSI ketosteroid isomerase 
LRC lysine-rich cluster 
LUV large unilamellar vesicle 
MALDI-TOF matrix-assisted laser desorption/ionization time-of-flight 
MES 2-(N-morpholino)ethanesulfonic acid 
MWCO molecular weight cut-off 
mTORC mammalian target of rapamycin complex 
NLS nuclear localization signal 
NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
PCS pseudocontact shift 
PDB protein data bank 
PDB ID protein data bank identification number 
PDBu phorbol 12,13-dibutyrate 
PDK-1 phosphatidylinositide-dependent kinase-1 
 viii 
 
pHM phosphorylated hydrophobic motif 
Pin1 peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 
PIP2 phosphatidylinositol 4,5-bisphosphate 
PKA protein kinase A 
PKC protein kinase C 
PKG protein kinase G 
PLC phospholipase C 
PMA phorbol 12-myristate 13-acetate 
PMSF phenylmethylsulfonyl fluoride 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPS 1-palmitoyl-2-oleoyl-sn-glycero-3- phospho-L-serine 
PRE paramagnetic relaxation enhancement 
PS pseudosubstrate 
PtdSer phosphatidylserine 
PtdIns(4,5)P2 phosphatidylinositol 4,5-bisphosphate 
PtdIns(3,4,5)P3 phosphatidylinositol 3,4,5-trisphosphate 
pTM phosphorylated turn motif 
pV5 bisphosphorylated V5 
RACK receptor for activated C-kinase 
RMSD root-mean-square deviation 
SEM standard error of the mean 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
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SH3 SRC Homology 3 
SSP secondary structure propensity 
STD standard deviation 
SUMO small ubiquitin-like modifier 
TCEP tris(2-carboxyethyl)phosphine 
TM turn motif 
WT wild-type 
YFP yellow fluorescent protein 
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CHAPTER I  
INTRODUCTION 
 
Introduction to protein kinase C and objectives 
 Protein kinase C (PKC) was first identified in 1977 by Nishizuka and colleagues 
as a cyclic nucleotide-independent protein that phosphorylates histone and protamine.
1
  
A few years later, PKC was discovered to be directly activated by tumor-promoting 
phorbol esters.
2
  Since then, accumulated research efforts have revealed that PKC 
controls a multitude of signaling cascades controlling cell proliferation, differentiation, 
migration and survival.
3,4
  Because of its central role in cell signaling, the up- and down-
regulation of PKC is associated with numerous diseases including cancers,
4-6
 
cardiovascular diseases
6-9
 and neurodegenerative diseases.
10-13
   
The isoenzymes of the PKC family have overlapping tissue distributions with 
distinct and sometimes opposing roles.
4,14
  Therefore, therapeutic strategies targeting 
PKCs require isoenzyme-specific modulation.  However, a lack of knowledge about the 
function and regulation of individual PKC isoenzymes is currently preventing the 
development of isoenzyme-specific regulatory agents.
12
  In addition, a detailed 
molecular mechanism of PKC action in cells is not yet fully understood.  Driven by a 
motivation to provide atomic-level understanding of the PKC function, this dissertation 
is focused on investigating the roles of the PKC C-terminal tail and the metal ion-
dependent C2 regulatory domain in PKC’s maturation, activation and down-regulation.  
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This chapter provides an overview of the structural components of PKC isoenzymes, 
regulation of PKC, the C-terminal V5 domain and the C2 regulatory domain.   
 
Structural components of PKC 
The PKC family of isoenzymes is a member of the AGC (PKA, PKG and PKC) 
superfamily of protein kinases.  These protein kinases share a highly conserved catalytic 
core fold, and a regulatory region that keeps the enzyme inactive prior to signaling 
events.  The regulatory region of PKC is located at the N-terminal half of the 
polypeptide, and the catalytic region is in the C-terminal half.  At least 10 mammalian 
PKC isoenzymes are traditionally divided into three subfamilies: conventional PKCs 
(cPKCs: α, βI, βII, and γ), novel PKCs (nPKCs: δ, ε, η, and θ) and atypical PKCs 
(aPKCs: ζ, ι/λ).   
 
 
 
 
Figure 1. Structural components of PKC isoenzymes and their cofactors.  10 
isoenzymes of PKC are divided into three subfamilies: conventional (cPKC), novel 
(nPKC) and atypical (aPKC).  The functional domain diagram and their cofactors are 
shown for each subfamily.  PS, DAG, PtdSer and PIP2 stand for the pseudosubstrate 
region, diacylglycerol, phosphatidylserine and phosphatidylinositol 4,5-bisphosphate, 
respectively.  Phosphorylation sites are shown as yellow spheres and annotated at the 
bottom. The glutamic acid in the blue sphere is shown for the aPKC subfamily.     
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The three subfamilies are categorized based on their differences in the N-terminal 
regulatory region and the cofactors they bind as shown in Figure 1.   
All PKCs are multi-modular serine/threonine kinases with a single polypeptide 
chain.  Domains in PKC are named based on their degree of conservation.  For example, 
conventional PKCs have four conserved domains (C1 through C4) and five variable 
domains (V1 through V5).  The C1 and C2 domains belong to the N-terminal regulatory 
region, whereas the C3, C4 and V5 domains comprise the C-terminal catalytic region.  
The C3 and C4 domains are often referred to as the N-lobe and C-lobe of the kinase 
core.  The C1 and C2 domains in the N-terminal regulatory region are independently 
folded functional modules that interact with cofactors both in cytosol and on cell 
membranes.   
As illustrated in Figure 1, the three subfamilies of PKC have different cofactor 
requirements.  This is due to differences in modular compositions for the N-terminal 
regulatory region of each subfamily.  Conventional PKCs (α, βI, βII, and γ) require both 
diacylglycerol and increased cellular calcium level for activation.  There are two tandem 
C1 domains (C1A and C1B) and a C2 domain in their N-terminal regulatory region.  C1 
domains are responsible for diacylglycerol association.  The C2 domain binds to anionic 
membranes in a calcium-dependent manner.  The lipid specificity of C2-membrane 
binding includes phosphatidylserine (PtdSer) and phosphatidylinositol 4,5-bisphosphate 
(PtdIns(4,5)P2).  PtdSer is also shown to interact with C1 domains.
15
   
Novel PKCs (δ, ε, η, and θ) have an altered arrangement of regulatory regions, 
with a C2-like domain that does not bind calcium ions followed by two tandem C1 
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domains.  As a result, nPKCs are activated by diacylglycerol, but not by calcium.  
Atypical PKCs (ζ, ι/λ) are activated through protein-protein interactions with a PB1 
(Phox and Bem 1) domain.
16,17
  The atypical C1 domain does not bind diacylglycerol.  
However, aPKCs can be activated or regulated by PtdSer, PtdIns(3,4,5)P3, ceramide and 
other lipid components.
18-20
   
To date, moderate structural data obtained by NMR and crystallography are 
available for individual domains of PKC, including C1 domains, C2 domain and the 
kinase core.
21,22
  However, there currently exists no structural model of any full-length 
PKC.  In the only structure available from a full-length construct of PKCβII (PDB ID 
3PFQ), multiple domains and linkers are still missing electron densities.
23
  This is 
largely because of the intrinsic flexibility of PKC due to its multi-modular structure and 
potential promiscuous modes of intramolecular interaction.  Another challenge to a full-
length structure determination lies in the post-translational phosphorylation events (vide 
infra) required for the maturation of these enzymes.  These phosphorylation events add 
to complexity and limitations of the expression systems needed to acquire a structural 
sample of PKC.       
 
Regulation of PKC 
PKC isoenzymes are regulated through four specific aspects: (1) maturation 
through phosphorylation, (2) activation by association with cofactors, (3) spatial 
localization through interaction with proteins and (4) down-regulation.  All of these 
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regulatory mechanisms are combined to determine the life cycle and activity at any 
given cellular state of PKC.   
 
PKC maturation through phosphorylation 
Newly synthesized PKC is unphosphorylated, inactive and partitions into an 
unidentified membrane cellular compartment.
24
  For conventional PKCs in the cells, the 
unphosphorylated precursor is fully released into the cytosol upon completion of three 
ordered phosphorylation events located at the activation loop, the turn motif and the 
hydrophobic motif, respectively (Figure 1).
25
  The first step of phosphorylation is 
characterized to be at the activation loop located in the C-lobe of the kinase domain and 
is mediated by the upstream kinase phosphoinositide-dependent kinase-1 (PDK-1).
24
  
For PKCα and PKCβII this phosphorylation is on T497 and T500, respectively.  This is 
followed by two additional phosphorylation events at the turn motif and hydrophobic 
motif at the C-terminal V5 region.
24,26
   
For novel and atypical PKCs, although phosphorylations at the three conserved 
sites occur, regulation by phosphorylation remains controversial.
22,27-29
  Notable 
differences from cPKCs are summarized in the following observations: (1) a glutamic 
acid substitutes for the phosphorylated residue in the hydrophobic motif for aPKCs, (2) 
PKCδ (an nPKC isoenzyme) can function without activation loop phosphorylation, and 
(3) alternative regulatory mechanisms have been suggested for PKCδ and PKCι/λ.17,22    
The reason why the three phosphorylation events are required for releasing the 
newly synthesized cPKCs into the cytosol appears to be that these events trigger a 
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conformational change from an “open” form (with the psdeudosubstrate region exposed) 
to a “closed” form (with the psdeudosubstrate tucked in the active site of the kinase 
domain).  This process is illustrated schematically in Figure 2.  The mature, closed form 
of PKC in the cytosol is catalytically competent, but it remains inactive until activated 
by corresponding cofactors in cell signaling events.  For this reason, the mature cytosolic 
PKC is also referred to as the latent form.  The driving forces behind the conformational 
changes that occur upon PKC maturation are not yet fully understood.  The specific roles 
of the two phosphorylation sites at the C-terminal tail are also only partially elucidated 
(vide infra).  
By treating the mature PKCβII with specific phosphatases and testing the kinase 
activity of the resulting dephophosphorylated species, it has been illustrated previously 
that once PKC becomes mature in the cells, only the phosphorylation at the turn motif is 
required for PKC catalytic activity; activation loop and hydrophobic motif 
phosphorylation sites are not essential for the activity of the mature kinase.
26
  The 
mutations at the hydrophobic motif phosphorylation site affect mainly the thermal 
stability and cytosolic population of the enzyme, but a mutation to Ala in PKCβII does 
not abolish the kinase activity of the soluble half population from the cell lysate.
30-32
  On 
the other hand, the T641AAA mutations of PKCβII, which abolishes the turn motif 
phosphorylation, resulted in completely unphosphorylated and inactive kinase with half 
of the population remained in the detergent-insoluble fraction of the cell.
30
  However, the 
newly-synthesized wild-type  and the T641AAA mutant of PKCβII (both are 
unphosphorylated) are soluble when expressed in cell-free translation system shown in 
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the same study.
30
  From the above discussions, the turn motif and hydrophobic motif 
phosphorylation events play important roles in the cytosolic population of PKC in cells. 
However, there seem to be unknown steps that remain to be elucidated between the PKC 
phosphorylation events and its final cytosolic localization.  These steps probably include 
protein-membrane and protein-protein interactions. 
 
 
 
 
 
Figure 2. A schematic view illustrating the regulation of conventional PKC 
isoenzymes.  Phosphorylation sites are shown as yellow spheres.  Calcium ions are 
shown as green spheres, and lipid cofactors are annotated at the left bottom.  The C-
terminal V5 domain is colored in red.  Regulatory domain (Reg) and kinase domain 
(Kin) are colored blue and brown, respectively.  Their modular compositions can be 
found in Figure 1.  
 
 
 
PKC activation by association with cofactors 
There are three conditional peripheral membrane-binding domains in 
conventional PKCs: C1A, C1B and C2 (Figure 1).  The activation of mature cPKC 
requires the binding of second messengers diacylglycerol and calcium ions to C1 and C2 
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domains, respectively. The association of second messengers releases the “closed”, 
latent form of cPKC and translocates the enzyme from cytosol to cell membrane.  The 
membrane associated cPKC then becomes fully active to phosphorylate target proteins 
downstream in the signaling pathways.  The signaling events triggering increased levels 
of both membrane diacylglycerol and cytosolic calcium lead to membrane translocation 
and activation of PKCα (first isoenzyme in cPKC subfamily), which can be visualized in 
Figure 3.  The extracellular signaling agonists simulates phospholipase Cβ through G-
proteins, which leads to hydrolysis of PtdIns(4,5)P2.  The hydrolysis of one 
PtdIns(4,5)P2 molecule results in one molecule of diacylglycerol remaining in the 
plasma membrane and one molecule of cytosolic messenger Ins(1,4,5)P3.  Ins(1,4,5)P3 
binds to receptor calcium channels and releases calcium ions from the calcium reservoir 
of endoplasmic reticulum to the cytosol.  Now both diacylglycerol and calcium levels 
are elevated in the cell for effective activation of PKCα.   
The order of cofactor binding events is generally thought to begin with calcium 
binding to the C2 domain.  This is supported by a few studies showing that the calcium 
binding event causes much faster membrane translocation kinetics of PKCγ in cells than 
that triggered by diacylglycerol alone and that cPKC membrane translocation 
synchronizes very well with cellular calcium spikes.
33-35
  The calcium spike causes a 
transient membrane association of cPKC, which reduces the dimensions required for a 
diacylglycerol search from the three-dimensional cytosolic space to the two-dimensional 
membrane surface.  C1 domain binding to diacylglycerol then provides enough energy 
accumulative with the energy contributed by C2 membrane binding to pull the 
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pseudosubstrate out of the active site, leading to full activation of cPKCs.
36
  For cPKCs, 
the C1B domain provides a weaker diacylglycerol site than that found in their C1A 
domain.  Replacement of a conserved Tyr with a Trp alone increases the diacylglycerol 
affinity of the conventional C1B domain.
37,38
  High diacylglycerol affinity applies to 
both C1A and C1B domains of novel PKCs, potentially compensating the reduced 
membrane binding ability of the C2-like domain when comparing to the conventional 
calcium-binding C2 domain.   
 
 
 
 
Figure 3. A model of signaling events leading to activation of PKCα.  GPCR, 
PLCβ and ER denote the G-protein coupled receptor, phospholipase Cβ and 
endoplasmic reticulum, respectively.  Figure adapted with permission from T. I. 
Igumenova. Biochemistry 2015, 54, 4953.
21
 
 
 
 
It is worth noting that tumor promoting phorbol esters, first discovered to directly 
activate PKC in 1982,
2
 associate with significantly higher affinity to the C1 domains 
than their natural agonist diacylglycerol.  As stated previously, the structural information 
regarding the activation process of PKC is still largely unknown.  This is due to a lack of 
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a full-length PKC structure in either latent or membrane associated form.  Thus, it is 
difficult to delineate the detailed structural changes that occur during PKC activation, 
other than the global change of activated PKC possessing no pseudosubstrate in the 
active site and the N-terminal regulatory domain associated with the membrane (Figure 
2).    
 
PKC spatial localization through interaction with proteins and PKC down-regulation 
PKC isoenzymes are rather generic kinases in regard to their substrate 
specificity.  It is suggested that spatial localization through protein interactions is an 
important pathway to deliver PKC isoenzymes to the appropriate cellular compartments 
and microdomains so that substrate specificity can be achieved.
22,39
  A broad range of 
substrates, receptors, cytoskeletal proteins and scaffold proteins have been shown to 
interact with PKC in an isoenzyme-specific manner, as discussed in detail in the review 
of Jaken and Parker.
39
  A notable example related to this dissertation is the receptors for 
activated C kinase (RACKs) scaffold proteins.  The RACK interaction sites are mapped 
to the C2 domain and V5 domain on PKCβ, δ and ε.22  Peptides with sequences based on 
RACK binding sites have been shown by Mochly-Rosen and colleagues to effectively 
modulate subcellular localizations of PKC isoenzymes.
40-43
 
Down-regulation of PKC is an integral part of PKC regulation, so that the PKC 
activities can be accurately controlled by cofactors and other signaling molecules.  The 
most basic down-regulation mechanism of PKC is through decreasing cofactor 
concentrations as a result of calcium oscillations and metabolism of lipid cofactors such 
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as diacylglycerol.  When cofactor concentrations are decreased in the cells, PKC 
dissociates from the membrane and become latent again.  However, when PKC is 
stimulated with phorbol esters, it is down regulated through dephosphorylation and 
degradation, since phorbol esters cannot be metabolized.
44
  Recent studies suggest the 
presence of both ubiquitination/proteasome dependent and endolysosome dependent 
degradation mechanisms for cPKCs.
45,46
               
 
V5 domain 
The C-terminal V5 (Variable 5) domains are 60 to 80 amino acid segments 
containing two highly conserved turn and hydrophobic phosphorylation motifs (Figure 
1).  These two phosphorylation sites in the V5 domain are among the three ordered 
phosphorylation events required for newly-synthesized cPKC isoenzymes to become 
mature and catalytically competent.  Due to its variability among PKC isoenzymes (vide 
infra), the V5 domain is an ideal candidate for isoenzyme-specific targeting.   
It was not until recently that the V5 domain has received significant attention 
from researchers who were trying to unveil the molecular mechanism of PKC regulation. 
Collectively, V5 domains are involved in (1) priming the maturation of newly-
synthesized PKCs (vide supra), (2) intramolecular interactions to maintain the latent 
form of PKCs until activation,
23,47
 and (3) intermolecular interactions with upstream or 
downstream proteins and kinases.
22,32,45,48-50
  However, the intrinsic properties of V5 
domains have caused difficulties for traditional structural techniques and for elucidating 
detailed information of protein-protein interactions involving the V5 domain.  The lack 
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of atomic level information is currently the missing link between the functional 
importance of V5 domain and a broader usage of V5 properties to modulate PKC 
activities. Driven by this motivation, this dissertation seeks to understand the role of V5 
domain and focuses on characterization of the isolated V5 domain from PKCα and 
probing its intramolecular and intermolecular interactions.   
 
The variability of V5 and its isoform specific properties 
As shown in Figure 4 for the sequence alignment of V5 domains from PKC 
isoenzymes, V5 domains have large variations in amino acid compositions outside of the 
three conserved motifs and an N-terminal PPXXP site.  The sequence at the extreme C-
terminus beyond the hydrophobic motif is the least conserved sequence with varying 
lengths (7–22 amino acids) among all PKC isoenzymes.  These highly variable terminal 
sequences of V5 can be used to identify each isoenzyme through specific antibodies.   
More importantly, V5 domains modulate the individual subcellular localization 
of each isoenzyme.  For example, PKCβI and βII are alternatively spliced products of the 
same gene and they only differ in their V5 sequences.  However, PKCβII localizes to the 
juxtanuclear region in addition to plasma membrane upon sustained PMA stimulation.  
But PKCβI only localizes to plasma membrane under the same conditions potentially 
due to a different V5 domain from PKCβII.51,52  For another example, expression of a 
chimeric PKCα with the last 13 amino acids from PKCβII resulted in a PKCβII-type 
nuclear localization of the chimeric protein upon prolonged PMA stimulation.
53
  In 
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addition, V5 domain from PKCδ contains a nuclear localization signal (NLS) sequence 
from residues 611–623.54       
 
 
 
Figure 4. Sequence alignment of V5 domains from PKC isoenzymes.  Identical 
residues are shaded in black, and similar residues are shaded in grey.  Conserved 
motifs of V5 domains are annotated at the top of each motif.  Phosphorylation sites 
are highlighted with yellow spheres, with blue Glu residues shown for aPKCs at the 
conserved hydrophobic motif phosphorylation site.  The amino acid sequences are 
from Mus musculus and are highly similar to those of Homo sapiens.  
 
 
 
Conserved motifs and their proposed function 
There are three conserved motifs in the V5 domains of PKC isoenzymes: NFD, 
turn and hydrophobic (Figure 4).  The NFD motif contains three highly conserved amino 
acids Asn (N), Phe (F), and Asp (D) as it is named, and another conserved Phe residue 
following the NFD trio.  This motif forms a short helix segment as observed in various 
crystal structures of PKC kinase domains.  The exact function of this motif is not known, 
but it is proposed to interact with C1B domain within the same PKC molecule judging 
from the contact observed from PKCβII crystal structure (PDB ID 3PFQ) (Figure 5).23  
However, the function of this proposed interaction remains controversial since a recent 
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study did not observe any difference in PKCβII activation by mutating the conserved 
Phe629.
55
   
 
 
 
 
Figure 5. Crystal structure of PKCβII (PDB ID 3PFQ) showing the structural 
elements.  The color coding of individual domains are the same as in Figure 1.  
Pseudosubstrate, C1A domain, and the hinge are missing in this structure.  Activation 
loop and the conserved motifs (NFD, turn and hydrophobic) of the V5 domain are 
labeled with black annotations, with the three phosphorylation sites shown in ball and 
stick representations for the phosphate moiety.  The ANP molecule is shown in orange 
stick, which is a non-hydrolysable ATP analog located between the N- and C-lobes.  
 
 
 
The conserved turn motif and hydrophobic motif contain two out of the three 
phosphorylation sites required for the maturation of cPKCs (vide supra).  The turn motif 
is named because it contains at least one proline residue immediately following the 
phosphorylated Thr residue for cPKCs and aPKCs.  However, three out of four nPKC 
isoenzymes do not share this property.  As described previously, the turn motif is most 
critical among the three phosphorylation sites for the catalytic competence of the mature 
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PKC enzyme but the reason for this is not fully understood.  It is possibly due to 
formation of a salt bridge between the phosphate group and a Lys residue on the N-lobe 
of the kinase domain (Figure 5).  The turn motif also appears to be important for at least 
two other functions.  The V5 domain of PKCβII is implicated in a direct interaction with 
the heat shock protein HSP70 potentially via the unphosphorylated turn motif and the 
invariant Leu residue preceding the Thr phosphorylation site.
50,56
  Most recently, the turn 
motif was proposed to be important for peptidyl-proyl isomerase Pin1-mediated down-
regulation of cPKCs.
45
    
The hydrophobic motif was shown to be the docking site for the upstream kinase 
PDK-1 during the maturation process of PKC.
32
  Due to the trans-activating property of 
PDK-1, the hydrophobic motif of PKC potentially functions in both recruitment and 
activation of PDK-1.
57
  The phosphorylation of the hydrophobic motif appears to happen 
after PDK-1 is disassociated from PKC.
32
  Interestingly, PDK-1 has a higher affinity for 
the phosphorylated isolated C-terminus (GST-V5 fusion protein) than the 
unphosphorylated mutants of GST-V5.
32
  On the contrary, PDK-1 interacts preferably 
with unphosphorylated full-length PKCβII.32  These data indicate that the hydrophobic 
motif becomes masked upon phosphorylation.  The phosphorylation of hydrophobic 
motif, on the other hand, is not as critical as the phosphorylation of the turn motif for the 
catalytic competence of mature PKCs.  However, the hydrophobic motif appears to 
affect the thermostability and calcium binding efficiency of PKCβII.30-32  In addition, 
negatively charged residues in the hydrophobic motif are important for the 
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diacylglycerol insensitivity of PKCα possibly due to intramolecular interactions that 
stabilize the closed conformation of latent PKCα.47   
The function of the conserved PPXXP site at the N-terminal part of the V5 
domain is less well studied.  Although overlapping with the NLS, it has been suggested 
to be important for nuclear exclusion of PKCδ.58  This proline rich site contains an SH3 
domain binding consensus PXXP, but the function has not yet been addressed to our 
knowledge.  
 
C2 domain 
C2 (Conserved region 2) domains are calcium dependent lipid binding modules 
that are currently found in about 140 different human proteins.
59,60
  Conventional PKCs 
all have one calcium-binding C2 domain, whereas novel PKCs have a C2-like domain 
insensitive to calcium, and atypical PKCs lack a C2 domain.  The C2 domains of cPKCs 
are implicated in modulating their PtdSer and PtdIns(4,5)P2 specific membrane 
translocation.
61
 
 
Structural elements of C2 
C2 domains share a common fold consisting of an eight-stranded β-sandwich 
interconnected with three calcium membrane binding loops (CMBLs) to provide metal 
coordination.  The sequence alignment and crystal structure of the C2 domain from 
cPKCs are shown in Figure 6, with the functional elements highlighted.   
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Figure 6. The calcium and lipid binding C2 domains from conventional PKC 
isoenzymes.  (A) Sequence alignment of C2 domains from cPKCs.  Conserved Lys 
residues are highlighted with blue fonts.  The amino acid sequences are from Rattus 
norvegicus and are highly similar to those of Homo sapiens.  (B) Crystal structure of 
C2 domain from PKCα indicating the structural and functional elements.  PDB entries 
used to generate this figure are 1DSY, 3RDJ and 3GPE.  In both panels, calcium 
membrane binding loops (CMBLs) are colored orange, and the lysine-rich cluster 
(LRC) is colored purple.  Calcium ions are shown as green spheres, and the lipid 
headgroups are shown as ball and stick representations.  
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The three CMBLs of conventional C2 domains bind two to three calcium ions, and 
interact with the PtdSer lipid headgroups in a calcium-dependent manner.  In addition to 
the CMBLs, the C2 domain from cPKCs has a polybasic lysing-rich cluster (LRC) 
located at the β3-β4 groove. The LRC was indicated by the crystal structure and 
functional studies to interact with PtdIns(4,5)P2 headgroups at the plasma membrane.
62-64
  
LRC was also suggested by a mutagenesis study to contribute to the diacylglycerol 
insensitivity together with the hydrophobic motif of V5 domain from PKCα.47  Another 
unique structural element for PKC C2 domains is the C-terminal Helix3, which does not 
exist in C2 domains from synaptotagmins or phospholipase C proteins.   Residues in this 
helix have been suggested to play a role in intramolecular C2–C1A interaction by 
mutagenesis and computational modeling.
65,66
 
 
Metal coordination and membrane interactions 
The CMBLs of C2 domains coordinate calcium ions using their conserved Asp 
side-chain carboxyl groups in combination with several backbone carbonyl groups.  The 
coordination ligand environment is oxygen based.  The calcium binding properties of C2 
domain is proposed to regulate C2 function in three ways: (1) modulation of the 
electrostatic potential of C2 domain by neutralizing the negative charges at the loop 
region, i.e., an electrostatic switch;
67
 (2) provision of a potential bridge with the lipid 
headgroups during membrane association
68
 and (3) initiation of large conformational 
changes in the host enzyme presumably by destabilizing the intramolecular 
interactions.
33,65,69
  Another important metal-coordination related aspect of C2 domains 
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is that it is one of the molecular targets for heavy metal toxicity in the cell, with 
representative evidences for C2A domain from synaptotagmin-I
70
 and C2 domain from 
PKCα71,72 as targets for lead toxicity. 
The C2 domain together with C1 domain from PKC were the first described 
conditional peripheral membrane protein domains.
59
  Numerous studies have provided 
insights into the mechanisms of C2 membrane binding.  As mentioned previously, the 
C2 domain interacts with PtdSer-containing membrane in a calcium dependent manner, 
with LRC rendering a PtdIns(4,5)P2 specificity for the plasma membrane.  However, it 
was suggested that the electrostatic switch mechanism does not fully explain the 
membrane binding behavior of C2 since CMBL mutations that increase the electrostatic 
potential decreased the membrane binding affinity of PKCβII.73  On the other hand, the 
“bridging” mechanism is only supported by the crystal structure of C2 in complex with 
calcium and a PtdSer analog.  Further investigation is needed to elucidate the molecular 
mechanism of C2 membrane interactions, and relate the two electrostatic switch and 
“bridging” mechanisms.  
 
Organization of dissertation 
In this dissertation, I further address the mechanisms regulating PKC activity 
with a focus on acquiring structural and dynamic information about the ligand binding, 
intramolecular and intermolecular interactions involving the C-terminal V5 domain and 
the C2 regulatory domain.  Given the functional importance of and sparse structural 
information about the C-terminal V5 domain of PKC, our main question is centered on 
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this highly variable V5 domain, with the C2 regulatory domain as a starting point to 
address the interplay between V5 domain and other PKC regulatory domains.  
Furthermore, I address questions about the role of the V5 domain in the down-regulation 
of conventional PKC.  The calcium dependent membrane binding mechanism of C2 
regulatory domain is also investigated. 
Specifically, in Chapter II, I address the intrinsically disordered nature of the 
isolated C-terminal V5 domain from PKCα.  In addition, an unexpected membrane 
interacting propensity of V5 domain is also investigated.  In Chapter III, I study the 
intramolecular interaction between V5 and C2 domains with both structural and 
functional approaches.  In Chapter IV, I examine the intermolecular interaction between 
V5 domain and the peptidyl-prolyl isomerase Pin1.  A “divide-and-conquer” strategy is 
used to demonstrate the specific interaction mode.  In Chapter V, metal coordination of 
the C2 domain is related to the membrane interaction mechanism using cadmium as a 
calcium surrogate.  The weak binding of a third calcium ion to C2 domain is also 
investigated.  The last chapter summarizes the results and suggests further studies to 
understand PKC regulations involving the C-terminal V5 domain. 
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CHAPTER II  
THE C-TERMINAL V5 DOMAIN IS INTRINSICALLY DISORDERED AND HAS 
MEMBRANE ASSOCIATING PROPENSITY
*
  
 
Background 
In order to develop therapeutic strategies for diseases involving PKCs, the first 
step is to achieve modulation of PKC activity in an isoform-specific manner. This is one 
of the current challenges in the PKC field.
74,75
  A promising target for this purpose is the 
most C-terminal region of PKCs comprising 60-80 amino acids, due to its variability.
76-
80
  In this chapter, we describe the experiments designed for (i) the first solution-state 
characterization of the C-terminal region from PKCα; (ii) probing the conformational 
differences between the unphosphorylated sequence and a phosphorylation-mimicking 
variant; (iii) investigating the potential membrane associating propensity with two 
different membrane mimetics. 
The most C-terminal region of PKCs is termed the “Variable 5”, or V5 domain. 
This domain contains two highly conserved turn and hydrophobic phosphorylation 
motifs, while the extreme C-terminal residues beyond the hydrophobic motif are the 
least conserved sequence both in length and amino acid composition among all PKC 
isozymes (Figure 7B).  Analysis of the existing literature prior to this study suggests that 
V5 plays multiple roles within its parent protein:  
                                                 
*
 Reproduced with permission from: Yuan Yang and Tatyana I. Igumenova. The C-terminal V5 
domain of protein kinase Cα is intrinsically disordered, with propensity to associate with a 
membrane mimetic. PLoS ONE 8(6): e65699 Copyright: © 2013 Yang, Igumenova. 
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(i) it serves as a docking site for the upstream phosphoinositide-dependent kinase-
1(PDK-1) to initiate the maturation process of newly-synthesized kinase
24,32
; (ii) the two 
phosphorylation events of V5 domain are required for the catalytic competency and 
thermal stability;
30,81
 (iii) it participates in the auto-inhibitory interactions for the latent 
conformation of the enzyme;
23,47,75,82
 and (iv) it mediates sub-cellular localization of 
different PKC isoforms by interacting with the isoform-specific adaptor proteins, 
receptors for activated C kinases (RACKs).
49
  
Newly synthesized (“immature”) PKC partitions into an unidentified membrane 
cellular compartment, from which it is released into cytosol upon completion of three 
ordered phosphorylation events.
24
 This is necessary for the conventional PKC isoforms 
to reach their full catalytic competence, or maturity.
83
  The first phosphorylation, 
catalyzed by phosphoinositide-dependent kinase, PDK-1, occurs at a conserved Thr 
residue on the activation loop that is located at the C-lobe of the kinase core.  However, 
V5 likely serves as an interaction site between the newly synthesized PKC and PDK-1.
32
  
Two other phosphorylation sites among the three belong to the V5 domain and include 
the Thr residue of the turn motif (TM) and the Ser residue of the hydrophobic motif 
(HM) in the case of PKCα and PKCβI/II, as shown in Figure 7B.  Both of these 
phosphorylation reactions occur after V5 is released from PDK-1.
32
  The identity of the 
kinase(s) responsible for the V5 phosphorylation is still under debate.  Experimental 
evidence supports the essential role of mTORC2 (mammalian target of rapamycin 
complex 2) in the phosphorylation of the TM for conventional and novel PKCs
84,85
 and 
auto-phosphorylation of the HM for conventional PKC.
86
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Figure 7. V5 domain is a variable C-terminal region of PKCs.  (A) Linear diagram 
of conventional PKC isoforms illustrating the multi-modular structure of the enzyme.  
(B) Alignment of V5 primary structures of PKC isoforms from M. musculus.  The 
conserved NFD motif is highlighted in gray; HM and TM motifs are boxed.  The 
Ser/Thr residue of the HM is a Glu residue (blue) in atypical isoforms.  (C) Catalytic 
domain (residues 339-679) taken from the crystal structure of the PKCβII 
“intermediate”, PDB ID 3PFQ.  The B-factors of backbone atoms are mapped onto the 
structure as a color gradient.  The N-/C-lobes of the kinase domain and V5 are shown 
with transparent and opaque representations, respectively.  (D) Circular dichroism 
spectra of micelle-free wtV5α and dmV5α domains. 
 
 24 
 
Despite the pivotal role of V5 in the maturation and regulation of the parent 
enzymes, little is known about its structure in the extended conformation of PKCs that is 
associated either with immature (i.e. un-phosphorylated) or with activated kinase 
(mature and membrane-bound).  The existing structural information about V5 domains 
comes exclusively from crystal structures of five isolated catalytic domains
87-91
 and of 
PKCβII that represents an intermediate state in the activation process.23  All crystal 
structures are of mature, fully-phosphorylated protein species. In some structures, the 
elctron density of the V5 domain is either missing or poorly defined.
89-91
  In others,
23,87,88
 
the V5 domain wraps around the N-lobe of the kinase sub-domain, as shown in Figure 
7C. Even in those structures, the B-factors of the V5 region are significantly elevated 
comparing to other regions pf the protein. This indicates that V5 domain has certain 
degree of either static or dynamic disorder (Figure 8). 
In this work, we seek to understand the conformational preferences of the V5 
domain from PKCα, a conventional PKC isoform. The obtained structural information 
enabled us to evaluate the effect of negative charges introduced into V5 upon the 
phosphorylation of TM and HM, and to assess the extent of the V5 conformational 
changes during maturation process. Unexpectedly, we found that V5 associates with 
micelles serving as a membrane mimetic. The domain acquires partial helical structure 
upon association with micelles. In order to assess the strength of interaction and 
relevance to physiological lipid bilayer, we also used large unilamellar vesicles (LUV) 
as a membrane mimetic. We incorporated paramagnetic components into the LUVs as 
sensitive probes for interaction by NMR.           
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Figure 8. The B-factors of Cα atoms extracted from the crystal structures of 
isolated PKCβII catalytic domain (2I0E88) and the PKCβII intermediate 
(3PFQ
23
).  The residues corresponding to the C-terminal V5 domain (609-669) are 
shaded.  V5 has elevated B-factors in both structures, indicating some degree of either 
static or dynamic disorder. 
 
 
 
Experimental procedures 
Materials 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3- phospho-L-serine (POPS), L-α-phosphatidylinositol-4,5-
bisphosphate (Brain, Porcine) (ammonium salt) (brain PtdIns(4,5)P2) and 1-palmitoyl-2-
stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (5-Doxyl PC) were obtained from 
Avanti Polar Lipids (Alabaster, AL).  
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Preparation of V5α samples 
V5α (residues 606–672 of Protein Kinase Cα, M. musculus) was cloned into a 
pET31b(+) vector (Novagen) as a C-terminal fusion with ketosteroid isomerase (KSI) 
using the following protocol.  A codon-optimized DNA sequence of V5α in a pUC57 
vector was obtained from Genscript.  Two identical AlwNI restriction sites with Met 
codons, 5’-CAGATGCTG-V5α-CAGATGCTG-3’, were engineered into the sequence.  
In addition, C619S mutation was introduced into the gene to prevent V5α dimerization 
via the formation of disulfide bonds.  The source plasmid, pUC57, was digested with the 
AlwNI restriction enzyme (NEB) at 37 °C for 4 hours.  The DNA fragment containing 
V5α was purified from the 2% agarose gel using the Gel Extraction Kit (Qiagen).  The 
target vector, pET31b(+), was linearized by treatment with AlwNI restriction enzyme at 
37 °C for 4 hours and dephosphorylated with alkaline phosphatase (NEB).  The V5α 
DNA insert was ligated into the pET31b(+) vector using T4 DNA ligase (NEB).  As a 
result, the V5α sequence was placed downstream of the 125 amino acids KSI gene and 
upstream of a His•tag sequence. QuikChangeTM protocol (Agilent Technologies) was 
used to (i) delete three extra nucleotides from each AlwNI restriction site; and (ii) 
introduce the phosphorylation-mimicking T638E/S657E mutations into the newly 
constructed wtV5α plasmid. In this manuscript, we refer to the T638E/S657E mutant as 
dmV5α. 
The fusion proteins KSI–(wtV5α or dmV5α)–His•tag, with KSI, V5α, and 
His•tag separated by Met residues, were expressed in BL21(DE3) pLysS E. coli cells.  
For natural abundance preparations, the expression was induced by adding isopropyl β-
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D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.5 mM to the cell cultures 
at OD600 of 0.5.  The induction period was 5 hours at 37 °C.  For uniformly [
15
N, 
13
C] (or 
[
15
N]-enriched) proteins, we used the re-suspension method of Marley et al.
92
 with M9 
minimal media containing 3 g/L of [
13
C-6]-D-glucose (or natural abundance glucose) 
and 1 g/L of 
15
NH4Cl (Cambridge Isotopes).  In this case, the protein expression was 
induced for 4 hours at 37 °C. 
The cells were harvested by centrifugation (30 min, 4,000 rpm at 4 °C) and lysed 
by sonication in a buffer containing 20 mM Tris-HCl, 0.5 M NaCl, and 5 mM imidazole 
at pH 7.9 (Buffer A).  The inclusion bodies containing KSI-V5-His•tag fusion protein 
were pelleted by centrifugation (15 min at 14,000 rpm, 4°C) and washed once with 1 M 
urea in Buffer A.  The pellet was then solubilized in Buffer B (8 M urea dissolved in 
Buffer A) and incubated with Ni-Sepharose resin (GE Healthcare) for 1 hour at room 
temperature.  The resin was washed four times with 16 mM imidazole in Buffer B, 
followed by the elution of the fusion protein by 300 mM imidazole in the same buffer. 
The eluted fraction was acidified by adding HCl to a final concentration of 0.5 
M.  The fusion protein was cleaved at Met residues with CNBr (Acros Organics).  CNBr 
was dissolved in acetonitrile and added to the acidified fusion protein to obtain a ~100-
fold molar excess.  The reaction was carried out in the dark under N2 at room 
temperature with constant stirring.  After 18 hours, the solvent was removed from the 
reaction mixture using a rotary evaporator at 28 °C.  The solid residue containing the 
target protein was dissolved in deionized water and neutralized with 10 M KOH.  The 
mixture contained V5α, its fusion partner KSI, His•tag, and un-cleaved fusion protein.  
 28 
 
All species containing a His•tag moiety were removed from solution by an extra 
incubation step with Ni-Sepharose resin. 
To remove urea, the protein solution was dialyzed into a buffer containing 20 
mM Tris-HCl and 0.1 mM EDTA at pH 7.0.  The precipitated KSI was spun down at 
8,000 rpm for 10 min at 4 °C.  The supernatant containing V5α was further purified on a 
HiTrap Q HP anion exchange column (GE Healthcare) using a linear gradient from 0 to 
0.4 M NaCl.  The purified V5α protein was dialyzed into deionized water, freeze-dried, 
and stored at –80 °C.  Molecular weights of wtV5α and dmV5α were verified by 
MALDI-TOF mass spectrometry. 
Protein stock solutions were prepared by dissolving lyophilized V5α in the NMR 
buffer containing 20 mM MES at pH 6.0, 100 mM KCl, 8% D2O, and 0.02% NaN3.  The 
protein concentration was determined using the bicinchoninic acid protein assay reagent 
(Thermo Scientific Pierce) with Bovine Serum Albumin (Sigma-Aldrich) as a standard.  
NMR samples were prepared by diluting the stock solutions to 250 μM [U-13C,15N] 
enriched V5α and [U-15N] enriched V5α for assignment and relaxation experiments, 
respectively. 
Natural abundance n-dodecylphosphocholine (DPC) and [U-
2
H38, 98%] DPC 
were purchased from Avanti Polar Lipids and Cambridge Isotopes, respectively.  
Aliquots of DPC stock solutions in chloroform were dried under a slow stream of N2 gas 
and then under vacuum for 2 hours.  The DPC film was re-suspended in NMR buffer by 
vortexing for 1 min to form a clear micelle solution.  The micelle and protein stock 
solutions were then mixed to produce a final concentration of 316 μM [U-13C,15N] V5α 
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and 100 mM DPC.  Natural abundance DPC and [U-
2
H38, 98%] DPC were used to 
prepare the wtV5α and dmV5α samples, respectively. 
 
Spectroscopy 
The circular dichroism spectra were collected using the Jasco J-815 CD 
instrument on samples containing either 10 μM V5α or 10 μM V5α/10 mM DPC, both in 
10 mM potassium phosphate buffer at pH 7.0. 
NMR experiments were performed on Varian spectrometers at magnetic field 
strengths of 11.7 Tesla or 14.1 Tesla, corresponding to the 
1
H Larmor frequencies of 500 
and 600 MHz, respectively.  The assignment of cross-peaks to the specific residues was 
carried out using the following triple-resonance NMR experiments: HNCACB
93
, 
CBCA(CO)NH
93
, HNCO
93
, HN(CA)CO
94
 (micelle-free sample only), and C(CO)NH
95
 
on the V5α samples uniformly enriched with 15N and 13C.  The NMR resonance 
assignments are deposited in BioMagResBank under accession numbers: 18927 
(wtV5α), 18928 (dmV5α), 18929 (micelle-associated wtV5α), and 18930 (micelle-
associated dmV5α).  The chemical shift perturbation Δ was calculated according to the 
following equation
96
: 
 
∆= [(∆𝛿𝐻)
2 + (0.152 × ∆𝛿𝑁)
2+(0.288 × ∆𝛿𝐶𝛼)
2 
(0.288 × ∆𝛿𝐶𝛽)
2 + (0.329 × ∆𝛿𝐶𝑂)
2]1/2 
2.1 
where ΔδH, ΔδN, ΔδCα, ΔδCβ, and ΔδCO are the chemical shift differences between the 
1
HN, 
15
N, 
13Cα, 13Cβ and 13CO nuclei.  In the conformational analysis of Pro-containing 
segments of V5α, the populations of cis- and trans- conformers were determined from 
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the peak intensities normalized to the combined intensity of all cross-peaks observed for 
a given residue. 
There are wtV5α/DPC and dmV5α/DPC residues that do not have a complete set 
of shifts for CSP analysis, and they are listed as following.  The missing chemical shifts 
are indicated in parentheses. wtV5α: Q611 (13CO), P612, P613 (1HN, 
15
N), K615 (
13
CO), 
P616 (
1
HN, 
15
N), G620 (
13Cβ), G622 (13Cβ), G633 (13Cβ), Q634 (13CO), P635 (1HN, 
15
N), 
T638 (
13
CO), P639, P640 (
1
HN, 
15
N), G655 (
13Cβ), N660 (13CO), P661 (1HN, 
15
N), F663 
(
13
CO), V664, H665, P666, I667 (
1
HN, 
15
N). dmV5α: Q611 (13CO), P612, P613 (1HN, 
15
N), K615 (
13
CO), P616 (
1
HN, 
15
N), G620 (
13Cβ), G622 (13Cβ), G633 (13Cβ), Q634 
(
13
CO), P635 (
1
HN, 
15
N), E638 (
13
CO), P639, P640 (
1
HN, 
15
N), G655 (
13Cβ), V659 (13Cα, 
13Cβ, 13CO), N660, P661 (1HN, 
15
N), Q662 (
13Cβ, 13CO), F663, V664, H665, P666, I667 
(
1
HN, 
15
N, 
13Cα, 13Cβ). 
Longitudinal relaxation rate constants (R1), transverse relaxation rate constants 
(R2), and {
1
H}-
15
N Nuclear Overhauser Enhancement (NOE) were measured for all 
spectrally resolved N-H groups of wtV5α and dmV5α using standard method.97  The 
measurements were carried out at a magnetic field strength of 11.7 Tesla corresponding 
to the 
1
H Larmor frequency of 500 MHz. Twelve time points ranging from 0.008 to 
0.200 s (R2) and 0.020 to 0.700 s (R1) were collected, three of which were duplicates.  
The NOE data were acquired in an interleaved manner, with a 3 s saturation period and a 
5 s recycle delay.  Cross-peak intensities were used to quantify relaxation, and the 
uncertainties of these intensities were estimated either from the root-mean-square noise 
level of the base plane (NOE) or from the duplicate measurements (R1 and R2).  The 
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reduced
98,99
 spectral density mapping
100,101
 approach was used to calculate the values of 
spectral density at 0, N, 0.87H, and 0.92H MHz.  N = 50 MHz and H = 500 MHz 
are the 
15
N and 
1
H Larmor frequencies, respectively. 
 
Interaction of wtV5α with membranes probed by paramagnetic relaxation enhancement 
with NMR spectroscopy 
To determine if V5α interacts with bilayer type of membrane mimetics, we used 
paramagnetic nitroxyl radical group doxyl covalently modified at 5-carbon position of 
POPC (5-doxyl-PC) incorporated into LUVs, as well as Mn(II) coated PtdSer containing 
LUVs.  The doxyl-LUVs were made by mixing lipid stocks to homogeneity of 
POPC:POPS:PtdIns(4,5)P2:5-doxyl-PC in a molar ratio of  88.5:10:1:0.5. The 
diamagnetic control sample contained separately prepared LUVs with 
POPC:POPS:PtdIns(4,5)P2 (89:10:1). Total lipid concentrations in NMR samples were 
20mM.  For the Mn(II) coated LUVs, MnCl2 stock solution was added to the 
diamagnetic LUV containing sample to a final concentration of 0.4mM. Since total 
concentration of POPS and PtdIns(4,5)P2 components was 2.2mM, all Mn
2+
 ions were 
associated with LUVs in the sample.  For the control sample in which Mn
2+
 was directly 
added to V5 in the absence of LUVs, final Mn
2+
 concentration was 35μM.  Protein 
concentrations of wtV5α used in all samples were 140μM.   
The 
1
H transverse paramagnetic relaxation enhancement experiments were 
measured as Γ2 rates with methods from Iwahara et al..
102
  Experiments were performed 
on Bruker AvanceIII spectrometer equipped with a cryogenic probe at magnetic field 
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strengths of 14.1 Tesla, corresponding to the 
1
H Larmor frequencies of 600 MHz. The Γ2 
rates are calculated for each residue according to the following equation: 
 𝛤2 = 𝑅2,𝑝𝑎𝑟𝑎 −  𝑅2,𝑑𝑖𝑎 2.2 
where the paramagnetic (R2,para) and diamagnetic (R2,dia) states were measured with the 
pairs of two samples containing the paramagnetic 5-doxyl-PC LUVs or Mn(II) coated 
LUVs and the diamagnetic LUVs, respectively. The relaxation delay ΔT was optimized 
to be 40ms by minimizing the error of Γ2 rates as described in Iwahara et al..
102
    
 
Results 
Recombinant V5α can be prepared in quantities sufficient for structural work 
Structural studies using NMR spectroscopy require milligram quantities of highly 
purified isotopically enriched proteins.  Heterologous expression of the full-length 67-
residue V5α by itself or with soluble fusion partners in E. coli produced a protein that 
was either un-inducible or severely proteolyzed.  Therefore, we directed the expression 
of V5α into inclusion bodies using the approach pioneered by Walsh’s laboratory.103  
The codon-optimized DNA sequence corresponding to the polypeptide sequence of V5 
domain from PKCα (M. musculus and identical in H. sapiens) was cloned as a fusion 
with ketosteroid isomerase (KSI) gene into a pET31b(+) expression vector, in which Met 
codons are inserted between the KSI, the V5 gene, and the (His)6 cassette.  The fusion 
protein was extracted from the inclusion bodies, purified using Ni-NTA affinity resin, 
and cleaved with CNBr.  V5 was separated from KSI using dialysis against an aqueous 
buffer solution and subsequently purified using anion-exchange chromatography.  We 
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obtained ~6-12 mg of >95% pure protein per 1 Liter of cell culture, depending on the 
expression medium.  The detailed expression and purification protocol is given in 
Experimental procedures (vide supra). 
We prepared two variants of V5: one is the unphosphorylated construct named 
wild type (wtV5α) and the other is a double mutant mimicking the fully phosphorylated 
state (dmV5α).  The C619S mutation was introduced into both constructs to prevent 
carbamylation of the Cys residue under the acidic conditions of the CNBr cleavage 
reaction.  The dmV5α contains two mutations: T638E and S657E, where the Glu residue 
at each position mimics the phosphorylated states of TM and HM (see Figure 7B).  
These or equivalent phosphorylation-mimicking mutations were shown to preserve the 
catalytic competency of both PKCα104,105 and PKCβII.30,31 
 
V5α is intrinsically disordered with a propensity to form α-helical and β structures 
We first used circular dichroism (CD) spectroscopy to evaluate the 
conformational preferences of the V5α variants.  The spectra shown in Figure 7D are 
essentially identical for the wtV5α and dmV5α, indicating that the introduction of two 
negative charges at the TM and HM does not appreciably influence the secondary 
structure content of the domain.  The spectra have a pronounced minimum at 200 nm 
that is typical for intrinsically disordered proteins.
106,107
  There is also a small shoulder at 
230 nm suggesting that V5α may have some secondary structure content.  Estimation of 
the secondary structure by the CONTIN
108,109
 software package revealed 4.0% and 8.9% 
content of the regular α-helical and β-structures, respectively, for wtV5α. The estimated 
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secondary structure convents are 4.1% and 9.2% of the regular α-helical and β-
structures, respectively, for dmV5α. One could see that the estimated secondary structure 
contents are also essentially identical between the two constructs. 
The 
15
N-
1
H hetero-nuclear single-quantum coherence (HSQC) spectra of the [U-
15
N] enriched V5α variants are superimposed in Figure 9A.  The cross-peaks in the 
spectra correspond to the amide 
15
N-
1
H groups of the protein backbone.  The assignment 
of cross-peaks to the specific residues was carried out using the triple-resonance NMR 
experiments on the V5α samples uniformly enriched with 15N and 13C as described in the 
Experimental procedures.  The HSQC spectra of Figure 9A are characterized by small 
chemical shift dispersion in the amide 
1
H region from 7.8 to 8.6 ppm, which is a 
spectroscopic signature of intrinsically disordered proteins.
110
  To evaluate the influence 
of phosphorylation-mimicking mutations, we carried out a chemical shift perturbation 
(CSP) analysis for the dmV5α-wtV5α pair using the 1HN, 
15
N, 
13
CO, 
13Cα, and 13Cβ 
chemical shifts.  Significant perturbations are observed at the mutation sites, Ser657 and 
Thr638, due to the change in amino acid identities.  In addition, the residues adjacent to 
the phosphorylation-mimicking mutations experienced minor chemical shift changes.  
We attribute those to the changes in the local electrostatic environment caused by the 
introduction of two negative charges at the TM and HM. 
To evaluate the conformational preferences of V5 variants, we calculated 
secondary structure propensity (SSP) scores
111
 using the Cα and Cβ chemical shifts 
(Figure 9C).  The sign and magnitude of SSP scores, which range from -1 to +1, reflect 
the propensity of a given residue in the polypeptide to form β- or α-structures.   
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Figure 9.  Conformational preferences and sub-nanosecond dynamics of wtV5α 
and dmV5α.  (A) Overlay of the 15N-1H HSQC spectra of wtV5α (black) and dmV5α 
(green).  The asterisks indicate the mutation sites, Thr638 (TM) and Ser657 (HM).  
HS673 stands for homoserine lactone, which is the C-terminal residue generated upon 
CNBr cleavage of the (His)6-tag from V5α.  (B) Chemical shift perturbation analysis 
of the dmV5α-wtV5α pair.  Purple vertical lines mark the mutation sites; the NFD 
motif is shaded.  (C) SSP scores plotted as a function of the primary structure.  The 
secondary structure elements of the V5 domain in the structure of the catalytic domain 
from PKCα (PDB ID 3IW4) are shown for comparison.  (D) Comparison of the 
hetero-nuclear {
1
H} -
15N NOE values obtained for wtV5α (black) and dmV5α (green).  
The NOE values and their difference are plotted against the V5 primary structure in 
the top and bottom panels, respectively. 
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The SSP scores vary significantly across the V5α domain.  The N-terminal quarter of 
both V5α variants has a rather high propensity to form β-structures, with a minimum 
SSP score reaching -0.43.  A region with weak α-helical propensity that contains a 
conserved NFD motif follows the β segment.  In three crystal structures of PKC catalytic 
domains, the NFD motif forms part of the 8-12 residue helical region.  The interaction 
partners of the NFD motif in the crystalline state vary depending on the PKC 
isoform/construct and include the adenine ring of ATP (catalytic domain of PKCι in 
complex with ATP, 3A8W
87
), the N-terminal lobe of the kinase (catalytic domain of 
PKCβII, 2I0E88), and the regulatory C1B domain (PKCβII intermediate, 3PFQ23).  
Another V5α segment with weak α-helical propensity is located between the TM and 
HM, which are marked with purple lines in Figure 9B-D.  The secondary structure 
elements of V5α taken from the crystal structure of the catalytic domain of PKCα (PDB 
ID 3IW4
91
) are plotted on the SSP graph.  In this crystal structure, most of V5α is 
unstructured, and the segment preceding the NFD motif is missing.  However, there are 
two short helical regions between the TM and HM that correlate with our positive SSP 
scores.  Taken together, these data suggest that the association of V5α with the N-
terminal lobe of the kinase domain during the final step of maturation may include both 
“conformational selection” and “folding upon binding” mechanisms.112 
To assess the conformational flexibility of the V5α backbone, we measured three 
relaxation parameters: longitudinal relaxation rate constants (R1), transverse relaxation 
rate constants (R2), and {
1
H}-
15
N Nuclear Overhauser Enhancement (NOE) for all 
spectrally resolved N-H groups (Figure 9 and Figure 10).  As shown in Figure 9D, the 
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NOE values are negative throughout most of the primary structure.  The negative NOE 
values indicate a large contribution of high frequency, i.e. sub-nanosecond, motions to 
the dynamics of the V5 backbone.  The NOE profile of V5 is non-uniform with lower 
values for the N- and C-termini, and higher values for the short N-terminal segment with 
high β-structure propensity; the region following the NFD motif; the region upstream of 
the TM; and the HM.  Overall, there is moderate correlation between the regions of 
lower conformational flexibility, manifested in elevated NOE values, and the regions 
with a propensity to form secondary structure.  The NOE difference graph of Figure 9D 
shows that phosphorylation-mimicking mutations increase the conformational flexibility 
of V5 at the N- and C-termini, as well as between the TM and HM. 
To determine the relative contribution of high- and low-frequency motions to the 
V5 dynamics, we carried out the reduced
98,99
 spectral density mapping
100,101
 analysis of 
the relaxation data (Figure 11).  The contributions of high-frequency components are 
reflected in two spectral density values, J(435 MHz) and J(460 MHz).  Both values are 
rather uniform throughout the V5 backbone but increase towards the N- and C-termini.  
The contributions of low-frequency motions are reflected in the J(0) and  
J(50 MHz) terms that show moderate variations across most of the V5 backbone but 
decrease significantly towards the terminal regions.  Overall, the relative average values 
of spectral densities for both V5 variants are given by J(0):J(ωN):J(0.87ωH):J(0.92ωH) 
=17:9:1:1.  These data are consistent with an extended spectral density frequency profile 
characteristic of unstructured proteins
113
, in which the values of low- and high-frequency 
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components are smaller and larger, respectively, than those of globular proteins of 
comparable size
98
.  The extended spectral density profile, along with the low average 
values of J(0) (0.60 ns for wtV5α and 0.55 ns for dmV5α), indicate that N-H groups in 
V5α undergo large-amplitude motions.114 
 
 
 
 
 
 
Figure 10.  (A) R1 and (B) R2 relaxation rate constants versus the primary 
structure of V5α.  The NFD motif is shaded.  The hydrophobic motif (HM) and turn 
motif (TM) are marked with purple lines. 
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Figure 11.  (A) J(0), (B) J(50 MHz), (C) J(435 MHz), and (D) J(460 MHz) versus 
the primary structure of V5α.  The NFD motif is shaded.  The hydrophobic motif 
(HM) and turn motif (TM) are marked with purple lines. 
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In summary, high-frequency large-amplitude motions dominate the backbone 
dynamics of both V5α variants.  Regions with weak propensity towards α-helical 
structure formation, such as the region upstream of the NFD motif and the TM-HM 
segment, show a higher degree of motional restriction than the rest of the protein 
residues.  Phosphorylation-mimicking mutations increase the conformational flexibility 
of V5α in the region between the TM and HM, and at the N- and C-termini. 
 
V5α samples multiple conformations due to cis-trans isomerization of the peptidyl-prolyl 
bonds 
The 
15
N-
1H HSQC spectra of both wtV5α and dmV5α showed a subset of cross-
peaks with minor intensities.  We were able to assign these peaks using three-
dimensional NMR experiments.  These peaks correspond to the residues that bracket 
specific prolines in the primary structure of V5α.  Given that our V5α preparations are 
homogeneous, we concluded that both wtV5α and dmV5α sample multiple 
conformations due to the cis-trans isomerization of Xaa-Pro bonds, where Xaa is the 
preceding amino acid.  These conformations are in slow exchange on the NMR chemical 
shift timescale.  A distinct spectroscopic signature of trans- and cis- conformations of the 
Xaa-Pro bonds is the difference between Pro Cβ and Cγ chemical shifts, Δ(Cβ-Cγ): 4.5 ± 
1.2 ppm and 9.6 ± 1.3 ppm, respectively.
115
  This is most conveniently detected in the 
15
N strips of the three-dimensional C(CO)NH spectra that correlate the chemical shifts of 
the N-H amide group of the residue following Pro to the 
13
C resonances of the Pro 
sidechain.   
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Figure 12.  Cis-trans isomerization of Pro residues modulates the conformation 
of V5α.  (A) The C(CO)NH strip plots of the F614 and V636 1H-15N amide planes 
showing the characteristic spectroscopic pattern of cis- and trans- Pro
612
-Pro
613
 and 
Gln
634
-Pro
635
 peptide bonds.  (B)-(D) Fractional populations of the V5α species 
having one Xaa-Pro bond in cis-conformation.  Isomerizing Pro residues are 
highlighted in orange.  The wtV5α and dmV5α data are shown in black and green, 
respectively.  The position of Pro residues is indicated with arrows.  Residues with 
quantifiable populations are underlined.  In (C), the mutation site T638E is 
highlighted in red.  The data for the turn motif Thr(Glu)
638
-Pro
639
-Pro
640
 are shown 
with filled bars. 
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Representative data are shown in Figure 12A for the cis- and trans-conformations of 
P613 and P635. 
V5α has a total of eight Pro residues highlighted in Figure 12B-D.  We 
determined that six of them are either involved in (P612, P613, P635, P639, and P666) 
or influenced by (P640) the cis-trans isomerization processes.  For the two isolated Pro 
residues, P635 and P666, the most abundant conformers with a population of ≳ 90% 
correspond to the trans Gln
634
-Pro
635
 and His
665
-Pro
666
 peptide bonds.  The average 
populations of cis-conformers are 9 (10)% and 8 (8)%, for the wtV5α (dmV5α), 
respectively.  The data for individual residues are given in Figure 12C and Figure 12D. 
The other four prolines occur as consecutive proline pairs, Pro
612
-Pro
613
 and 
Pro
639
-Pro
640
.  Each pair could potentially give rise to four possible conformations due to 
cis-trans isomerization.  We identified a total of three sets of cross-peaks for the residues 
that bracket the Pro
612
-Pro
613
 segment.  Based on the Δ(Cβ-Cγ) values of P613, they 
correspond to the trans-, cis-, and trans- conformations of the Pro
612
-Pro
613
 peptide bond, 
with the populations of the latter two given in Figure 12B.  The isomerization state of 
Gln
611
-Pro
612
 cannot be determined directly because Pro
613
 does not have an N-H group.  
However, extensive thermodynamic data on unstructured peptides
116
 suggest that the 
“cis-cis” conformation of Gln611-Pro612-Pro613 would be the least populated of the four 
possible conformations.  Therefore, we assigned the three V5α species to “trans-trans” 
(80%), “trans-cis” (12%), and “cis-trans” (8%) conformers of the Gln611-Pro612-Pro613 
segment; the populations are comparable in the wtV5α and dmV5α. 
 43 
 
In contrast to the Pro
612
-Pro
613
 pair, the conformational exchange behavior of the 
Pro
639
-Pro
640
 segment that immediately follows the turn motif, T638, differs between 
wtV5α and dmV5α.  In both V5α constructs, we identified two conformers: major and 
minor.  Based on the Δ(Cβ-Cγ) values of P640, both conformers have a trans Pro639-
Pro
640
 peptide bond.  Using the same thermodynamic considerations as above, we 
assigned the major conformer to the “trans-trans” and the minor conformer to the “cis-
trans” conformations of the Thr(Glu)638-Pro639-Pro640 segment.  The average population 
of the minor species increases from 8% in the wtV5α to 13% in the dmV5α (Figure 12C, 
right). 
The shift of the equilibrium towards the cis peptidyl-prolyl bond in the 
phosphorylation-mimicking variant is likely a property of the local amino acid context of 
V5 rather than a general consequence of introducing a negative charge.  Indeed, studies 
of model pentapeptides revealed that having Xaa = Glu instead of Thr does not alter the 
population of the cis Xaa-Pro bond, (9.0% versus 9.4% at pH6).
116
  In another peptide 
study, phosphorylation of the Thr residue slowed down the rate of cis-trans 
isomerization compared to that of the Thr-Pro, but did not produce a systematic change 
in the population of the cis-isomers.
117
  The conformational preferences of the Thr
638
-
Pro
639
 bond may play a role in the Pin1-mediated down-regulation of PKCα.  Pin1 is a 
peptidyl-prolyl isomerase that, according to the recently proposed model
45
, docks onto 
the hydrophobic motif of V5 and catalyzes the cis-trans isomerization of turn motif, 
pThr
638
-Pro
639
.  In this model, the trans conformer of the pThr
638
-Pro
639
 peptidyl-prolyl 
bond in the agonist-activated PKC is potentially more susceptible to dephosphorylation 
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and ubiquitin-mediated degradation than the cis conformer. Our NMR data provide 
direct evidence of the existing equilibrium between the cis- and trans- conformers of the 
turn motif in V5α.  Structural characterization of the Pin1-V5α complex is required to 
determine the molecular basis of V5α-Pin1 interaction and its dependence on the 
conformation of the pThr
638
-Pro
639
 bond. 
 
V5α binds to DPC micelles and acquires partial α-helical structure 
To determine the propensity of V5α to partition into membrane-mimicking 
hydrophobic environment, we conducted NMR experiments on both variants in the 
presence of dodecylphosphocholine (DPC) micelles.  DPC micelles were chosen as a 
membrane-mimicking medium because it worked well for the two peripheral membrane 
domains of PKCα, C1B38,118 and C2.119  Unexpectedly, the NMR HSQC spectrum of 
wtV5α changed dramatically upon addition of DPC micelles (Figure 13A), resulting in 
significant cross-peak shifts for all but the most N-terminal amino acids.  The changes in 
cross-peak positions are accompanied by changes in the peak line-widths, indicating that 
wtV5α binds to the micelles.   
The same pattern of spectral changes was observed for dmV5α, as shown in 
Figure 14A.  The backbone resonances of wtV5α and dmV5α complexed to DPC 
micelles were then assigned using triple-resonance NMR experiments and subjected to 
CSP analysis using the DPC-free chemical shifts as references.  The residue-specific Δ 
values of wtV5α (Figure 13B) are small for the first 15 amino acids, up to the start of the 
NFD motif at position 625.     
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Figure 13.  wtV5α associates with DPC micelles (DPCm) and acquires partial α-
helical structure.  (A) Overlay of the 
15
N-
1H HSQC spectra of wtV5α (black) and 
wtV5α/DPCm (red).  HS673 stands for homoserine lactone, which is the C-terminal 
residue generated upon CNBr cleavage of the (His)6-tag from V5α.  (B) Chemical 
shift perturbation analysis of the wtV5α/DPCm and wtV5α pair.  Residues having an 
incomplete set of chemical shifts are listed in Experimental Procedures.  (C) SSP 
scores plotted as a function of the primary structure.  (D) Circular dichroism spectra of 
wtV5α domains in the presence (red) and absence (black) of DPC micelles.  (E) 
Potential role of V5 as a membrane anchor.  Reg and Kin are the regulatory and 
kinase domains, respectively.  The regulatory domain comprises the tandem C1A and 
C1B domains, commonly referred to as C1, and the C2 domain.  PS stands for the 
pseudo-substrate region.  V5α is shown in red. 
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The chemical shifts of the NFD-containing region (residues 625-634) are significantly 
perturbed, as well as the region between the TM and HM.  Downstream of HM, Δ values 
increase further reaching the largest values at the C-terminus.  Two residues, 664 and 
665, are broadened beyond detection indicating a presence of a chemical exchange 
process that is intermediate on the NMR chemical shift timescale. 
Calculated SSP values of the micelle-associated wtV5α, calculated based on Cα 
and Cβ chemical shifts, are plotted against the primary structure in Figure 13C.  The 
micelle-free wtV5α data are also shown for comparison.  According to the SSP data 
analysis, V5α acquires higher propensity to form helical structures in two regions upon 
binding to DPC micelles.  The first region is the NFD motif, where the SSP score 
reaches a maximum value of 0.43.  The second region is the last one-third of the V5α 
domain starting from residue 649.  The helical propensity increases along the 
polypeptide backbone reaching the maximum of 0.83 at residue 667, and then decreases 
to 0.34 at the C-terminus.  Our findings are further corroborated by the circular 
dichroism data that we collected for both V5α variants in the presence of DPC micelles.  
The CD spectrum of micelle-bound wtV5α is overlaid with the DPC-free spectrum in 
Figure 13D.  The negative signal at 200nm becomes larger and shifted, indicating 
formation of more structured elements globally.  The shoulder region between 220 and 
230 nm becomes more prominent, indicating an increase in the helical structure content.  
Estimation by the CONTIN
108,109
 software package produces a ~two-fold increase in the 
regular α-helical structure content, from 4 to 9%, compared to the micelle-free wtV5α.   
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Figure 14.  dmV5α binds to DPC micelles (DPCm) and acquires partial α-helical 
structure.  (A) Overlay of the 
15
N-
1H HSQC spectra of dmV5α (green) and 
dmV5α/DPCm (blue) collected at 11.7 Tesla.  The DPC concentration is 100 mM.  
The cross-peaks are labeled according to the residue identity and number.  HS673 
stands for homoserine lactone, which is the C-terminal residue generated upon CNBr 
cleavage of the (His)6-tag from V5α.  (B) Chemical shift perturbation analysis of the 
dmV5α and dmV5α/DPCm pair.  Residues having an incomplete set of chemical 
shifts are listed in Experimental Procedures.  Purple vertical lines indicate the turn and 
hydrophobic motifs.  The NFD motif is shaded.  (C) SSP scores plotted as a function 
of the primary structure.  Compared to the micelle-free dmV5α, the helical propensity 
increases for the NFD motif and the surrounding region, the region between the TM 
and HM, and the most C-terminal amino acid stretch.  (D) CD spectra of dmV5α in 
the presence (blue) and absence (green) of DPC micelles. (E) Proposed model for 
activated PKCα interacting with PDZ domain containing signaling proteins. 
PtdIns(4,5)P2 and diacylglycerol (DAG) lipid molecules are as indicated in the insert. 
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The β-structure content remains unchanged for wtV5α.  Micelle-associated dmV5α 
shows a similar pattern of chemical shift perturbations, SSP scores, and CD spectrum 
(Figure 14). 
 
V5α interacts weakly with LUVs in two modes 
In light of our work with DPC micelles, we seek to understand if V5α would 
interact with bilayer type of membrane mimetics.  Liposomes are commonly used 
bilayer membrane mimetics, which mimics the basic environment of biological cellular 
membranes.  However, they are large in sizes and tumble significantly slower to be 
detectable using solution NMR methods.  For example, the LUVs we use have a size 
distribution centered at 100nm, which has an estimated molecular weight of >60.8MDa.  
Therefore, we reason that the crosspeaks of LUV-associated V5α will be broadened 
completely beyond detection. By comparing the 
15
N-
1H HSQC spectra of V5α in the 
absence and presence of LUVs (POPC/POPS/PIP2 89:10:1 molar ratio), there are no 
significant chemical shift changes on the V5α cross-peaks (Figure 15).  There are three 
possible scenarios associated with the identical chemical shifts: (1) there is no 
interaction between V5α and the LUVs; (2) there is interaction, but the exchange process 
between free V5α and an invisible “dark” state is slow in NMR chemical shift timescale; 
or (3) the exchange process can be fast or intermediate, with a very small population of 
LUV-bound V5α contributing to undetectable chemical shift perturbations.  
By measuring R2 values of the amide 
1
H both in the absence and presence of 
LUVs, we observe an overall increase of R2 by 0.32 ± 0.01 s
-1
 with the addition of LUVs 
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(Figure 16B).  This value of increase is small but significant, indicating a minor 
interaction.  This can be attributed to the relatively low concentration of LUVs (20mM 
lipids correspond to 2μM of liposomes) or a relatively low binding affinity.  By close 
inspection of the ΔR2 along the sequence (Figure 16B), there are regions that have 
decreased R2 values in the presence of LUVs, especially residues around the HM (644-
663).  This observation indicates a more complicated system than a simple two-state 
exchange between monomer V5α and LUV-bound V5α.  In the simple two-state 
exchange case, R2 is typically increased close to uniform across the protein sequence.
120
  
Since the average value of ΔR2 is overall <1 s
-1
, we could not use the dark-state 
saturation transfer based experiments to reliably probe residue-specific information 
about LUV interaction.
121
  Instead, we utilize paramagnetic relaxation enhancement 
(PRE) experiments to investigate this case.  PRE methods are sensitive for even low 
population of weak interactions.  We first use 5-doxyl-PC doped LUVs (see 
Experimental procedures), to probe the interaction between V5α and LUVs.  The 
resulting Γ2 rates (i.e. change in R2) by comparing the paramagnetic LUVs containing 
sample and the V5α only sample display a complex pattern (Figure 16C).  For example, 
the N-terminal region (residues 610-615) and the hydrophobic motif region (residues 
651-658) have slightly negative Γ2 rates, while most other residues have positive Γ2 
rates.  The positive Γ2 rates at NFD region (residues 623-631) and C-terminal region 
(residues 665-672) match well with the micelle-induced association (Figure 16A, C). 
The overall average Γ2 value is 0.14 ± 0.16 s
-1
.  This small Γ2 value is probably due to 
that the binding interface between LUVs and V5α is restricted to the headgroup region.   
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Figure 15.  HSQC spectral overlay of wtV5α without (red) and with (black) the 
addition of bilayer membrane mimetic LUVs. The lipid components of the LUVs 
used are POPC, POPS, and PIP2 with a ratio of 89:10:1. Total lipid concentration was 
20mM. Backbone resonance identities are labeled next to the cross-peaks or with a 
line directing the labels.   
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Figure 16.  wtV5α interaction with LUVs probed by 5-doxyl-PC induced PRE.  
(A) SSP scores plotted as a function of the primary structure of the wtV5α/DPC 
micelles and wtV5α experiments.  (B) The calculated ΔR2 of wtV5α in the presence 
and absence of LUVs. (C) Γ2 rates induced by paramagnetic doxyl-LUV. The 
reference is wtV5α only sample.    
 
 
 
The amino acid composition of V5α is largely charged with some scattered hydrophobic 
residues, displaying amphiphilic properties.  In other words, all interacting V5α residues 
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are probably far away from the hydrophobic core of LUVs where the doxyl groups are 
located.  This could explain the relatively small Γ2 values induced by the doxyl-LUVs.  
In order to further investigate the potential interaction of V5α with the headgroup 
region of LUVs, we use Mn(II)-coated LUVs.
122
  It was previously shown that when 
negatively charged lipids are incorporated into LUVs, sub-stoichiometric Mn
2+
 ions 
spontaneously coat the surface of LUVs with relatively high affinity.
122
  By using the 
Mn(II)-coated LUVs, we observe large positive Γ2 rates for the NFD region and the HM 
region in which helical conformation was induced upon micelle binding (Figure 17).  
We then added Mn
2+
 to V5α in the absence of LUVs, to look at broadening due to direct 
Mn
2+
 binding instead of Mn(II)-coated LUV interactions.  This is illustrated in Figure 
17, where NFD region is not broadened by solution Mn
2+
 ions. HM region is broadened 
by solution Mn
2+
 ions, but a different set of residues are affected when comparing to the 
Mn(II)-coated LUV experiment (Figure 17C, D). This indicates that the HM region 
broadened by Mn(II)-coated LUV is a result of membrane binding, instead of simply 
metal binding to the negatively charged HM residues. 
From the above data, we conclude that V5α also interacts with bilayer membrane 
mimetics.  The interaction between V5α and LUVs is probably weak but significant.  
The regions affected by interaction with LUVs are overall similar to those affected by 
DPC micelles, but the effect was more pronounced with micelles than LUVs.  This is 
likely due to the more exposed hydrophobic environment of micelles compared to the 
well-packed bilayer of LUVs.   
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Figure 17.  wtV5α interaction with bilayer membrane LUVs probed by Mn2+ 
induced PRE.  (A) Chemical shift perturbation analysis of the wtV5α/DPCm and 
wtV5α pair.  (B) SSP scores plotted as a function of the primary structure.  (C) Γ2 
rates which reports on PRE induced by Mn(II)-coating of LUV. The reference is 
diamagnetic LUV containing sample.  (D) Γ2 rates which reports on PRE induced by 
Mn
2+
 ions in solution. The reference is wtV5α sample in the absence of metal.   
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Interestingly, we observed a slowly formed conformation of V5α, when checking 
the LUV added samples in a period of 22 hours (Figure 18). This slowly induced change 
of an intrinsically disordered region or a disordered peptide upon membrane interaction 
has been observed previously, with noted examples for membrane penetrating peptides 
forming pores
123
 and Aβ peptide aggregation induced by membrane binding.124 
 
Discussion of results 
Immature, or newly synthesized, PKC is not phosphorylated.  It has been shown 
that immature PKC partitions some into the detergent-soluble membrane fraction of the 
cell
24
 and loosely associates with the membrane; the nature of the membrane 
compartment (internal membranes or plasma membrane) is not known.  The current 
thinking in the field is that immature PKC is tethered to the membranes via the pseudo- 
substrate region
125
 and weak cofactor-free interactions of the C1 and C2 domains.
83
  
Together, these domains make up the entire N-terminal half of the enzyme, as shown in 
Figure 7A.  The propensity of wtV5α to partition into the hydrophobic membrane-
mimicking environment suggests that it can potentially serve as a membrane anchor in 
immature PKCα, as illustrated in our model (Figure 13E).  In this model, not only the N- 
terminal regulatory domain and the pseudo-substrate regions are tethered to the 
membrane, but also the V5 domain, which provides the anchoring point at the C 
terminus of the enzyme.  The binding affinity is probably weak, as illustrated with our 
LUV experiments.  
. 
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Figure 18.  HSQC spectral overlay of wtV5α with the addition of LUVs (black) 
and after incubation. The 22hrs spectrum (cyan) was acquired after 22 hours 
incubation at 25°C. The 86hrs spectrum (magenta) was acquired for additional 64 
hours incubation at 4°C. The resonances that appeared after incubation are marked 
with red arrows, combined with dashed line circles if resolved better. The very 
different resonance at 
1
H 7.211ppm is from Arg side-chains, where the 86hrs 
spectrum has a larger 
15
N spectral width resulting in a different folded 
15
N chemical 
shift position. Backbone resonance identities are labeled next to the cross-peaks or 
with a line directing the labels.   
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This is in agreement with two studies showing that the association of newly synthesized, 
immature PKCs with membranes are of low affinity and can translocate to plasma 
membrane upon PDBu stimulation.
24,126
   
The maturation process involves three ordered phosphorylation reactions, with 
two phosphorylation sites residing on the conserved hydrophobic and turn motifs, 
respectively.
83
  It is well established that, upon maturation, majority of PKCα localizes 
in the cytosol.
24
  In the cytosol, it adopts a compact latent form, in which the pseudo-
substrate region is involved in the auto-inhibitory interactions with the active site of the 
kinase, as shown in Figure 13E.
127
 
What could be the driving force for the mature (i.e. phosphorylated) V5α to 
disengage completely from the membrane and associate with the N-terminal lobe of the 
kinase?  We speculate that this process is driven by the hydrogen-bonding and 
electrostatic interactions between the phosphate groups of TM and HM and the residues 
of the N-terminal lobe of the kinase.  These interactions are present in several structures 
of PKC catalytic domains.
23,87-89
  Other intramolecular interactions that differ upon 
phosphorylations of TM and HM could also be crucial factors, as we will illustrate later 
in Chapter III.  Our data on dmV5α show that the overall interaction mode of V5α with 
zwitterionic detergent DPC is not significantly influenced by the introduction of negative 
charges at the HM and TM (compare Figure 13 and Figure 14).  If negatively charged 
lipids are present in the membrane compartment where PKCα undergoes the maturation 
process, then the electrostatic repulsion between the phosphate groups of TM and HM 
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and the negatively charged lipid head-groups will also promote the dissociation of the 
phosphorylated V5α from the membrane.   
Upon activation, the compact latent form of the enzyme releases its pseudo-
substrate region from the active site of the kinase domain.  This domain rearrangement is 
driven by the C1 and C2 domains undergoing membrane insertion in response to binding 
their respective cofactors, diacylglycerol (C1 domains) and Ca
2+
/phosphatidylserine (C2 
domain).  The ability of the dmV5α to associate with micelles suggests that V5 can 
potentially function as a membrane anchor for the fully activated mature PKC, in which 
the N-terminal regulatory domain is membrane-associated.  Such an interaction will be 
dependent on the lipid composition of the membrane and the availability of other V5 
binding partners, such as receptors for activated C kinases. PICK1 (protein that interacts 
with C kinase 1) has been indicated in PKC related signaling
128
, and it could potentially 
interact with V5 domain from PKCα specifically through a PDZ domain binding 
consensus sequence “-QSAV” at the extreme C-terminus.129  Another scaffold protein 
DLG1 (Discs large homolog 1) was also shown to interact with PKCα through its PDZ 
domain, and acts as a substrate for PKCα.130  Our data here provide a potential 
mechanism by which the residues preceding this PDZ consensus provides a membrane 
anchor for the C-terminus of V5 domain from PKCα, whereas the QSAV motif remains 
accessible for PDZ domain recognition (Figure 14E). This hypothesis is further 
supported by the PtdIns(4,5)P2-containing membrane association of PDZ domain.
131
  
Upon PKCα translocating to PtdIns(4,5)P2-enriched plasma membrane, PDZ-contained 
signaling proteins like PICK1 could readily interact with V5 domain by coincidence 
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detection. This could increase the lifetime of PKCα’s membrane bound state, at the same 
time assist in protein-protein interactions of PKCα with its isoform-specific downstream 
substrates. 
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CHAPTER III  
INTRAMOLECULAR INTERACTION BETWEEN C2 REGULATORY DOMAIN 
AND THE HYDROPHOBIC MOTIF OF V5 DOMAIN – STRUCTURAL AND 
FUNCTIONAL STUDIES 
 
Background 
Although the regulatory and catalytic domains of Protein Kinase C (PKC) 
isoforms contain functionally independent modules, intramolecular interactions between 
these domains are generally considered to be the keys to PKC regulation.  Even though a 
complete picture connecting these interactions is lacking, many valuable studies have 
shed light on the potential interactions between PKC domains.  In the auto-inhibited 
latent form of mature PKC enzymes, the pseudosubstrate (PS) region occupies the active 
site, located between the N- and C-lobes of the catalytic domain.
127
  So far there exists 
no structural information for this interaction, but it is believed to be a key inhibiting 
physical interaction for the latent kinase.  This interaction becomes destabilized upon 
activation of the kinase, by potentially concerted conformational changes of other 
regulatory domains triggered by signaling events.  It is generally believed that the latent, 
cytosolic PKC is stabilized by autoinhibitory interactions, in addition to the PS region 
interacting with the active site, prior to binding of second messengers to the kinase.     
One interaction suggested for stabilizing the latent conformation is the C1A–C2 
interaction.  The C1A–C2 interaction was detected experimentally with isolated and full-
length constructs, and the identities of residues involved in this putative interaction were 
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inferred based on the computational docking study.
66
  The other proposed main 
interactions are the C-terminal Variable 5 (V5) domain with both C2
47
 and C1B
23
 
regulatory domains.  The interaction between V5 and C1B is highly controversial with 
one study pointing out the minimal effect on the function by mutating the V5–C1B 
interface.
55
  The potential V5–C2 interaction, on the other hand, was shown by 
mutagenesis to be important for the DAG-insensitivity of PKCα in the absence of 
calcium signaling.
47
  The hydrophobic motif of V5 was shown to be critical in this 
potential interaction.  Moreover, the importance of the V5 hydrophobic motif for Ca
2+
 
sensitivity was observed in another mutagenesis study.
31
  These data indicate important 
roles of V5 domain in both auto-inhibition and enzyme activation, but it is not yet clear 
what kind of interaction is involved in either process.  All the potential intramolecular 
interactions are illustrated in Figure 19. 
 
 
 
 
Figure 19. Schematic view of intramolecular interactions proposed for PKCα 
and PKCβII.  PS represents the pseudosubstrate region.  Figure adapted with 
permission from T. I. Igumenova. Biochemistry 2015, 54, 4953.
21
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The C-terminal V5 domains are made up of 60 to 80 amino acid segments 
containing two highly conserved turn and hydrophobic phosphorylation motifs (Figure 
7B in Chapter II), while the extreme C-terminal residues beyond the hydrophobic motif 
are the least conserved sequence both in length and amino acid composition among all 
PKC isoenzymes.  These two phosphorylation motifs of V5 domain are among the three 
ordered phosphorylation events required for newly-synthesized PKC enzymes to become 
mature and catalytically competent.
30,81
  The phosphorylated mature enzymes then can 
be activated by association with second messengers, which are Ca
2+
 ions and 
diacylglycerol in the case of conventional PKCs.  
We established in Chapter II that the V5 domain of PKCα is intrinsically 
disordered, which is consistent with its potential ability to participate in multiple 
intramolecular interactions.  In order to overcome the intrinsic dynamics of full-length 
PKC, we use a “divide-and-conquer” strategy with a focus on the hydrophobic motif 
(HM) of the V5 domain.  In this chapter, we show that the phosphorylation of the 
hydrophobic motif facilitates the C2–V5 interaction.  Notably, this interaction is 
synergistically enhanced by Ca
2+
, indicating a function of this intramolecular interaction 
to sensitize the C2 domain to Ca
2+
.  To investigate the molecular basis of the detected 
interaction, we next determined the solution structure of the C2(Ca2+)2pHM complex 
by nuclear magnetic resonance, revealing several important electrostatic and 
hydrophobic interactions.  
Guided by our structure, we designed full-length PKCα variants to systematically 
mutate the observed C2–V5 interface residues.  With these variants, we verified that 
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both the latent conformation and C1 ligand activated membrane translocation are 
significantly affected. In addition, we showed that externally added V5-pHM peptide is 
able to activate the kinase in the absence of the C2 domain agonists.  Our results indicate 
that the C-terminal tail of PKCα functions as an intramolecular interaction site with the 
C2 domain, bridging the regulation stages of PKC through potential conformational 
switches in response to cytosolic Ca
2+
 and anionic membrane lipids.  Our proposed 
model may provide insights into a common regulation mechanism for other multi-
domain kinases containing intrinsically disordered segments.    
 
Experimental procedures 
Protein and peptide preparation for NMR experiments 
C2 domain of protein kinase C from R. norvegicus (residues 155-293) was 
expressed in E. coli and purified as previously described.
72
  Uniformly 
15
N- ([U-
15
N]) 
and 
13
C, 
15
N-enriched ([U-
13
C, 
15
N]) C2 were prepared using (
15
N, 99%) ammonium 
chloride and (6-
13
C, 99%) glucose as the sole nitrogen and carbon sources, respectively.  
C2 samples were decalcified by incubation with 0.1 mM EDTA, followed by extensive 
buffer exchange into an EDTA- and Ca
2+
-free buffer.  All buffer solutions were 
decalcified by passing through Chelex resin (Sigma-Aldrich).  For NMR-monitored 
binding experiments, the final buffer composition was 20 mM or 10 mM MES at pH 6.0, 
8% (v/v) D2O, and 0.02% (w/v) NaN3.  The peptides were purchased from either 
GenScript or Eton Bioscience.  Crude peptide mixtures were purified on a C18 column 
using HPLC.  Peptide concentration was determined from the absorbance at 280 or 205 
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nm; additional concentration measurements were carried out for phosphorylated peptides 
using a phosphate assay.
132
  The molecular weight and purity of the peptides after HPLC 
purification were verified using MALDI-TOF mass spectrometry.  The peptide stock 
solutions were prepared in HPLC-grade water and adjusted to pH 6.0 with ammonium 
hydroxide. 
 
Insect cell expression and purification of PKC 
pBiEx1 plasmid carrying the mCer-hPKC-mCit-FLAG gene was a generous 
gift of Dr. Sivaraj Sivaramakrishnan (University of Minnesota).  mCer and mCit encode 
mCerulean and mCitrine fluorescent proteins, and they form a Förster Resonance Energy 
Transfer (FRET) donor-acceptor pair.  Human and rat PKC have identical amino acid 
sequences of their V5 domains and a single amino acid difference in the C2 domain at 
position 169 (Ala in human, Thr in rat), which is not part of any functional region.  For 
recombinant PKC expression, the mCer-hPKC-mCit-FLAG sequence was sub-cloned 
into pAcGHLT-C (BD Biosciences) and pBac-1 (EMD Millipore) vectors.  QuikChange 
site-directed mutagenesis of hPKC was conducted using the pcDNA3 plasmid carrying 
the YFP-hPKC gene to overcome challenges associated with high DNA sequence 
degeneracy of mCer and mCit.  The mCer-hPKC-mCit-FLAG variants were generated 
by replacing the wild-type gene with the mutagenic hPKC sequence using the In-
Fusion cloning kit (Clontech).  Either pAcGHLT-C or pBac-1 plasmid was co-
transfected with ProGreen linearized baculovirus DNA (AB Vector) into Sf9 cells to 
generate recombinant baculovirus.  The Sf9 cells at a density of 2.5 × 10
6
/mL were 
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infected with recombinant baculovirus of high titer in a serum-free medium (Expression 
Systems). 
The cells were cultured in suspension at 27 °C and harvested after 60 hours.  The 
cell pellets were resuspended in a lysis buffer containing 50 mM Tris-HCl at pH 7.5, 1 
mM EGTA, 1 mM EDTA, 3 mM MgCl2, 150 mM NaCl, Halt protease inhibitor cocktail 
(Thermo Scientific), 1 mM PMSF, and 1% Triton X-100.  The cell suspension was 
gently mixed on a nutator at 4 °C for 30 min to complete the lysis.  The mCer-hPKC-
mCit-FLAG proteins in the lysate were purified using anti-FLAG M2 affinity gel 
(Sigma-Aldrich) according to the manufacturer’s instructions.  The eluted proteins were 
further purified from low-molecular-weight contaminants and buffer-exchanged on a 50 
kDa MWCO spin concentrator (Corning).  Purified proteins were analyzed by SDS-
PAGE.  Protein concentrations were measured with mCitrine absorbance at 516 nm with 
extinction coefficient of 77,000 M
-1
cm
-1
.
133
 
The kinase activities of the purified mCer-hPKC-mCit-FLAG proteins were 
assayed with the PepTag non-radioactive protein kinase C assay kit (Promega) 
according to the manufacturer’s instructions.  For all activity assays mCer-hPKCα-mCit-
FLAG proteins were added to a final concentration of 6 nM, which was 20ng in the 
reaction volume of 25μL.  As a PKC activator, we used large unilamellar vesicles (LUV) 
consisting of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-L-serine (POPS), and 1,2-dimyristoyl-sn-glycerol (DAG), 
all from Avanti Polar Lipids Inc.  The molar ratio of the components was 
POPC/POPS/DAG = 65:30:5.  The total lipid concentration of LUVs was 1 mM.  
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Activity reactions contained a final buffer of 20 mM HEPES (pH 7.4), 1 mM 
dithiothreitol (DTT), 1.3 mM CaCl2, 10 mM MgCl2 and 1 mM ATP.  
For the V5-pHM peptide activating PKC experiments, separate reaction buffers 
were made to control Ca
2+
 and total concentration of divalent metals.  The Ca
2+
-free 
reactions contained a final buffer of 20 mM HEPES (pH 7.4), 1 mM DTT, 3.5 mM 
MgCl2 and 1 mM ATP, whereas the corresponding Ca
2+
-containing reactions had 
additional 1 mM CaCl2.  Reactions with pHM added had a final concentration of 1 mM 
peptide.  The 10 aa version of the pHM peptide was used.  PDBu was added with a stock 
of 5 μM in DMSO to a final concentration of 500 nM.  The LUV activator had the same 
components as listed above.  EGTA was added to a final concentration of 40μM in the 
Ca
2+
-free experiment with LUV.  Reactions were carried out at 30 °C for 30 minutes and 
quenched for 10 minutes at 95 °C.  The amount of phosphorylated peptide was 
quantified using a photon counting spectrofluorometer (ISS). 
 
NMR-detected binding of ligands to C2 
The ligand-binding experiments were conducted by adding aliquots of 
concentrated pHM15 (Ca
2+
) stock solutions to apo and Ca
2+
-bound (pHM15-bound) [U-
15
N] C2 domain.  The protein concentration in the NMR samples ranged from 80 to 100 
M.  Ca2+ stock solutions were prepared from 1.0 M standard calcium chloride solution 
(Fluka Analytical).  For each ligand concentration, [
15
N-
1
H] HSQC spectra were 
collected at 25 °C on Varian INOVA spectrometers operating at the Larmor 
1
H 
frequencies of 500 MHz or 600 MHz.  For the chemical shift perturbation (CSP) and 
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binding curve analysis, the residue-specific chemical shift change between any given 
pair of C2 states was calculated as follows: 
 ∆= √(∆𝛿𝐻)2 + (0.152 × ∆𝛿𝑁)2 3.1 
where H and N are the residue-specific differences in 
1
H and 
15
N chemical shifts, 
respectively.  The binding curves were constructed by plotting Δ against total ligand 
concentration.  The dissociation constants Kd for the pHM15 binding to C2 were 
determined by fitting the binding curves with the single-site equation: 
 ∆= ∆𝑚𝑎𝑥
𝑃0 + 𝐿0 + 𝐾𝑑 − √(𝑃0 + 𝐿0 + 𝐾𝑑)2 − 4𝑃0𝐿0
2𝑃0
 3.2 
where Δδmax, P0 and L0 are the chemical shift change at complete saturation, total protein 
concentration and total ligand concentration, respectively.  The dissociation constants Kd 
for Ca
2+
 binding to C2 were acquired by fitting the binding curves with the modified Hill 
equation
134
 to account for the moderate cooperativity of Ca
2+
 binding: 
 ∆= ∆𝑚𝑎𝑥
(𝐿0 − (𝑃0 + 𝐿0 + 𝐾𝑑 − √(𝑃0 + 𝐿0 + 𝐾𝑑)2 − 4𝑃0𝐿0)/2)
𝑛
𝐾𝑑
𝑛 + (𝐿0 − (𝑃0 + 𝐿0 + 𝐾𝑑 − √(𝑃0 + 𝐿0 + 𝐾𝑑)2 − 4𝑃0𝐿0)/2)
𝑛 3.3 
where n is the Hill coefficient.  This equation assumes that 2 Ca
2+
 ions bind to C2 with 
the same affinity. 
 
NMR experiments for structure validation, resonance assignment, and structural 
restraints 
We used lanthanide (Ln
3+
)-induced pseudocontact shift (PCS) values to assess 
the structure of the pHM-complexed C2.  The peptide pHM corresponds to a highly 
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soluble 10 amino acid version of the hydrophobic motif, Ac-DQSDFEGFpSY-NH2.  The 
complexes of [U-
15
N,
13
C] C2 with Ln
3+
 (Ln=La, Tb, and Tm) were prepared by 
combining equimolar amounts of C2 and LnCl3 (Sigma Aldrich) dissolved in HPLC-
grade water.  In the pHM-containing sample, the concentration of pHM was 600 M and 
the concentration of the C2•Ln
3+
 complexes ranged from 40 to 60 M.  [15N-1H] HSQC 
spectra were collected at 25 °C on Avance III spectrometers (Bruker Biospin) operating 
at 
1
H Larmor frequencies of 500 and 600 MHz.  The PCS values were determined by 
subtracting the residue-specific 
1
H and 
15
N C2 chemical shifts of La
3+
-containing 
diamagnetic complexes from those of Tm
3+
-and Tb
3+
-containing paramagnetic 
complexes.  The resonance assignment of diamagnetic C2•La
3+
 spectra was done by 
comparison with the previously assigned spectrum of single Pb
2+
-bound C2.
72
  The 
resonance assignment of the paramagnetic C2 spectra was done iteratively as 
implemented in Numbat,
135
 using the Pb
2+
-complexed structure of C2 (PDB ID 3TWY). 
Two NMR samples, with either C2 or the hydrophobic motif peptide in molar 
excess, were prepared for the structural characterization of the C2Ca2+pHM complex.  
Sample 1 contained 0.89 mM [U-
13
C, 
15
N] C2, 2.23 mM CaCl2, and 2 mM pHM.  
Sample 2 contained 1.47 mM [U-
13
C, 
15
N] C2, 3.75 mM CaCl2, and 0.6 mM pHM.  The 
final buffer conditions after the preparation of the C2•Ca
2+
•pHM complex were 6.7 mM 
MES at pH 6.0, 67 mM KCl, 8% (v/v) D2O and 0.02% (w/v) NaN3.  All NMR data were 
collected at 23 °C using Avance III NMR instruments (Bruker Biospin) operating at the 
1
H Larmor frequencies of 500, 600, and 800 MHz, the latter two equipped with a 
cryogenically cooled probe.  For sample 1, the resonances of backbone 
1
H, 
13
C and 
15
N 
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atoms of the pHM-complexed C2 were assigned using 2D [
15
N-
1
H] HSQC, 3D HNCO,
93
 
3D HN(CA)CO
94
 and 3D HNCACB
93
 experiments.  The resonances of side-chain 
13
C 
and 
1
H atoms were assigned using 2D [
13
C-
1
H] HSQC, 3D CC(CO)NH,
95
 3D 
H(CCO)NH,
136
 3D HCCH-TOCSY,
137
 3D HCCH-COSY
138
 and 3D 
15
N-TOCSY-
HSQC
139
 experiments.  The resonances of aromatic 
1
H atoms were assigned with 2D 
aro-[
13
C-
1
H] HSQC and 3D aro-HCCH-TOCSY experiments. 
The NOE restraints for calculating the structure of C2 were obtained from the 3D 
13
C-edited NOESY-HSQC and 
15
N-edited NOESY-HSQC experiments
139-141
 conducted 
on sample 1.  Inter-molecular C2-pHM NOE restraints were obtained from 2D [F2] 
15
N, 
13
C-filtered NOESY, 3D [F1] 
15
N,
13
C-filtered NOESY-
15
N-HSQC, and 3D [F1] 
15
N, 
13
C-filtered NOESY-
13
C-HSQC spectra.
142
  The inter-molecular origin of these cross-
peaks was verified using 2D [F1] 
15
N, 
13
C-filtered NOESY and 2D [F1, F2] 
15
N,
13
C-
filtered NOESY experiments.
143
  The 
1
H atoms of the C2-bound pHM in sample 2 were 
assigned with 2D [F1, F2] 
15
N, 
13
C-filtered TOCSY and 2D [F1, F2] 
15
N,
13
C-filtered 
NOESY spectra; the latter was used to obtain the NOE restraints for the calculation of 
the pHM structure.  The mixing time for all NOESY experiments was 120 ms.  All NMR 
data were processed using NMRPipe.
144
  The analysis and all-atom assignments were 
performed with Sparky.
145
 
 
Calculation of NMR structures and assembly of the ternary complex 
Automated NOE assignment, calculation of Ca
2+
-bound C2 structure in the 
context of the C2•Ca
2+
•pHM complex, and its refinement in explicit solvent was carried 
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out using ARIA software (version 2.3).
146
  The 
1
H-
1
H distance restraints were 
determined from the volumes of cross peaks in the 3D NOESY spectra.  Hydrogen 
bonds were identified based on the 
1
H-
2
D exchange rates of amide 
1
H atoms.  Dihedral 
angles were predicted by TALOS+
147
 using a complete set of 
15
N, 
13
C, 13C, 13Cβ, 1H 
and 
1
H
N
 chemical shifts.  Metal coordination restraints in the range of 2.1-2.5 Å between 
the Ca
2+
 ions and the coordinating oxygens of C2 were also included.  We also carried 
out the structure calculation and refinement of C2 without Ca
2+
 restraints and obtained 
essentially identical ensemble of structures albeit with more variability in the loop 
regions.  The structure of the C2-bound pHM was calculated using 100 NOE restraints 
obtained from the 2D [F1, F2] 
15
N,
13
C-filtered NOESY spectrum.  After refinement in 
explicit solvent, the 20 lowest energy structures were selected for the final NMR 
ensembles and validated by PROCHECK-NMR.
148
 
The model of the C2•Ca
2+
•pHM complex was generated using HADDOCK 2.2 
software.
149,150
  To generate initial structures for rigid-body docking, all combinations of 
Ca
2+
-bound C2 and pHM structures were drawn from their respective NMR ensembles.  
The unambiguous distance restraints consisted of 29 intermolecular NOEs between the 
1
H atoms of C2 and pHM, and 12 metal ion-oxygen restraints for the two Ca
2+
 ions 
bound to C2.  The ambiguous restraints were based on the extent of 
1
H and 
15
N chemical 
shift perturbations experienced by the C2 residues as a result of pHM binding.  The 
“active” residues of C2 were defined as those having CSP values at least one standard 
deviation above the mean and an all-atom surface accessibility of  > 50%, determined 
using Naccess.
151
  All pHM peptide residues were treated as “passive”.  The calculations 
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generated 6000/400/400 models for the rigid body docking, semi- and fully- flexible 
simulated annealing, and explicit solvent refinement stages.  The final 400 models were 
subjected to cluster analysis, as described in Daura et al.
152
  The interface RMSD cutoff 
of 3.0 Å was used to generate the clusters.  To assess the influence of the initial pHM 
conformation on the final structure of the complex, extended and -helical peptide 
conformations with the dihedral angles (φ, ψ) of (-139°, -135°) and (-60°, -45°), 
respectively, were generated and used for docking. 
The HADDOCK models for full-length PKCα and PKCβII were docked with the 
set unambiguous and ambiguous intermolecular restraints from the C2–pHM 
experiments.  In addition, pHM intramolecular NOEs were incorporated for the PKCα 
docking.  For the full-length PKCα docking, input structures are kinase domain crystal 
structure from PDB ID 3IW4 and C2 domain solution structure from this study, 
respectively.  For the full-length PKCβII modeling, both kinase domain and C2 domain 
structures are from crystal structure PDB ID 3PFQ.  The calculations generated 
1000/200/200 models for the rigid body docking, semi- and fully- flexible simulated 
annealing, and explicit solvent refinement stages.  The final 200 models were subjected 
to cluster analysis, as described in Daura et al.
152
  The interface RMSD cutoff of 7.5 Å 
was used to generate the clusters.  The intermolecular restraints used for all three 
HADDOCK modeling are listed in Table 1.  Cluster analysis results for C2–pHM 
docking are summarized in Table 2 and Table 3.  Cluster analysis results for full-length 
PKCα and PKCβII docking are lists in Table 4. 
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Table 1. Distance restraints used for HADDOCK modeling 
 C2–pHM and full-length PKCα Full-length PKCβII 
Interdomain restraints  
 C2 V5 C2 V5 
Unambiguous W 247 Hε1 G 655 Hα W 247 Hε1 G 658 Hα 
4.0 -2.2 +2.5 Å  F 656 Hα  F 659 Hα 
  F 656 Hβ  F 659 Hβ 
  F 656 Hε  F 659 Hε 
  F 656 Hδ  F 659 Hδ 
  Y 658 H  F 661 H 
  Y 658 Hα  F 661 Hα 
  NH2/V 659 H  V 662 H 
a W 247 Hζ2 pS 657 Hβ   
  G 655 Hα   
  F 656 Hβ   
 W 247 Hη2 pS 657 Hβ   
 W 247 Hδ1 pS 657 Hβ   
 N 253 H F 653 Hδ N 253 H F 656 Hδ 
 K 197 Hε F 653 Hα K 197 Hε F 656 Hα 
  F 653 Hε  F 656 Hε 
  F 653 Hδ  F 656 Hδ 
 R 252 Hδ F 653 Hα R 252 Hδ F 656 Hα 
  F 653 Hε  F 656 Hε 
  F 653 Hδ  F 656 Hδ 
 R 252 Hγ F 653 Hδ R 252 Hγ F 656 Hδ 
 R 252 Hα F 656 Hδ R 252 Hα F 659 Hδ 
 R 252 Hβ F 656 Hδ R 252 Hβ F 659 Hδ 
 K 199 Hε F 653 Hα K 199 Hε F 656 Hα 
  F 653 Hδ  F 656 Hδ 
 K 209 Hγ F 653 Hε K 209 Hγ F 656 Hε 
 K 211 Hε F 656 Hα K 211 Hε F 659 Hα 
  F 656 Hε  F 659 Hε 
 T 214 H F 656 Hε T 214 H F 659 Hε 
Ambiguous K 209 All passive K 209 All passive 
2.0 -2.0 +0.0 Å W 247  W 247  
 T 250  T 250  
 T 251  T 251  
 R 252  R 252  
 N 253  N 253  
Ca
2+
 coordination 
 2.30 -0.2 +0.2 Å 
Original crystallographic 
distances with -0.2 +0.2 Å 
 C2 calcium C2 calcium 
 D 187 Oδ1 1 D 187 Oδ1 1 
 D 187 Oδ2  D 187 Oδ2  
 D 193 Oδ2  D 193 Oδ2  
 D 246 Oδ1  D 246 Oδ1  
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Table 1. Continued 
 C2 calcium C2 calcium 
 D 248 Oδ1 1 D 248 Oδ1 1 
 W 247 O  W 247 O  
 M 186 O 2 M 186 O 2 
 D 187 Oδ1  D 187 Oδ1  
 D 246 Oδ2  D 246 Oδ2  
 D 248 Oδ1  D 248 Oδ1  
 D 248 Oδ2  D 248 Oδ2  
 D 254 Oδ2  D 254 Oδ2  
   D 248 Oδ2 3 
   S 251 Oγ  
   D 254 Oδ1  
   D 254 Oδ2  
   R 252 O  
a. Restraints colored blue are specific to C2–pHM docking 
 
 
 
The NMR resonance assignments and structure coordinates are deposited in 
BioMagResBank/PDB under accession numbers/entry codes: 26016/2NCE (C2), 
26017/2NCF (C2(Ca2+)2pHM complex). 
 
Steady-state fluorescence spectroscopy 
The steady-state fluorescence emission spectra of purified mCer-hPKC-mCit-
FLAG proteins were recorded at 25 C on a photon counting spectrofluorimeter (ISS) 
using the excitation wavelength of 430 nm and the detection range of 450–650 nm.  The 
excitation and emission slit widths were set to 8 nm.  The cuvettes were coated with 
Sigmacote (Sigma-Aldrich) to minimize protein adsorption on the walls.  Protein 
samples with concentrations ranging from 7 to 50 nM were prepared in a decalcified 
buffer containing 20 mM HEPES at pH 7.4, 100 mM KCl, and 5 mM β-
mercaptoethanol.   
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Table 2. Cluster statistics of C2–pHM HADDOCK docking with RMSD cutoff of 3.0 Å 
 
 
 
Table 3. Intermolecular energies and violation analysis for all clusters of C2–pHM HADDOCK docking 
 
 
 
 
 
a. Einter = ENOE(all restraints) + Evdw + Eelec 
Cluster 
rank 
Cluster 
population 
HADDOCK 
score (a.u.) 
(based on 
best 10) 
RMSD from 
overall lowest 
energy 
structure (Å) 
iRMSD from 
the average 
structure of 
each cluster (Å) 
Evdw 
(kcal/mol) 
Eelec 
(kcal/mol) 
EAIR 
(kcal/mol) 
Edesolv 
(kcal/mol) 
1 166 -133.8 ± 4.4 1.4 ± 0.7 1.4 ± 0.7 -35.1 ± 7.5 -378.2 ± 75.1 48.7 ± 47.3 6.5 ± 4.9 
2 134 -103.4 ± 2.6 2.2 ± 0.2 1.1 ± 0.5 -33.0 ± 6.0 -349.7 ± 57.9 78.9 ± 21.1 11.1 ± 5.2 
5 21 -96.1 ± 4.3 2.0 ± 0.3 1.0 ± 0.6 -29.7 ± 6.8 -320.9 ± 45.6 42.3 ± 27.5 2.7 ± 5.9 
4 22 -96.0 ± 4.0 2.3 ± 0.1 0.6 ± 0.1 -31.9 ± 3.1 -356.8 ± 26.4 45.0 ± 8.8 8.5 ± 3.7 
3 43 -85.2 ± 4.9 1.7 ± 0.2 1.9 ± 0.4 -37.8 ± 3.9 -184.4 ± 46.4 32.4 ± 36.8 -1.5 ± 4.4 
6 8 -58.0 ± 7.9 2.1 ± 0.2 0.9 ± 0.4 -28.2 ± 3.3 -174.4 ± 41.6 83.2 ± 21.0 -3.2 ± 5.6 
Cluster 
rank 
Cluster 
population 
Buried Surface 
Area (Å
2
) 
Einter
a.
 (based on 
best 10) 
(kcal/mol) 
Einter  
(kcal/mol) 
ENOE  
unambiguous 
only (kcal/mol) 
Violations 
> 0.5 Å 
Violations 
> 0.3 Å 
1 166 1109.0 ± 98.1 -528.0 ± 35.6 -364.6 ± 101.4 3.4 ± 5.1 0.9 ± 1.2 0.9 ± 1.2 
2 134 1099.1 ± 69.9 -383.6 ± 25.8 -303.9 ± 57.6 7.2 ± 2.1 1.8 ± 0.5 1.8 ± 0.5 
5 21 961.2 ± 43.9 -333.7 ± 28.2 -308.4 ± 41.9 2.2 ± 3.5 0.6 ± 0.9 0.8 ± 0.8 
4 22 1101.7 ± 40.8 -362.4 ± 23.2 -343.6 ± 30.2 4.1 ± 1.1 1.0 ± 0.0 1.0 ± 0.0 
3 43 1076.3 ± 40.8 -221.6 ± 25.9 -189.8 ± 25.2 2.4 ± 2.8 0.8 ± 0.9 0.8 ± 0.9 
6 8 876.4 ± 84.7 -119.4 ± 52.8 -119.4 ± 52.8 8.0 ± 2.8 1.6 ± 0.7 1.6 ± 0.7 
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Table 4. Cluster statistics of full-length PKCα and βII HADDOCK docking with RMSD cutoff of 7.5 Å 
 
 
Cluster 
rank 
Cluster 
population 
HADDOCK 
score (a.u.) 
(based on 
best 10) 
RMSD from 
overall lowest 
energy 
structure (Å) 
iRMSD from 
the average 
structure of 
each cluster (Å) 
ENOE  
unambiguous 
only (kcal/mol) 
Violations 
> 0.5 Å 
Violations 
> 0.3 Å 
PKCα 
1 151 -123.5 ± 5.2 1.9 ± 1.0 2.3 ± 1.5 15.9 ± 7.2 2.6 ± 1.2 2.9 ± 1.3 
3 12 -105.7 ± 12.8 4.4 ± 0.5 2.1 ± 1.4 12.0 ± 7.8 2.6 ± 1.2 3.0 ± 1.4 
2 18 -89.1 ± 10.8 5.3 ± 0.4 1.2 ± 1.1 8.3 ± 7.4 1.8 ± 1.4 2.1 ± 1.6 
4 10 -77.5 ± 22.5 10.9 ± 1.2 2.6 ± 1.2 11.0 ± 6.2 2.9 ± 1.9 3.6 ± 2.2 
5 4 -76.8 ± 11.1 6.2 ± 1.0 1.6 ± 1.0 18.1 ± 7.4 4.5 ± 2.2 5.3 ± 2.0 
PKCβII 
1 200 -124.2 ± 7.4 0.9 ± 0.3 0.9 ± 0.3 38.2 ± 3.9 4.4 ± 1.0 5.8 ± 1.5 
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FRET efficiency was calculated as the ratio of peak intensities corresponding to the 
emission maxima of mCit at 525 nm and mCer at 475 nm.  To obtain the reference 
fluorescence spectra of mCit and mCer in the absence of intramolecular interactions, 
wild-type mCer-hPKC-mCit-FLAG was subjected to limited proteolysis with 
endoproteinase Lys-C (Thermo Scientific) that leaves the fluorescent proteins intact.  
The reaction was carried out at 30 °C at a protein to Lys-C ratio of 20:1 (w/w).  The 
fluorescence spectrum was acquired 30 minutes after initiating the reaction.  The 
completeness of the cleavage reaction was verified using SDS-PAGE. 
 
Membrane translocation experiments
*
 
Human YFP-PKCα was generated by sub-cloning PKCα into pcDNA3 with YFP 
at the N-terminus.  Membrane-targeted CFP
34
 has been previously described.  All 
variants were generated by QuikChange
TM
 site-directed mutagenesis.  The pan anti-
phospho-PKC activation loop antibody was previously described.
153
  The anti-PKCα 
(610108) antibody was from BD Transduction Laboratories.  The anti-phospho-
PKCα/PKCβ turn motif (9375S) and the pan anti-phospho-PKC hydrophobic motif 
(9371S) antibodies were from Cell Signaling Technology.  The anti-α-Tubulin (T6074) 
antibody was from Sigma-Aldrich.  PDBu was purchased from Calbiochem. 
COS7 cells were cultured in DMEM (Cellgro) containing 10% fetal bovine 
serum (Atlanta Biologicals) and 1% penicillin/streptomycin (Gibco) at 37 ºC in 5% 
                                                 
*
 Membrane translocation experiments and FRET imaging were conducted by J. A. Callendar 
from Dr. A. C. Newton’s Lab at University of California, San Diego. 
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CO2.  Transient transfections were carried out using jetPRIME (PolyPlus Transfection) 
for ~24 hrs prior to analysis. Cells were lysed in 50 mM Tris pH 7.4, 1% Triton X-100, 
50 mM NaF, 10 mM Na4P2O7, 100 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 1 mM 
PMSF, 50 µg/mL Leupeptin, 1 µM Microcystin, 1 mM DTT, and 2 mM Benzamidine.  
Whole cell lysates were analyzed by SDS-PAGE and immunoblotting via 
chemiluminescence on a FluorChemQ imaging system (ProteinSimple).  For PDBu-
induced translocation experiments, cells were treated with 200 nM PDBu. 
 
FRET imaging and analysis 
Cells were imaged as described previously.
154
  COS7 cells were co-transfected 
with the indicated YFP-tagged PKC and plasma membrane-targeted CFP.  Cells were 
rinsed once with and imaged in Hanks’ balanced salt solution containing 1 mM Ca2+.  
Images were acquired on a Zeiss Axiovert microscope (Carl Zeiss Microimaging, Inc.) 
using a MicroMax digital camera (Roper-Princeton Instruments) controlled by 
MetaFluor software (Universal Imaging, Corp.).  Using a 10% neutral density filter, 
CFP, YFP, and FRET images were obtained every 7 or 15 seconds.  YFP emission was 
monitored as a control for photo bleaching and to ensure that overexpressed PKC levels 
were equal in all experiments.  Base-line images were acquired for ≥ 2 min before PDBu 
addition and data were normalized to the baseline FRET ratios.  Data are plotted as the 
average ± S.E.M. of this normalized FRET ratio for n > 20 cells from at least 3 
independent experiments. 
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The membrane translocation data were modeled phenomenologically, using a 
pseudo-first-order kinetic process.  The FRET-detected translocation curves, with 
baseline FRET ratios normalized to 1, were fit using the following equation: 
 𝑦 = 1.0 + 𝐴(1 − 𝑒−𝑘𝑡) 3.4 
where y is the FRET ratio; k is the sum of the on- and off- rate constants, (kon + koff); A 
is the steady-state FRET ratio that reflects the amount of translocated protein and is ~ (1 
+ koff / kon)
-1
.  For variants that showed non-saturatable behavior, we have added a linear 
term, D×t, to describe the time dependence. 
 
Results 
Phosphorylation of the hydrophobic motif enhances its interaction with C2 
We first investigated whether the isolated hydrophobic motif of V5 domain 
interacts with the Ca
2+
-sensing C2 domain in solution.  We designed four peptides to 
probe this potential interaction (Figure 20B).  The unphosphorylated peptide uHM 
mimics the state of hydrophobic motif in the immature (i.e., unphosphorylated) kinase; 
S657E has the phospho-mimicking amino acid in place of the phosphorylated Ser657; 
pHM is the phosphorylated HM representing its state in the mature kinase; and SCB is 
the scrambled version of uHM with the same overall charge and amino acid identities.  
The binding of peptides to Ca
2+
-complexed [U-
15
N] enriched C2 domain was monitored 
using 
1
H-
15
N hetero-nuclear single-quantum coherence (HSQC) experiments. 
In all four cases, we observed changes in the 
1
H and 
15
N chemical shifts of 
several C2 amide groups, indicating that their electronic environment changed as a result 
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of peptide binding (Figure 20B).  A full scale spectral overlay is shown in Figure 21.  
Because essentially the same subset of C2 residues is affected, the peptides likely 
interacted with the same site on C2.  The SCB and pHM peptides caused the smallest 
and largest chemical shift changes of the C2 resonances, respectively.  The final 
concentrations of C2 and peptides used in the experiments as shown in Figure 20B were 
identical.  Therefore, we can use the extent of chemical shift perturbation to qualitatively 
evaluate the affinity of peptides to C2, which gives us the following order: pHM > 
S657E > uHM > SCB.   
 
 
 
 
Figure 20. Host protein context and interactions between C2 and V5 domains.  
(A) Domain sub-structure of conventional PKC isoenzymes and schematic 
representation of the inactive form.  The Ca
2+
-sensing C2 and C-terminal V5 domains 
are shown in gray and red, respectively; PS is the pseudo-substrate region.  (B) 
Expansions of 
15
N-
1
H HSQC spectra of Ca
2+
-bound C2 domain (C2Can, n=2,3), in 
the absence (black) and presence of four V5-derived peptides: pHM15 (red), S657E 
(gold), uHM (green), and SCB (blue).  The changes in cross-peak positions indicate 
the changes in electronic environment of the backbone N-H groups of C2 due to 
binding. 
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Figure 21. Full-scale 
15
N-
1
H HSQC spectra overlay of Ca
2+
 bound [U-
15
N] C2 
domain, in the absence or presence of four HM peptides: SCB, uHM, S657E and 
pHM.  The color coding of spectra are indicated by the legend in the left top corner of 
the figure.  Arrows indicate a qualitative trend of increasing binding affinity. 
 
 
 
Electrostatic contacts make a significant contribution to this interaction, based on the 
observation that the peptide with a scrambled amino acid sequence can still bind to C2, 
albeit with a reduced affinity compared to uHM.  We conclude that the phosphorylation 
of the hydrophobic motif enhances its interactions with C2.  For all subsequent studies, 
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we use the pHM peptide to represent the hydrophobic motif of the C-terminal V5 
domain. 
 
Synergy between Ca
2+
 and hydrophobic motif  
Ca
2+
 binding to the C2 domain is the first step of the PKC activation process.  
We used solution NMR to determine the effect of Ca
2+
 on the interactions of the 
hydrophobic motif with C2.  The concentration of pHM15 in the sample containing 
either [U-
15
N] apo C2 or C2Can varied from zero to 1.5 mM.  The 
1
H-
15
N HSQC spectra 
were collected at each concentration of pHM15 and overlaid to identify C2 residues that 
had experienced chemical shift perturbations due to interactions with the peptide.  For 
both C2 states, a significant number of C2 residues showed changes in their N-H 
chemical shifts (Figure 22A, B).  The cross-peaks of the C2 species follow a smooth 
trajectory as a result of increasing pHM15 concentration, indicating that the binding 
process is fast on the NMR chemical shift timescale irrespective of the state of metal 
ligation. 
We applied chemical shift perturbation (CSP) analysis to identify the C2 regions 
affected by the interactions with the hydrophobic motif.  CSP values  were calculated 
between a pair of C2 states containing no peptide and 1.5 mM pHM15, and plotted 
against the amino acid sequence of C2 (Figure 22C).  While the magnitude of chemical 
shift changes in the apo C2 (Figure 22C, bottom panel) is smaller than that of C2Can 
(Figure 22C, top panel), the overall pattern is quite similar.  We conclude that Ca
2+
 
binding does not significantly change the interaction mode of C2 with HM. 
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Figure 22. pHM interacts with apo and Ca
2+
-bound C2.  Expansions of 
1
H-
15
N 
HSQC spectra of [U-
15
N] apo C2 (A) and C2Can (B) showing the effect of increasing 
pHM15 concentration [pHM15].  The spectra are overlaid and color-coded according 
to [pHM15].  The N-H groups of C2 whose chemical shift changes as a result of 
binding are labeled.  (C) Chemical shift perturbations Δ due to pHM15 binding for all 
spectrally resolved residues of C2Can (top panel) and apo C2 (bottom panel).  
Residue-specific Δ values were calculated using spectra with zero and 1.5 mM 
[pHM15] for apo C2 (top panel) and C2Can (bottom panel).  Asterisks indicate 
residues that are either prolines or broadened/not spectrally resolved.  The inserts 
show chemical shift perturbations for the indole side chain amine groups of the four 
Trp residues.  (D) Crystal structure of the C2 domain complexed to two Ca
2+
 ions 
(PDB ID: 1DSY).  CMBLs and LRC stand for Ca
2+
- and membrane-binding loops and 
lysine-rich cluster, respectively.  Ca
2+
 ions are shown as green spheres. 
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Figure 23. Synergistic action of Ca
2+
 and hydrophobic motif. (A) Representative 
binding curves of pHM15 to apo C2 (open circles) and C2Can (filled circles). (B) 
Representative binding curves of Ca
2+
 to apo C2 (open triangles) and C2Can (filled 
triangles).  In both cases, the affinity of one ligand is enhanced in the presence of the 
other. 
 
 
 
The crystal structure of the Ca
2+
-bound C2 provides a structural context for 
interpreting the observed chemical shift perturbations.  The C2 domain has two major 
functional regions, the Ca
2+
- and membrane-binding loops (CMBLs) and the lysine-rich 
cluster (LRC).  CMBL1 and CMBL3 provide oxygen-containing ligands for Ca
2+
 ions 
that bridge the protein and negatively charged groups of anionic phospholipids.  LRC is 
the interaction site of the C2 domain with a signaling lipid PtdIns(4,5)P2.  The CSP data 
show that the regions affected by the interactions with the hydrophobic motif include the 
major functional elements of C2, namely CMBL1, CMBL3, and LRC, plus the C-
terminal helix H3.  A similar pattern of chemical shift perturbations was previously 
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observed in the NMR studies of PtdIns(4,5)P2-C2 interactions, suggesting that the 
hydrophobic motif and PtdIns(4,5)P2 bind to the same C2 site. 
To determine the affinity of pHM15 to C2, we constructed binding curves using 
the chemical shifts of all responsive residues that fall into the fast-exchange regime.  We 
found that Ca
2+
 increases the affinity of C2 to the hydrophobic motif ~2.0-fold, based on 
the Kd values of 120  4 M and 203  6 M for the Ca
2+
-bound and apo C2, 
respectively (Figure 23A).  We then conducted a converse experiment, where we 
measured the affinity of the C2 domain to Ca
2+
 in the absence and presence of pHM15 
(Figure 23B).  The presence of pHM15 decreased the Ca
2+
 Kd approximately 3-fold, 
from 356  9 M to 126  4 M, while the Hill coefficient increased from 1.3 to 1.5.  In 
summary, our data demonstrate that both apo and Ca
2+
-complexed C2 domains interact 
with the hydrophobic motif of the C-terminal V5 domain in solution.  A clear synergy 
between Ca
2+
 and pHM15 is manifested in the mutual enhancement of their respective 
affinities to the C2 domain. 
 
Structural characterization of the C2(Ca2+)2pHM complex 
To dissect the structural basis of the interactions between C2 and the 
hydrophobic motif, we prepared a complex consisting of Ca
2+
-bound C2 and a 10-
residue pHM peptide.  pHM has a higher solubility and slightly higher affinity to Ca
2+
-
complexed C2 compared to its 15-residue variant, with a Kd of 105 ± 2 μM.  As a first 
step, we determined the structure of the C2 domain in the context of the complex using 
NMR spectroscopy.   
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Table 5.  NMR-based restraints and structure refinement statistics. 
NOE restraints   
total 2689  
ambiguous 520  
unambiguous 2169  
intra (|i-j|=0) 618  
medium (0<|i-j|<5) 786  
long (|i-j|≥5) 765  
hydrogen bonds 33  
dihedral angles (Φ, Ψ) 210  
Ca
2+
/ligands  12  
average no. of violations   
NOE > 0.3 Å 1.4 ± 0.9 
0.3 ± 0.6 
0.0 ± 0.0 
NOE > 0.5 Å 
dihedral angles > 5° 
mean rmsd from ideal geometry 
bond length (Å) 0.004 ± 0.0001 
0.5 ± 0.01 
1.4 ± 0.09 
bond angle (°) 
impropers (°) 
rmsd values from the mean (Å)   
secondary structure (backbone) 0.4 ± 0.07 
0.8 ± 0.08 secondary structure (heavy) 
all heavy atoms 1.4 ± 0.1 
Ramachandran analysis (PROCHECK)   
most-favored region, %  80.8 
18.5 
0.4 
0.3 
additionally allowed region, %  
generously allowed region, %  
disfavored region, %  
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Figure 24. pHM binding does not significantly affect the backbone conformation 
of C2 domain.  (A) Backbone superposition of the C2(Ca2+)2 NMR ensemble 
(2NCE, gray) in the pHM complex with the crystal structures of the apo- (3RDJ, blue) 
and Ca
2+
-complexed C2 (1DSY, orange).  (B) Expansions of the 
15
N-
1
H HSQC 
spectra showing Ln
3+
-induced pseudocontact shifts of C2Ln3+ in the absence and 
presence of 15-fold molar excess of pHM.  The corresponding correlation plot of the 
PCS values is given in (C).  The inset shows the PCS correlation data for the LRC 
residues; LRC is the interaction site of pHM with C2.  The solid lines are x = y, 
whereas dashed lines are x = y ± 0.15; ± 0.15 is a typical uncertainty of the PCS 
measurements. 
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The experimental restraints included NOE intensities, dihedral angles, hydrogen bonds, 
and metal ion-oxygen coordination restraints for two Ca
2+
 ions (Table 5).  Superposition 
of the solution NMR ensemble of C2(Ca2+)2 onto the crystal structures of apo (3RDJ) 
and Ca
2+
-bound C2 (1DSY) C2 produced the backbone RMSD value of 1.1 ± 0.1 Å for 
both (Figure 24A).  This indicates that the structure of C2 does not significantly change 
upon binding with pHM.  It is evident from the inspection of the NMR structural 
ensemble that the CMBL3 and the loop region between strands β3-β4 of the lysine-rich 
cluster show more variability than the other C2 regions.  This is due to a lower number 
of restraints in these regions, which are highly dynamic in the complex. 
To establish if the structures of pHM-free and complexed C2 are similar in 
solution, we compared the 
1
H and 
15
N pseudo-contact shifts (PCS), which are induced by 
paramagnetic lanthanides.  Lanthanide-induced PCSs are sensitive reporters of protein 
structure through their dependence on polar coordinates of NMR-active nuclei in the 
coordinate frame of the magnetic susceptibility tensor, Δχ.  The C2 domain binds one 
Ln
3+
 ion with high affinity.  The binding site coincides with the high-affinity Pb
2+ 
binding site that we previously characterized.  This was established based on the near-
identity of 
1
H and 
15
N chemical shifts, and slow exchange behavior in the spectra of 
single Ln
3+
- and Pb
2+
-complexed C2.  We chose two paramagnetic lanthanide metal 
ions, Tb
3+
 and Tm
3+
 that have relatively large Δχ.  They also have opposite signs of axial 
and rhombic Δχ components (Figure 24B).  The PCS values were calculated as the 
difference between the chemical shifts in the paramagnetic and diamagnetic complexes 
of C2.  To ensure that the majority of C2 is in the pHM-bound form, we used samples 
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with a 15-fold molar excess of pHM over C2.  For both Tb
3+
 and Tm
3+
, we observed an 
excellent correlation between the backbone PCS values of C2 residues—including those 
that belong to the LRC—in the absence and presence of pHM (Figure 24C).  These 
results indicate the similarity of the C2 backbone conformation in the pHM-free and 
pHM-bound forms. 
The next step was to determine the conformation of pHM in the C2(Ca2+)2pHM 
complex.  A separate NMR sample was prepared that had C2 in molar excess with 
respect to pHM. This sample was used to ensure that  90% of pHM was in the C2-
complexed form.  We obtained the intra-peptide NOEs from the [
15
N,
13
C]-filtered 2D 
1
H-
1
H NOESY spectrum of the complex.  We detected no long-range NOEs in the 
spectrum of the bound pHM.  Except for the changes associated with the increase in the 
rotational diffusion correlation time due to the complex formation, there were no drastic 
differences between the NOE patterns of the free and C2-bound pHM.  This indicates 
that pHM does not undergo any significant conformational change upon C2 binding.  
The structural ensemble of pHM, which was calculated using 58 intra-residue and 41 
medium-range NOEs, revealed moderate conformational variability with a backbone 
RMSD of 1.9±0.5 Å.  The NMR ensembles of Ca
2+
-bound C2 and pHM were then used 
to generate the structural model of the complex. 
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Figure 25. The C2-pHM interface is stabilized by electrostatic and aromatic 
interactions.  (A) 20 top-ranking structures of the C2(Ca2+)2pHM complex with 
pHM and LRC/CMBL3 highlighted in red and purple, respectively.  Ca
2+
 ions are 
represented with green spheres.  The interface of the complex is stabilized by aromatic 
(B) and electrostatic (C) interactions.  The charged/polar and aromatic side-chains of 
C2 are shown in green and dark gray, respectively; all pHM side chains are colored 
gold.  The interacting residues are labeled with red (pHM) and black (C2) fonts. 
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C2(Ca2+)2pHM complex is stabilized by electrostatic and aromatic interactions 
To obtain structural restraints for the C2(Ca2+)2pHM complex, we conducted  
isotope-filtered/edited NOESY experiments that produced 29 inter-molecular NOEs 
between the C2 and pHM.  These NOEs were used as unambiguous restraints in the 
docking and refinement protocol, as implemented in HADDOCK 2.2/CNS 1.3.  The 
other type of restraints was the chemical shift perturbations of the 
15
N and 
1
HN of C2 due 
to pHM binding; those were incorporated as ambiguous restraints.  The 400 structures of 
the C2(Ca2+)2pHM complex produced during the final refinement step consistently 
have the pHM interacting with the concave face of C2 that bears the LRC region.  Some 
conformational variability is observed only for the N-terminal part of pHM that 
comprises residues 649–651.  This is due to a lack of unambiguous restraints in this 
region, as most inter-molecular NOEs were observed for the C-terminal and middle parts 
of pHM.  The most populated cluster 1 contained 41.5 % of the structures and also had 
the lowest average inter-molecular interaction energy among the six clusters.  The 20 
lowest-energy structures of the C2(Ca2+)2pHM complex also belong to cluster 1 and 
form a tight ensemble with an all-residue backbone RMSD of 0.41 ± 0.05 Å.  
The top-ranking structures of C2(Ca2+)2pHM illustrate the interaction mode 
between the hydrophobic motif and C2 domain (Figure 25A).  pHM binds to the concave 
face of the C2 domain, and makes contact with two major functional elements: the LRC 
region and the calcium binding loop CMBL3.  The conformation of pHM is extended, 
with the N-terminus pointing towards the loop between strands 3 and 4 of the LRC 
and the C-terminus pointing towards CMBL3.  The C2-pHM interface is stabilized by 
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electrostatic and aromatic interactions (Table 6).  Electrostatic interactions involve salt 
bridges between the negatively charged sidechains of the pHM residues and the 
positively charged sidechains of the C2 domain.  For example, Lys197, Lys209 and Lys 
211 form a salt bridge with the sidechain of Asp652, while Lys213 forms a salt bridge 
with the phosphoryl oxygens of Ser657 (Figure 25C).  Two phenylalanine residues of 
the hydrophobic motif, 653 and 656, are involved in ring stacking interactions with the 
aromatic residues of C2: Y195, Trp245, and Trp247 (Figure 25B).  
  
 
 
Table 6. Analysis of the C2-pHM interface 
 
 C2 residue /atom V5 residue /atom Distance (Å) 
Electrostatic    
salt bridges K213/Nζ pS657/O3P 2.6 
K213/Nζ pS657/O2P 2.8 
R252/Nη2 E654/O1 2.8 
R252/Nε E654/O1 3.0 
K209/Nζ D652/Oδ2 2.7 
K197/Nζ D652/Oδ2 2.9 
K211/Nζ D652/Oδ2 4.1b 
 K209/Nζ D649/Oδ2 2.7 
 N206/Nδ2 D649/Oδ2 2.7 
Aromatic    
ring stacking Y195/Cε F656/Cζ 3.4
a
 
weak H-bond Y195/OH F653/Cδ 3.8 
ring stacking W247/Cδ2 F656/Cδ 3.6a 
ring stacking W245/Cγ F653/Cε 3.8
a
 
cation-π R252/Nε F653/Cδ 3.4 
cation-π K197/Nζ F653/Cε 3.7 
a 
Representative distances are given to illustrate the proximity of the aromatic rings 
b
11/20 structures of the ensemble have this distance smaller than 2.8 Å.  In the other 9 
structures K211 is forming a H-bond with the backbone carbonyl of G655. 
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The cation-π interactions between Lys197, R252 and the aromatic ring of Phe653 
additionally stabilize the interface. All residues listed in Table 6, with the exception of 
Asn206, are conserved among the conventional PKC isoenzymes. 
 
Residues at the C2–V5 interface contribute to stabilization of the auto-inhibited 
conformation 
The next step was to determine the role of C2-V5 interactions in maintaining the 
auto-inhibited conformation of PKC.  Guided by the structural information about the 
C2(Ca2+)2pHM complex, we designed mutations that target electrostatic and aromatic 
interactions at the C2–V5 interface (Table 7).  The mutations were introduced into the 
full-length PKC construct fused with a FRET pair of fluorescent proteins: mCer at the 
N-terminus and mCit at the C-terminus.  To assess the effect of these mutations on the 
conformation of inactive PKC, we conducted intra-molecular steady-state FRET 
experiments in vitro, using mCer-PKC-mCit-FLAG variants purified from Sf9 cells.  
All PKC variants were kinase-active (Table 7).  The activity assays were conducted 
with endogenous activators, Ca
2+
 and diacylglycerol, incorporated into 
phosphatidylserine-containing large unilamellar vesicles. 
Steady-state FRET experiments were conducted in the absence of PKC 
activators.  Representative fluorescence spectra of PKC variants illustrate the 
magnitude of the FRET response (Figure 26A).  The “no-FRET” control spectrum (black 
trace) was collected for the wild-type protein, which was subjected to partial proteolysis 
that left mCit and mCer intact.   
 92 
 
 
Table 7. Mutated residues in each construct and their kinase activities relative to WT. 
Variant C2 V5 Kinase Activity
a
 
WT   1.00 ± 0.12 
S657A  S657A 1.19 ± 0.10 
K213A K213A  0.62 ± 0.17 
D652A  D652A 0.31 ± 0.09 
DS  D652A/S657A 0.81 ± 0.16 
KKRDS K197A/K209A/R252A D652A/S657A 0.42 ± 0.04 
D652K  D652K 1.10 ± 0.09 
KK K209E/K211E  0.74 ± 0.07 
DKK K209E/K211E D652K 0.42 ± 0.11 
YW Y195A/W247A  0.20 ± 0.02 
FYYW Y195A/W247A F656A/Y658A 0.13 ± 0.03 
F656A  F656A 0.22 ± 0.01 
a
 Performed in the presence of POPC:POPS:DAG=(65:30:5) LUVs. All activities are 
scaled relative to WT proteins. 
 
 
 
 
Figure 26. Destabilization of the autoinhibited PKCα conformation by targeted 
mutagenesis at the C2–V5 interface. (A) Fluorescence emission spectra of WT, 
FYYW variant, DS variant and the Lys-C treated WT. The inset schematic on the left 
depicts the mCer-PKCα-mCit-FLAG construct used for in vitro fluorescence 
measurements of autoinhibited PKCα. (B) The FRET ratio ± SEM of WT and all 
variants are from at least three independent experiments. The dashed lines group the 
variants the same as in Table 7. 
 
 93 
 
In the spectrum of the intact wild-type PKC (blue trace), the intensity of mCit emission 
peak at 525 nm increases due to FRET between the protein termini.  The fluorescence 
spectra of two PKC variants, D652A/S657A and Y195A/W247A/F656A/Y658A, 
illustrate the decrease in FRET efficiency due to perturbations of electrostatic and 
aromatic interactions at the interface. 
The FRET data, presented as acceptor/donor intensity ratios, show that all PKC 
variants have lower FRET efficiencies compared to the wild-type protein (Figure 26B).  
The data are divided into three groups, according to the type/specifics of the targeted 
interaction.  To probe the contribution of electrostatic interactions, we disrupted two salt 
bridges by mutating charged residues to an alanine.  The S657A and its K213A  
variants showed similar values of FRET ratios, ~0.9, compared to 1 in the wild type.  
The other salt bridge involves Asp652 that interacts with the lysines of the LRC.  
Mutation of D652 to either alanine or lysine decreased the FRET ratio to 0.74 or 0.71, 
respectively.  A similar result was obtained for the DS variant where both negatively 
charged amino acids of the V5, phosphorylated Ser657 and Asp652, were replaced with 
alanine. 
The charge reversal of the Asp652 interacting partners, Lys209 and Lys211, in 
the KK PKC variant produced an even lower FRET ratio of 0.69.  A simultaneous 
charge reversal of Asp652 and Lys209/Lys211 in the DKK variant generated a FRET 
ratio that was comparable to what we observed in the individual charge reversal variants 
D652K and KK.  These data indicate that the wild type-like conformation of auto-
inhibited PKC is not fully recovered by a simple charge reversal of the interacting 
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sidechains.  Mutations involving aromatic residues generated a more moderate decrease 
in FRET ratios compared to those observed in Asp652 variants.  A surprising finding 
was that a mutation of a single aromatic amino acid in the hydrophobic motif, Phe656, 
was sufficient to produce a FRET ratio comparable to that of the S657A variant. 
  
 
 
 
Figure 27. pHM activates PKCα under various conditions.  (A) Basal activities of 
mCer-hPKCα-mCit-FLAG in the absence of lipid ligand, with and without pHM 
peptide added. (B) Activities in the presence of 500nM PDBu, with and without pHM 
peptide added.  (C) Activities in the presence of LUV (POPC/POPS/DAG = 65/30/5 
mole %) and 1mM Ca
2+
, with and without pHM peptide added. All activities are 
averaged for at least three independent experiments, with ±STD. 
 
 
 
In summary, our fluorescence data indicate that conserved PKC residues at the 
C2–V5 interface contribute to the stabilization of the auto-inhibited conformation of the 
enzyme.  It should be noted that while FRET data provide a general (and motionally 
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averaged) view of the PKC conformation, they do not directly report on the exposure 
of membrane binding sites. 
 
pHM activates PKCα under various conditions 
In an effort to further demonstrate the autoinhibited role of the observed C2–V5 
interface, we measured kinase activities of the wild-type mCer-hPKCα-mCit-FLAG 
protein in the absence and presence of the pHM peptide. If the C2–V5 interaction 
contributes to autoinhibition, we would expect a competition by the externally added 
pHM peptide with the intra-molecular pHM site, which would destabilize the closed 
conformation to increase kinase activity. This is indeed what we see: the basal activity is 
increased significantly 3.6-fold by pHM peptide in the absence of Ca
2+
 (Figure 27A).  
We further tested the kinase activities in the presence of PDBu, which binds the 
C1 domains with high affinity. PDBu alone activates the kinase some (2.00 ± 0.23 
pmol/min with the quantity of kinase added, see Experimental procedures) (Figure 27A, 
B), which is consistent with previous findings.
2
  We also see a further activation of 2.4-
fold by the addition of pHM peptide. This is consistent with pHM destabilizing the 
autoinhibited conformation of the kinase, which results in a higher exposure of C1 
domains to PDBu binding. The activities in the presence of LUVs and Ca
2+
 are much 
higher than the equivalent PDBu conditions, consistent with C2 domain binding PtdSer-
containing membranes in a Ca
2+
-dependent manner. However, we observed an inhibiting 
effect of pHM peptide with Ca
2+
 and LUVs (Figure 27C). This could be explained by 
pHM occupying the LRC of C2 to prevent C2 associating with LUVs. It is worth 
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mentioning that with the pHM peptide alone, the kinase activity is already 47% of the 
fully activated state (LUV and Ca
2+
) (Figure 27A, C). In the absence of Ca
2+
, PDBu and 
pHM together can activate the kinase to 80% of the fully activated power (Figure 27B, 
C).  
In summary, the pHM peptide is able to activate the full-length kinase under 
various conditions, with the largest enhancing effects seen in the absence of PKC 
agonists. This is consistent with our model where the C2–pHM interface contributes 
predominantly to the closed, autoinhibited conformation of the latent kinase. 
 
Altered membrane translocations of PKCα by targeted mutagenesis at the C2-V5 
interface 
To investigate the effects of mutating C2–V5 interface on the activation of 
PKCα, we used a different FRET pair setup to measure membrane translocation in 
mammalian cells.  This part of the work was done in collaboration with Julia Callender 
and Dr. Alexandra Newton at UC-San Diego.  The experimental setup is shown in 
Figure 28A, where YFP was fused to the N-terminus of PKCα, and CFP is anchored on 
the plasma membrane through fused signal sequences for myristoylation and 
palmitoylation. All variants still retain a significant amount of phosphorylation at the 
turn motif (Figure 28B pT638 panel). Two variants, FYYW and F656A, display a 
noticeable decrease in the turn motif phosphorylation, and an undetectable 
phosphorylation at the activation loop (Figure 28B pT497 panel).   
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Figure 28.  Altered membrane translocations of PKCα by targeted mutagenesis 
at the C2–V5 interface. (A) Schematic diagram showing the experimental setup for 
monitoring the YFP-tagged PKCα membrane translocation to plasma membrane (PM) 
containing myristoylated/palmitoylated CFP used in (C-E). (B) Western blot 
displaying the cell lysates transfected with the YFP-PKCα constructs. The primary 
antibodies used for each panel are listed on the right.  (C-E) FRET ratio changes 
(mean ± SEM) displaying PDBu induced PKCα plasma membrane translocation of 
WT and variants S657A, FYYW and F656A in (C); D652K, KK and DKK in (D), 
and the rest of the variants in (E).  Figure credits: J. A. Callendar and A. C. Newton 
panel (B); T. I. Igumenova panels (C-E). 
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This indicates that the variants containing Phe656 mutation are correctly phosphorylated 
by PDK-1 in the cell, but are more susceptible to phosphatases due to more open 
conformations.  The lack of signal for S657A, KKRDS variants at hydrophobic motif, is 
due to the mutation (Figure 28B pS657 panel). It is hard to determine the 
phosphorylation states at hydrophobic motif for the FYYW and F656A variants.  The 
Phe656 mutation may affect antibody binding; because the pS657 antibody was 
commercially produced by immunizing animals with a synthetic phosphopeptide 
corresponding to residues surrounding Ser660 of human PKCβII including the Phe 
residue (see Experimental procedures for source of antibody). 
The change in FRET ratio upon PDBu addition exclusively reports on membrane 
translocation to the plasma membrane (PM).  It is worth noting that the PM contains a 
majority of cellular PtdIns(4,5)P2, which is the ligand for the LRC of C2 domain.  PDBu 
is an analogue of the natural ligand DAG, and it binds much tighter than DAG to the C1 
domains of PKC.  Ca
2+
 concentrations in the cells were kept at basal level in these 
experiments, since mutations on the C2–V5 interface would also affect the overall 
affinity for Ca
2+
 and the following Ca
2+
-dependent membrane binding.  Thus, the 
membrane translocation data here relies in part on the exposure of C1 domains in each 
construct.  Other factors also play a role in modulating the membrane translocation, 
since the system is quite complex as described in the following text. 
The kinetics of membrane translocation of the wild-type YFP-PKCα construct is 
biphasic upon PDBu stimulus (Figure 28C, black).  The wild-type FRET ratio trace can 
be fit very well with a combination of “fast” and “slow” functions (Figure 28C, dashed 
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lines).  In a previous study where both YFP-tagged PKCα and PKCβII were tested, YFP-
PKCβII seems to translocate with a single exponential kinetics.155  The single 
exponential kinetics of YFP-PKCβII indicates that the biphasic behavior of YFP-PKCα 
is not likely due to an intrinsic biphasic behavior of the YFP upon membrane 
translocation of the fusion protein.  A more possible interpretation for the biphasic 
behavior is that there is an intermediate PKCα conformation, in addition to the fully-
closed conformation, existing in the cell.  This intermediate conformation responds to 
PDBu stimulation much faster than the fully-closed conformation.  The possible 
intermediate conformations are: (1) a “pre-DAG” membrane-associated conformation 
which is partially open,
156
 (2) a dimer conformation pre-formed at plasma membrane
157
 
and (3) a dephosphorylated conformation.  The “pre-DAG” conformation is the most 
likely one.  The dimer conformation was proposed to be induced by the presence of 
Ca
2+
/PMA or Ca
2+
/PS/DAG.
157
  The dephosphorylated conformation for WT PKCα is 
induced by prolonged stimulus of PDBu but not DAG.
45,158
  The maximum time window 
here is 10 min, which should not cause active dephosphorylated conformation at the 
moment of PDBu addition.  In addition, the western blots showed that the 
phosphorylation levels at pT497 and pT638 for wild-type PKCα were high, and that of 
pS657 was also significant (Figure 28B).  The “pre-DAG” and dimer conformations 
were both investigated in the case of PKCα, explaining potential isoform discrepancy 
from PKCβII.    
In the frame of the mostly likely scenario, i.e., the faster-responding intermediate 
conformation corresponds to the partially open “pre-DAG” conformation, the variants 
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can be categorized into three groups.  The first group consists of variants S657A, F656A 
and FYYW as shown in Figure 28C.  Their membrane translocation traces contain only a 
“fast” stage compared to the wild-type.  This indicates that these three variants 
completely disrupted the fully-closed conformation of the kinase, resulting in only the 
intermediate conformation in the cell.  The equations for fitting the apparent rate 
constants are shown in the Experimental Procedure section.  It is important to note that 
the apparent rate constant is the sum of forward and reverse rates (kapp = kon + koff, where 
kon is the pseudo first-order rate constant, assuming the simplest model in which 
available membrane ligands far exceeds the amount of cytosolic protein).  When 
comparing the fitted apparent rate constants for these three variants to the “fast” stage of 
wild-type, the variants are still translocating faster than the intermediate of wild-type 
(Table 8).  This is consistent with our hypothesis that HM is involved in stabilizing the 
compact form.  
 
 
 
Table 8. Apparent membrane translocation rates for wild-type and variants. 
Variant Components     Step kapp (min
-1
) 
WT 2 fast 1.10 ± 0.06 
  slow (4.10 ± 0.26) × 10
-3
 
S657A 1 fast 1.20 ± 0.04 
F656A 1 fast    1.22 ± 0.05 
FYYW 1 fast 1.28 ± 0.03 
D652K 1 slow 0.20 ± 0.01 
KK 1 fast 0.77 ± 0.03 
DKK 1 slow 0.22 ± 0.01 
K213A 2 fast 1.11 ± 0.03 
  slow (2.48 ± 0.15) × 10
-3
 
KKRDS 2 fast 1.32 ± 0.07 
  slow (3.32 ± 0.19) × 10
-3
 
 
 101 
 
The second group consists of D652K, KK and charge-reversal DKK variants.  
D652K mutation results in high total translocation levels compared to all variants tested 
in this work.  A high translocation level of D652K is consistent with a large koff/kon ratio 
(fraction of protein translocated at steady state equals 1/(1+Kd), where Kd = koff/kon).  
It is unlikely that D652K mutation affects the off-rate, because it is potentially not in the 
membrane-binding part of the kinase.  Therefore, high total translocation levels are due 
to an increased kon value, which would be consistent with the destabilization of the 
inactive conformation.   
The translocation trace of D652K appears to contain only one component (Figure 
28D).  It is possible that the Asp652 to Lys mutation interferes with the formation of the 
intermediate conformation existing in wild-type protein.  In this case, the D652K variant 
only has one conformation in the cell, which is similar to the fully-closed conformation 
of wild-type.  However, the apparent translocation rate of the D652K variant is much 
faster than the “slow” rate of wild-type (Table 8).  This is still consistent with a more 
open mature conformation by mutating residue Asp652.   
In the DKK variant, the apparent rate is the same as in D652K (Table 8).   This 
means that the sum of kon and koff is the same for both.  However, the steady-state 
translocation level of DKK is lower, indicating an increase in the ratio koff/kon.  If koff in 
DKK goes up compared to D652K, this should be accompanied by a decrease of kon.  
Decrease in kon in DKK is consistent with the stabilization of the inactive conformation 
by simultaneous charge reversal of D652 and the LRC residues.  However, it does not 
exhibit the biphasic behavior of wild-type protein.  In the KK variant, the apparent rate 
 102 
 
goes up to 0.77 min
-1
 but the steady-state levels are smaller compared to D652K (Table 
8 and Figure 28D).  This is consistent with an increase the koff/kon ratio compared to 
D652K.  It is likely due to the effect of an increased koff, which previously occurred in 
mutations of positively charged residues near this region.
61,63
 
The last group consists of K213A and KKRDS variants.  Their translocation 
kinetics are similar to wild-type in the sense of biphasic behavior (Figure 28E).  The 
K213A variant seems to increase the koff/kon ratio slightly compared to wild-type 
behavior. This is consistent with an increased koff as seen for the KK variant (see above).  
However, the change is small due to the fact that LRC has a high density of positive 
charges and can still interact with pSer657 in the variant.  The KKRDS variant increases 
the apparent rate for the “fast” stage compared to the wild-type.  However, it has a 
similar steady-state translocation level to the wild-type behavior.  This is consistent with 
a simultaneous increase of both koff and kon.          
 
Discussion of results 
We present here the solution structural model of the ternary C2(Ca2+)2pHM 
complex, which unveils the first atomic details of the C2–V5 intramolecular interaction 
of PKCα.  The interacting interface of the complex structure involves both electrostatic 
and hydrophobic residues from C2 and V5.  All interacting residues are highly 
conserved throughout conventional PKCs.   
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Figure 29. Model for the calcium-sensitizing and autoinhibitory roles of C2–V5 
interaction during PKCα activation. (A) Overlay of binding sites between the pHM 
and PtdIns(4,5)P2.  The PtdIns(4,5)P2 headgroup-associated crystal structure is PDB 
ID: 3GPE.  Atoms of pHM peptide are colored red, and PtdIns(4,5)P2 headgroup is 
colored gold with purple phosphorus atoms.  (B) HADDOCK model of C2–V5 
interaction using the crystal structure of PKCα kinase domain (PDB ID: 3IW4) and the 
solution structure of C2 domain determined in this work. C2 domain is colored dark 
grey, V5 domain is in red and the rest of kinase domain is colored cyan.  (C) 
HADDOCK model of C2–V5 interaction using the crystal structure of PKCβII (PDB 
ID: 3PFQ), overlaid with the “Mode ii” of the original crystal structure.23  C2 domains 
are colored dark grey in the HADDOCK model, and blue in the “Mode ii” model.  (D) 
Model depicting the dual roles of C2–V5 interaction during PKCα activation.  The C2–
V5 interaction is enhanced by the phosphorylation of hydrophobic motif upon 
maturation, which contributes largely to the closed conformation of cytosolic, 
autoinhibitory PKCα.  The same interaction alters the electrostatic potential of C2 
domain such that the calcium binding affinity is enhanced during activation.  
Interaction between C2 lysine-rich cluster with PtdIns(4,5)P2 on the plasma membrane 
displaces V5-pHM and leads to maximum activation of PKCα.  Panel D figure credit: 
T. I. Igumenova. 
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Among the V5 residues involved in this interaction, Asp652 is identical in PKCγ and is a 
Glu in PKCβI and PKCβII; Phe653 and Phe656 are identical throughout all four cPKCs; 
and the conserved phosphorylation residue Ser657 is identical in PKCβI and PKCβII, 
and is Thr in PKCγ (Figure 7B in Chapter II).  All C2 residues on the interacting 
interface are identical throughout cPKCs, with the exception of Asn206.  Since Asp649 
is located on the edge of the interface, and the N-terminus is not restrained well when 
inspecting the whole HADDOCK pool of 400 structures, we concluded that the 
interaction involving Asp649 and Asn206 does not play an indispensable role.  
This structural model is validated by the functional impact of mutating the 
residues at the C2–V5 interacting interface guided by the same structure.  From the 
FRET ratios of purified autoinhibited proteins, we concluded that all the charged and 
hydrophobic residues contribute in concert to the interaction.  We also observed an 
unambiguous activating effect of externally added pHM peptide on the wild-type full 
kinase.  From the membrane translocation studies, we concluded that the mutation of the 
Phe656/pSer657 dual from HM of V5 both significantly increased the kon to plasma 
membrane upon PDBu stimulation.  The Asp652 centered interaction disrupts the 
biphasic behavior of the wild-type protein, potentially resulting in a faster membrane-
translocating mature conformation.  Taken together, the C2–V5 interface described here 
plays a pivotal role in maintaining the closed conformation of the autoinhibited kinase, 
in which the membrane-binding sites of C1 domains are masked by intra-molecular 
interactions. 
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Another role of C2–V5 interaction, which seems contradictory from the 
autoinhibitory aspect, is to sensitize the calcium binding to the C2 domain by lowering 
the overall electrostatic potential of C2.  This is seen here by our extensive in vitro 
investigation of the interplay between pHM and Ca
2+
 ligands to C2 domain.  A similar 
effect was also seen previously with PtdIns(4,5)P2 enhancing the binding affinity of the 
C2 domain to Ca
2+
 and Pb
2+
.  As observed with the structural overlay of our complex 
structure to the PtdIns(4,5)P2 bound C2 crystal structure (Figure 29A), the Asp652 
centered interactions masks the PtdIns(4,5)P2 binding site for C2.  From these, we infer 
that the C2–V5 interaction presented here is crucial for PtdIns(4,5)P2 selectivity of 
cPKCs.  
In order to visualize the C2–V5 interaction described here in the context of full-
length cPKCs, we modelled the interaction with the crystal structures of PKCα and 
PKCβII, using the same set of inter-molecular restraints derived from our solution 
C2(Ca2+)2pHM complex.  The LRC concave of C2 domain contacts extensively the 
HM of V5 for both cases (Figure 29B, C), whereas the CMBLs of C2 remains solvent 
exposed and Ca
2+
 accessible.  In a superimposed comparison of the previously proposed 
C2–kinase model23,55 and our docked model (Figure 29C), C2 domain is rotated around 
the tip of the beta3-4 loop towards V5-HM in our model for 161°.  Both models are 
validated by mutagenesis studies, and support the importance of LRC from the C2 
domain as well as the HM from the V5 domain.  However, our data that the externally 
added pHM peptide effectively activates the kinase support the HM as an interacting 
partner for C2.  Since the hinge linker between the C2 and N-lobe of the kinase domain 
 106 
 
consists of about 43 amino acids, the C2 domain in theory can sample around the entire 
kinase domain with a large degree of freedom.  Thus these two models present a delicate 
illustration of the potential conformational plasticity relating to the C2 domain at 
different stages of kinase regulation.   Given the extent and conservation of interacting 
residues in our model, as well as the functional aspect of Ca
2+
 and PtdIns(4,5)P2 
interactions, we think that the C2-V5 interaction described herein resembles closely the 
conformation between the initial Ca
2+
 binding event and C2 association with the 
PtdIns(4,5)P2-containing plasma membrane.  The reason this interaction was not 
observed in the intermediate state of PKCβII crystal structure could be due to the 
intrinsically dynamic properties of the entire V5 region preventing the formation of 
stable crystal packing.  In our docked model with full kinase domains of PKCα and 
PKCβII, no extra interaction is observed between C2 domain and residues of kinase 
domain other than V5-HM.  Thus the C2–V5 interaction probably does not provide 
much further stabilization of V5 conformation.  
We propose a model of cPKC activation by second messengers pertaining to the 
C2–V5 interaction described here (Figure 29D).  The phosphorylated HM of V5 masks 
the LRC of C2 domain in the auto-inhibited conformation of PKC prior to the upstream 
signaling event leading to an increase of cytosolic calcium concentration.  The altered 
electrostatic potential of the C2 domain assists in acute response for calcium binding by 
interacting with the HM.  Once calcium ions are bound to the CMBLs of C2, the C2 
domain is now capable of associating with the PtdSer lipid headgroup through 
completion of the calcium coordination sphere (to be discussed in Chapter V).  However, 
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the HM of V5 remains associated with C2 domain until a search for PtdIns(4,5)P2 
headgroup is successful, replacing the HM from LRC and leading to a full release of C2 
domain.  The C2–V5 interaction here plays both calcium-sensitizing and autoinhibitory 
roles.  Once fully activated, the C2–V5 interaction probably contributes to the recycling 
of the kinase when the calcium concentration is decreased.  Alternatively, V5-HM was 
shown important for Pin1 peptidyl-propyl isomerase dependent down-regulation,
45
 
which according to our model would only be accessible to Pin1 when V5-HM is 
displaced by PtdIns(4,5)P2 (to be discussed in Chapter IV).  
Caution needs to be taken when interpreting the significance of our docked 
models with PKCα and PKCβII, since C1A and C1B domains are not included. The 
exact placement of these two domains in the full-length kinase is still largely elusive. It 
is worth noting that neither our C2–V5 model nor the previously proposed C2–kinase 
model supports the intra-molecular interaction between C1B domain and the NFD region 
of V5 domain, due to the limited length of the C1B–C2 linker. To discern the locations 
of C1 domains and the order of actions relative to the C2 domain conformations 
discussed in this work, future research is required investigating intra-molecular 
interactions involving C1 domains. However, our study certainly illustrates the atomic-
level information about the significant contribution from the HM of V5 domain to both 
auto-inhibition and activation of cPKC. Although the interacting residues between C2–
V5 are conserved within cPKCs, the V5 region is highly variable throughout all PKC 
isozymes. The information provided here could shed light on designing therapeutic 
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agents targeting the C2–V5 interaction, in order to up- or down-regulate kinase activities 
specific to conventional PKC isoforms.      
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CHAPTER IV  
INTERMOLECULAR INTERACTION BETWEEN V5 DOMAIN AND PEPTIDYL-
PROLYL ISOMERASE PIN1 REVEALS NON-CANONICAL BINDING SITE AND 
NON-CATALYTIC MECHANISM. 
 
Background 
As discussed in Chapter II and III, the C-terminal V5 domain is intrinsically 
disordered and interacts with the Ca
2+
-dependent membrane-binding C2 domain within 
the same PKCα molecule.  In addition to these characteristics, the V5 domain has also 
been implicated in potential intermolecular interaction with the peptidyl-prolyl 
isomerase Pin1 by Abrahamsen et al.
45
  This study revealed that the proteasome-
dependent down-regulation of conventional PKC isoforms is controlled by the peptidyl-
prolyl isomerase Pin1.  The authors proposed a model in which conventional PKCs 
directly interact with Pin1; this interaction facilitates dephosphorylation of PDBu-
stimulated conventional PKCs and leads to down-regulation through ubiquitination and 
proteasome-dependent degradation.  This chapter focuses on understanding the 
molecular basis of Pin1 interaction with the C-terminal V5 domain. 
Pin1 is a eukaryotic peptidyl-prolyl isomerase, which belongs to the parvulin 
sub-family.
159
  It contains two domains each possessing a distinct structure and function: 
(1) a type IV WW domain that preferentially binds phosphorylated-(Ser/Thr)-(Pro) 
(referred to as pS/T-P in the following text) motifs and (2) a PPIase domain that 
catalyzes proline cis-trans isomerization of the same motif (Figure 30A).   
 110 
 
 
Figure 30. The two proposed binding partners: Pin1 protein and the V5 domain 
from conventional PKCs.  (A) Crystal structure of full-length Pin1 protein is 
displayed in both ribbon and surface representations (PDB ID: 1PIN).  Surface of the 
WW domain is dark gray, the PPIase domain is salmon, and the linker is green.  The 
PEG molecule (gold) and the AlaPro dipeptide (red) from the crystal structure are 
shown to indicate pS/T-P motif binding sites. (B) Sequence alignment is shown for 
the V5 domain from conventional PKC isoforms.  Turn and hydrophobic motifs are 
shown in the boxes, with phosphorylation sites indicated.  Proline residues in the turn 
motif are highlighted with purple fonts.  (C) Sequences of phosphorylated peptides 
used in this study are indicated.  The pTM, pHM and pV5 peptides are highlighted 
with blue, red and black lines, respectively. 
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The two domains of Pin1 both recognize the pS/T-P motif, but for several known Pin1 
targets the WW domain has been observed to have significantly higher substrate affinity 
than the PPIase domain.
160
  The substrate selectivity of Pin1 is unique among the PPIase 
family, which allows it to modulate protein interactions following the phosphorylation 
events during kinase signaling.
161
  Due to these features, Pin1 plays a role in various key 
signaling pathways and has been associated with many human diseases such as 
neurodegenerative diseases and cancers.
162-164
   
The molecular mechanism of the Pin1 function is not well understood.  This is 
due to three main challenges.  The first challenge has to do with the linker between the 
two domains of Pin1, which is long and flexible.  The linker length between the two 
domains is 16~18 amino acids, calculated from the last amino acid of WW domain 
folded core Pro37
165,166
 to Arg54, Val55 or Arg56, the first amino acid of β4 defined in 
PDB ID 1NMV, 1F8A or 1PIN, respectively.  This relatively long and solvent-exposed 
linker allows a large degree of freedom for the linker itself, and consequently, the 
conformational flexibility of the full protein.  This can be visualized by inspecting the 
large conformational deviations in the Pin1 NMR structural ensemble (PDB ID 1NMV), 
and a lack of inter-domain NOE in the same study.
167
  The NMR structural ensemble is 
shown in Figure 31, with the flexible linker highlighted.  Although the domain 
interaction is probably weak in solution, numerous studies have provided information on 
the change of conformational sampling between the two domains upon ligand binding.  
It was proposed that domain interactions of Pin1 could affect substrate recognition.
168
  
Another study observed transient and intricate open and closed conformations of Pin1 
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under various conditions.
169
  A most recent mutagenesis study indicated an auto-
inhibiting role of domain interactions in the case of the pCdc25C substrate.
170
  These 
studies together demonstrated the complexity of the ligand binding mode due to the large 
domain flexibility of Pin1. 
 
 
 
 
Figure 31.  The large conformational flexibility of the two domains visualized in 
the NMR structural ensemble of Pin1 (PDB ID 1NMV).  The first structure in the 
ensemble is selected to illustrate the domain compositions, and the rest of structures 
are colored gray.  The folded core of the WW domain is colored green; the PPIase 
domain is blue; the flexible N-terminus and the flexible inter-domain linker are red.  
 
 
 
 113 
 
The second challenge to understanding the Pin1 function is related to the 
mechanism of the Pin1 catalysis.  The PPIase domain of Pin1 catalyzes the cis-trans 
isomerization of the substrate peptidyl-prolyl bond.  The two main proposed 
mechanisms for this process are: (1) nucleophilic addition by the enzyme thiol of 
Cys113 at the carbonyl carbon of phosphorylated residue, which is supported by the 
apparent pH dependence of enzymatic activity;
159
 (2) twisting the amide bond out of 
conjugation by hydrogen bonding to the prolyl nitrogen, which is supported by normal 
2° KIE (kinetic isotope effect) on the phosphorylated residue and inverse 2° KIE on the 
proline residue.
171
  Each mechanism has a crystal structure of Pin1 as a support, but the 
twisted amide mechanism seems to be more favored due to a similar mechanism of other 
PPIase proteins.    
The third challenge is the role of catalysis in the Pin1 function.  Despite the 
catalyzing function of its PPIase domain, Pin1 has been proposed to play a non-catalytic 
role especially in the cytoplasm of the cell.
172
  In this study, mutations of the phosphate 
binding loop on the PPIase domain had a negative effect on Pin1 binding to some target 
proteins; however, this did not apply to the mutation of the potential active site residue 
Cys113.
172
  Even though the Cys113 was thought to be associated with the nucleophilic 
catalytic mechanism, which still remains controversial, this information still reveals 
importance of the PPIase-substrate binding in addition to the catalytic activity.  On the 
other hand, a quite significant number of known Pin1 substrates contain a pS/T-P-P 
sequence, with an additional proline at the +1 position.  The −1 and 0 positions by 
convention refer to the phosphorylated serine/threonine (pS/T) and the first proline (P) 
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residues, respectively.  NMR experiments of Tau protein indicated that the pS/T-P-P 
sequence interacted preferentially to the WW domain.
173,174
  Two other Pin1 target 
proteins were also indicated to be PPIase domain independent.
175,176
  In addition, various 
Pin1 target proteins contain more than one binding site, suggesting potential multi-valent 
protein-protein interactions.  However, it is not clear yet how the non-catalytic aspect of 
Pin1 relates to its cellular function and regulation due to limited information. 
It is worth mentioning that since the PPIase domain has a weak affinity and 
catalytic activity towards the pS/T-P motifs, the only structures of a PPIase domain 
bound to a longer peptide were co-crystalized with peptide inhibitors.
177
  With all 
aspects of Pin1 complexity in mind, we seek to understand the molecular mechanism 
relating to the Pin1-mediated down-regulation process of conventional PKCs.  In the 
model of Abrahamsen et al., Pin1 was proposed to bind the hydrophobic motif (HM) of 
the V5 domain and catalyze the proline isomerization of the turn motif (TM).
45
  
However, the sequence in the hydrophobic motif of the V5 domain lacks a proline 
following the phosphorylated serine residue (Figure 30B), raising the question as to why 
this non-canonical site is essential for Pin1 binding.  On the other hand, the turn motifs 
of PKCα, βII and γ isoforms have an additional proline residue that immediately follows 
the conventional isomerization site, i.e., p(Thr)-(Pro)-(Pro).  It is not clear whether or not 
the turn motif of these isoenzymes is an efficient substrate for Pin1 catalysis.  In addition 
to the above questions, the proposed interaction between V5 and Pin1 involves four 
potential players: TM and HM of the V5 domain; the WW domain and the PPIase 
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domain of Pin1 (Figure 30).  Unfortunately, the mode of Pin1–V5 interaction could be 
complicated by all the possible binding combinations. 
In this chapter, we demonstrate the binding preferences of Pin1 to V5 with a 
“divide-and-conquer” approach.  We first isolated the four basic interaction elements to 
investigate protein-protein interactions.  We then assembled the full-length Pin1 and V5 
motifs to obtain the whole picture.  We also showed that the TM of V5 from PKCα is 
not an efficient substrate for the PPIase activity of Pin1.  These results provided valuable 
insights into the first step of conventional PKCs down-regulation mediated by Pin1, 
which could assist in developing strategies for isoform-specific regulation of PKC.  The 
study herein is, to our knowledge, the first detailed characterization of a cooperative 
multivalent Pin1 interaction containing both a non-catalytic site and a non-canonical site 
for Pin1.  
 
Experimental procedures 
Plasmid construction 
The human Pin1 (residue 1–163 full length, codon-optimized DNA sequence) 
construct was cloned into a pET-SUMO vector (Invitrogen). Isolated WW domain (1–
50) and PPIase domain (41–163) constructs were generated by QuikChangeTM site-
directed mutagenesis using the original pET-SUMO-Pin1 plasmid as a template.  
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Protein and peptide purification 
The human Pin1 (residue 1–163 full length) construct was transformed in E.coli 
BL21(DE3) cells for overexpression.  The isolated WW domain and PPIase domain have 
significant leaky expression in the regular BL21(DE3) cells before addition of IPTG, so 
instead BL21(DE3)pLysS cells are used for expressing isotope-enriched proteins.  For 
natural abundance proteins, cell cultures were grown to OD600 value of 0.6 and induced 
with 0.5 mM IPTG for 4–5 hrs at 37 °C.  For 15N-enriched (13C,15N-enriched) proteins, 
we used the resuspension method of Marley et al.
92
 with M9 minimal media containing 1 
g/L of 
15
NH4Cl and natural abundance glucose (1 g/L 
15
NH4Cl and 3 g/L 
13
C-D-glucose) 
(Cambridge Isotopes).  In the case of isotope-enriched preparations, the protein 
expression was induced for 15 hrs at 15 °C for regular BL21(DE3) cells, or 5 hrs at 37°C 
for BL21(DE3)pLysS cells. 
The cells were harvested by centrifugation (30 min, 4,000 rpm at 4 °C) and lysed 
by sonication in a buffer containing 20 mM Tris-HCl, 0.5 M NaCl, 5 mM imidazole and 
10 mM βME at pH 7.5.  The His6-tagged SUMO-Pin1[fl, WW or PPIase] fusion proteins were 
purified using a HisTrap™ HP Ni affinity column (GE Healthcare Life Sciences).  The 
fractions containing fusion protein were buffer exchanged on a HiPrep 26/10 column 
(GE Healthcare Life Sciences) into a cleavage buffer containing 20 mM Tris-HCl, 0.15 
M NaCl at pH 8.0.  Tag-free Pin1[fl, WW or PPIase] proteins were obtained by cleaving the 
fusion proteins for 30 minutes with His6-tagged SUMO protease at room temperature, 
followed by another Ni affinity purification step to remove SUMO and SUMO protease.  
The purified proteins were further buffer exchanged with a 5 kDa MWCO membrane 
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concentrator (Sartorius Vivaspin) for full-length Pin1 or the isolated PPIase domain, or a 
3kDa MWCO membrane concentrator (Sartorius Vivaspin) for the isolated WW domain, 
into freshly made final NMR buffer containing 10 mM d4-imidazole, pH 6.6, 100 mM 
KCl, 1mM TCEP, 8% D2O, and 0.02% NaN3.  The purity of Pin1[fl, WW or PPIase] proteins 
was evaluated using SDS-PAGE.  The concentrations were measured with A280 nm 
with the corresponding extinction coefficients: full-length Pin1 20,970 M
-1
cm
-1
, isolated 
WW domain 13,980 M
-1
cm
-1
, and isolated PPIase domain 6,990 M
-1
cm
-1
.  The molecular 
weights of purified proteins were verified by MALDI-TOF mass spectrometry.  
The peptides were purchased from Eton Bioscience, with acetylation and 
amidation at the N- and C-termini, respectively.  Amino acid sequences of peptides used 
in this study are shown in Figure 30C.  The pTM-P640A is a single alanine substitution 
peptide at the P640 position of pTM peptide. Crude peptide mixtures were purified on a 
C18 column using HPLC.  The buffers used for HPLC were: A 5 mM NH4HCO3 in 
HPLC-grade water and B 5 mM NH4HCO3 in 82% HPLC-grade acetonitrile and 18% 
HPLC-grade water.  Linear gradients from 0–20%, 0–30%, 10–30%, 10–40% buffer B 
were used to purify pTM-P640A, pTM, pHM and pV5 peptides, respectively.  The 
molecular weight and purity of the peptides after HPLC purification were verified using 
ESI mass spectrometry.  The peptide stock solutions were prepared in HPLC-grade 
water and adjusted to pH 6.6 with ammonium hydroxide.  Stock concentrations of 
purified phosphorylated peptide were measured using a phosphate assay.
132
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NMR-monitored binding experiments and resonance assignments 
The peptide-binding experiments were conducted by adding aliquots of 
concentrated peptide stock solutions to [U-
15
N] Pin1 full-length protein or isolated WW 
domain protein.  The protein concentration in the NMR samples ranged from 90 to 100 
M.  For each ligand concentration, [15N-1H] HSQC spectra were collected at 25 °C on 
Bruker Avance III spectrometers operating at the Larmor 
1
H frequencies of 600 MHz or 
800 MHz.  For the chemical shift perturbation (CSP) and binding curve analysis, the 
residue-specific chemical shift change between any given pair of Pin1 (or WW) states 
was calculated as follows: 
 ∆= √(∆𝛿𝐻)2 + (0.152 × ∆𝛿𝑁)2 4.1 
where H and N are the residue-specific differences in 
1
H and 
15
N chemical shifts, 
respectively.  The binding curves were constructed by plotting Δ against total ligand 
concentration.  Residues with Δ values above the mean value for all residues were 
selected to determine binding affinities.  The dissociation constants Kd for the peptides 
binding to Pin1 or WW domain were determined by fitting the binding curves with the 
single-site equation:
134
 
 
∆= ∆𝑚𝑎𝑥
𝑃0 + 𝐿0 + 𝐾𝑑 − √(𝑃0 + 𝐿0 + 𝐾𝑑)2 − 4𝑃0𝐿0
2𝑃0
 4.2 
where Δδmax, P0 and L0 are the chemical shift change at complete saturation, total protein 
concentration and total ligand concentration, respectively.   
To evaluate dissociation constants with two binding sites, a two-site equation is 
used: 
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∆= ∆𝑚𝑎𝑥
𝑃0 + 𝐿0 − 𝐴 + 𝐾𝑑1 − √(𝑃0 + 𝐿0 − 𝐴 + 𝐾𝑑1)2 − 4𝑃0(𝐿0 − 𝐴)
2𝑃0
 
𝐴 =
𝑃0 + 𝐿0 + 𝐾𝑑2 − √(𝑃0 + 𝐿0 + 𝐾𝑑2)2 − 4𝑃0𝐿0
2
 
4.3 
where Kd1 and Kd2 are the dissociation constants for the two binding sites, respectively. 
Assignment of Pin1 residues was carried out with a sample containing 1.5 mM 
[U-
13
C, 
15
N] full-length Pin1 protein, dissolved in the final NMR buffer (vide supra).  
Backbone resonances of 
1
H, 
13
C and 
15
N were assigned with experiments 2D [
15
N-
1
H] 
HSQC, 3D HNCACB,
93
 3D CBCA(CO)NH,
93
 3D HNCO,
93
 and verified with 3D 
CC(CO)NH
95
 and 3D H(CCO)NH
136
 experiments.  Resonances of WW domain residues 
were transferred from the assignments of full-length Pin1 and verified with 3D 
15
N-
edited NOESY-HSQC
139-141
 spectrum with a sample containing 1 mM [U-
15
N] WW 
domain. 
Assignment of Pin1 residues saturated with pV5 peptide was carried out with a 
sample containing 1 mM [U-
13
C, 
15
N] full-length Pin1 protein and 1.25 mM pV5 
peptide.  3D CBCA(CO)NH
93
 spectrum was collected for this purpose.  All assignment 
experiments were carried out at 25 °C on a Varian VNMRS spectrometer operating at 
the Larmor 
1
H frequencies of 600 MHz, or on Bruker Avance III spectrometers 
operating at the Larmor 
1
H frequencies of 600 MHz or 800 MHz. 
Assignments of the pTM and pV5 peptides were carried out at 25 °C with 2D 
NOESY,
178,179
 2D TOCSY
180
 and 2D ROESY
181
 experiments collected on Bruker 
Avance III spectrometers, operating at the Larmor 
1
H frequencies of 500 MHz or 800 
MHz.  The NOE mixing time was kept at 500 ms.  The TOCSY spectra were collected 
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with 80 ms mixing time.  The ROE spin-lock duration was 240 ms, corresponding to a 2 
kHz field at a low power of 0.06 W.  Additional verifications were performed by 
comparing protein chemical shifts with our assignments of full-length dmV5α as 
described in Chapter II.  The pTM peptide assignments were further verified by 
collecting a natural abundance [
15
N-
1
H] HSQC spectrum.  
 
NMR EXSY experiments and data analysis 
Observations of exchange cross-peaks were done by collecting 2D NOESY and 
ROESY spectra.  NOE mixing time and ROE spin-lock duration are the same as 
specified above.  One sample consisted of 2 mM pTM peptide in the presence of 50 μM 
fresh proteins (full-length Pin1 or isolated PPIase domain).  The other sample consisted 
of 1.53 mM pV5 peptide in the presence of 90 μM fresh full-length Pin1 protein.  
Spectra in the absence of Pin1 or PPIase proteins did not exhibit exchange cross-peaks.   
Exchange spectroscopy (EXSY) experiments of pTM peptide were carried out at 
25 °C with 2D NOESY at exchange mixing times of 40, 70, 100, 200 (×2), 300, 400 and 
500 (×2)  ms.  For pTM peptide, the exchange rate constant, kEXSY, was estimated by 
fitting the intensity ratios as following:
182,183
 
 𝐼𝑡𝑐
𝐼𝑐𝑐
=
𝑘𝑐𝑡(1 − 𝑒
−𝑘𝐸𝑋𝑆𝑌𝑡)
𝑘𝑡𝑐 + 𝑘𝑐𝑡𝑒
−𝑘𝐸𝑋𝑆𝑌𝑡
 4.4 
where kEXSY = kct + ktc, Itc is the intensity of the exchange cross-peak from trans to cis, Icc 
is the intensity of the diagonal peak for the cis conformation, kct (ktc) is the rate constant 
from cis to trans (trans to cis), and t is the mixing time of each experiment.  The 
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intensity of trans diagonal resonance was not included due to an overlap with an 
adjacent diagonal resonance. 
 
Results 
Hydrophobic motif is a non-canonical interaction site for Pin1 
The amino acid sequence of the hydrophobic motif (HM) from PKCα has a 
tyrosine immediately following the phosphorylated-serine residue, rendering it a non-
canonical interaction site for Pin1 if the proposed interaction
45
 does exist (Figure 30B).  
In order to address this, we started out to investigate if the proposed interaction between 
the PKCα and Pin1 can occur with the isolated phosphorylated-HM (pHM).  The 
isolated WW domain of Pin1 was first tested since a target-recognizing role is generally 
considered for this domain.  With the addition of the pHM peptide, we observed 
unambiguous chemical shift perturbations of the isolated WW domain residues 
monitored by NMR HSQC experiments (Figure 32).  The time scale of the binding event 
overall is in the fast exchange regime, allowing us to plot and fit the binding curves to 
extract an accurate dissociation constant value.  The global fitting of 13 responsive 
amino acids (Equation 4.2) generated a dissociation constant Kd of 1006 ± 9.33 μM.  
Representative binding curves are shown in Figure 34A.  This indicates a direct 
interaction between the pHM and the isolated WW domain of Pin1, albeit with a 
relatively weak binding affinity. 
We next tested binding between the full-length Pin1 and the pHM peptide.  
Unexpectedly, we observed chemical shift perturbations (CSP) on both WW domain and 
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PPIase domain residues of Pin1 upon increasing concentration of the pHM peptide, 
indicating potential interactions of the pHM peptide with both domains (Figure 33).   
The binding curves of WW domain residues globally fit to a dissociation constant Kd of 
893 ± 13.7 μM (Figure 34B), whereas global fitting of the PPIase domain residues 
generated a dissociation constant Kd of 772 ± 7.33 μM (Figure 34C).   
 
 
 
 
 
Figure 32. The pHM peptide interacts with isolated WW domain from Pin1 
detected by NMR.  [
15
N-
1
H] HSQC spectra of [U-
15
N] enriched isolated WW domain 
(residue 1-50) of Pin1 with increasing concentration of the pHM peptide are shown as 
an overlay. The color coding of each spectrum with increasing pHM peptide 
concentrations is indicated as insert in the bottom right corner. 
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Figure 33. The pHM peptide interacts with full-length Pin1 detected by NMR.  [
15
N-
1
H] HSQC spectra of [U-
15
N] enriched full-length Pin1 with increasing concentration of the pHM peptide are shown as an overlay. The color 
coding of each spectrum with increasing pHM peptide concentrations is indicated as insert in the bottom right corner. 
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Figure 34. The pHM peptide interacts with the isolated WW domain and both 
domains of full-length Pin1 with a similar affinity.  Representative NMR-detected 
pHM binding curves are shown for the isolated WW domain experiment (A), the full-
length Pin1 experiment with residues from the WW domain (B) and PPIase domain 
(C). All solid lines are global fitting results. 
 
 
 
Both apparent affinities are similar to the binding affinity of pHM to the isolated WW 
domain (Kd = 1006 ± 9.33 μM), with the affinity of PPIase domain being slightly higher 
than WW domain in the context of full-length Pin1. 
It is worth mentioning that CSP indicates a change in the chemical environment 
of the atom in question.  Thus, CSP herein may not necessarily reflect a direct binding.  
Due to the high similarity of CSP patterns between the isolated WW domain experiment 
and the WW domain residues in the full-length Pin1 experiment, we are certain that the 
pHM peptide directly interacted with the WW domain in both experiments (Figure 35).   
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Figure 35. Chemical shift perturbation analysis of the pHM binding experiments. 
(A) Combined chemical shift perturbation (CSP) of the isolated WW domain with 18-
fold molar excess of pHM peptide vs. no peptide is plotted against residue number.  
Residues with no CSP values are prolines, residues broadened beyond detection and 
residues that are not spectrally resolved.  (B) The CSP values are mapped onto the 
isolated WW domain structure (PDB ID 2M8I).  (C) Combined CSP of the full-length 
Pin1 pHM-binding experiment and (D) mapped on the Pin1 structure (PDB ID 1PIN). 
 126 
 
However, the CSP of PPIase domain residues can be an indirect effect of WW–pHM 
interaction.  Although given the similar scale of CSP values between the two Pin1 
domains responding to pHM addition (Figure 35B), we believe that the PPIase residues 
are more likely responding to a direct binding event with a similar affinity to the WW 
domain binding event.  An additional support is that the identities of PPIase responding 
residues match well with the previously indicated phosphorylated peptide binding 
pocket.
159,170
  Further control experiment is required with isolated PPIase domain in 
order to fully verify this. 
With the above discussion, we think of the isolated pHM peptide interaction with 
the full-length Pin1 as two independent binding events: pHM–WW and pHM–PPIase.  
The two apparent Kds shown in Figure 34 are extracted from fitting the binding curves 
with the single-site equation (4.2).  However, with two independent binding sites of 
similar affinity, we are slightly underestimating the affinities due to a depleted pool of 
free ligand concentration for one site while the other is occupied.  The extent of 
underestimation is evaluated with a two-site equation (4.3), with one Kd fixed at various 
values and extract the other Kd extracted with global fitting.  From the evaluation results 
shown in Table 9, we conclude that the overestimation of Kd is about 14% for the WW 
site and about 11% for the PPIase site.  Since the overestimation is minor, we will use Kd 
values from fitting with the single-site equation (4.2) to compare with those from the 
pTM and pV5 peptides (vide infra) for consistency.  
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Table 9. Evaluation of the pHM–Pin1 binding curves with two-site equation 
Equation WW residues  PPIase residues 
 
Kd / μM Hold Kd / μM 
 Kd / μM Hold Kd / μM 
Single Site 893 ± 13.7 
 
 772 ± 7.33 
 
  
PPIase  
 
WW 
Two Sites 800 ± 12.0 1000  692 ± 6.33 1000 
 
779 ± 11.6 772  684 ± 6.23 893 
 
769 ± 11.5 684  674 ± 6.10 769 
 
 
 
Turn motif specifically associates with the WW domain over the PPIase domain 
The turn motif (TM) from PKCα, βII and γ contains consecutive proline residues 
following the phosphorylated threonine.  According to previous studies on Tau protein, 
the pT
231
-P-P site of Tau was shown to be a WW domain specific interaction 
site.
173,174,184
  Phosphorylation sites with consecutive proline residues from peroxisome 
proliferator-receptor γ (PPARγ) and CREB-regulated transcriptional coactivator 2 
(CRTC2) were also shown responsible for interaction with Pin1.
175,176
  In order to see if 
the TM from the three conventional PKC isoforms (α, βII and γ) is a WW domain 
specific interaction site, we first took the isolated phosphorylated-TM (pTM) and tested 
binding with the isolated WW domain monitored by NMR.  With this experiment, we 
observed significant chemical shift perturbations with a much tighter association of pTM 
to the isolated WW domain than the pHM peptide.  This is manifested by both the fast-
to-intermediate behavior for most responding resonances on the NMR exchange 
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timescale (Figure 36) and the globally fitted dissociation constant Kd of 25.2 ± 0.215 μM 
(Figure 38A).  The binding affinity of the isolated pTM was 40-fold tighter than the 
isolated pHM associated with the isolated WW domain.  This was surprising to us since 
the HM was attributed a more critical role in the peptide array experiment in 
Abrahamsen et al.
45
  
 
 
 
 
 
Figure 36. The pTM peptide interacts with isolated WW domain from Pin1 
detected by NMR.  [
15
N-
1
H] HSQC spectra of [U-
15
N] isolated WW domain of Pin1 
with increasing concentration of the pTM peptide are shown as an overlay. The color 
coding of each spectrum with increasing pTM peptide concentrations is indicated as 
insert in the bottom right corner. 
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Figure 37. The pTM peptide interacts with full-length Pin1 detected by NMR.  [
15
N-
1
H] HSQC spectra of [U-
15
N] full-
length Pin1 with increasing concentration of the pTM peptide are shown as an overlay. The color coding of each spectrum 
with increasing pTM peptide concentrations is indicated as insert in the bottom right corner. 
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Figure 38. The pTM peptide interacts with the isolated WW domain and the WW 
domain residues of full-length Pin1 with similar affinity.  Representative NMR-
detected pTM binding curves are shown for the isolated WW domain experiment (A) 
and the WW domain residues of the full-length Pin1 experiment (B). All solid lines are 
global fitting results. 
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Figure 39. Chemical shift perturbation analysis of the pTM binding experiments. 
(A) Combined chemical shift perturbation (CSP) of the isolated WW domain with 18-
fold molar excess of pTM peptide vs. no peptide is plotted against residue number.  
Residues with no CSP values are prolines, residues broadened beyond detection and 
residues that are not spectrally resolved.  (B) The CSP values are mapped onto the 
isolated WW domain structure (PDB ID 2M8I).  (C) Combined CSP of the full-length 
Pin1 pTM-binding experiment and (D) mapped on the Pin1 structure (PDB ID 1PIN). 
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We next performed binding experiments of pTM peptide to the full-length Pin1.   
Similar to the perturbation pattern of the isolated WW domain experiment, we observed 
pTM perturbing the WW domain residues within the full-length Pin1 protein (Figure 
39).  Both the resonance shifts and globally fitted Kd (35.4 ± 0.594 μM) were similar to 
those of the isolated WW domain experiment (compare Figure 36, Figure 37 and Figure 
38).  However, very little CSP was observed for the PPIase domain residues (Figure 
39C). This result supports the previously proposed argument that p(Thr/Ser)-Pro-Pro 
motif could interact exclusively with the WW domain.
172
  We cannot rule out the 
existence of any interaction between pTM and the PPIase domain with these data.  The 
interaction could occur with a very low affinity or could cause minimal CSP. 
In order to address if there is an interaction between the pTM peptide and the 
PPIase domain, we looked closely at the residues that responded slightly to the addition 
of peptide.  Despite the small CSP values, we calculated mean and standard deviation of 
CSP for the PPIase domain residues in the binding experiment of the pTM peptide to 
full-length Pin1.  For the residues perturbed above (mean + STD) within PPIase domain 
residues, we observed two types of response by inspecting the individual binding curves.  
Group 1 residues responded in concert with the WW domain residues to the pTM 
binding event, with individual Kd fitted to values close to the globally fitted Kd of 35.4 
μM for WW domain residues.  Group 2 residues have their binding curves displaying 
linear response within the range of the peptide concentrations we tested, potentially due 
to a much weaker binding affinity.  The identities of the residues and individual Kd are 
shown in Table 10.   
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Interestingly, when looking at the two groups of residues on the crystal structure, 
we found that Group 1 residues are located at the domain interface of the crystal 
structure (Figure 40).  Group 2 residues, on the contrary, map to the substrate binding 
pocket of PPIase domain (Figure 40).  We think that Group 1 residues respond to the 
same pTM–WW binding event, potentially due to a change in domain interactions 
triggered by the WW domain associating with the pTM peptide.  Group 2 residues likely 
represent a very weak binding site for pTM.  We could not obtain the affinity of this 
group because of the limitations of the protein and peptide concentrations tested.  We 
roughly estimate that the Kd of this weak binding event is larger than 3 mM.   
 
 
 
Table 10. Two groups of PPIase residues in response to pTM binding to Pin1 
Group Residue Kd / μM 
1 E51 39.3 ± 4.28 
 G91 32.0 ± 2.30 
 Q94 35.3 ± 2.11 
 K97 54.0 ± 4.79 
 D102 40.9 ± 2.20 
 M146 29.2 ± 3.37 
 V150 42.5 ± 1.72 
 H157 137 ± 68.0 
 I159 25.0 ± 2.51 
2 R68 >3000 
 R69  
 S71  
 W73  
 S114  
 S115  
 M130  
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Figure 40. Two groups of PPIase residues responding to addition of pTM 
mapped on the crystal structure of Pin1.  Group 1 and 2 residues are colored green 
and magenta, respectively.  The WW domain residues are colored the same as in 
Figure 39D to represent the direct pTM–WW binding interface.  
 
 
 
Turn motif is not an efficient catalytic substrate for Pin1 due to the consecutive prolines 
For the previously known Pin1 catalytic substrates, the rate of cis–trans 
isomerization was significantly accelerated by Pin1 catalysis.  With Pin1 catalysis, the 
exchange between cis and trans conformations of the substrate could be directly 
observed with NMR experiments including a mixing time for chemical exchange.
185
  To 
test if the pTM is a catalytic substrate for the peptidyl-prolyl isomerase activity, we 
collected the NOESY spectrum of the isolated pTM peptide in the presence of Pin1 with 
a 500 ms mixing time.  In the NOESY spectrum, we unambiguously observed and 
assigned (see Experimental procedures) all four conformations of the pT
638
-P
640
-P
641
 
motif due to the two peptidyl-prolyl bonds, corresponding to trans/trans, cis/trans, 
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trans/cis and cis/cis conformations, respectively (Figure 41).  The two cis and trans 
conformations of the Q
634
-P
635
 site were also assigned (Figure 41).  Under these 
conditions, we did not observe any detectable exchange cross-peak from any 
combinations of the four conformations from the pT
638
-P
640
-P
641
 motif (Figure 42).  The 
absence of exchange cross-peak indicates a lack of catalysis or inefficient catalysis.  This 
is in agreement with the proposed non-catalytic role for Pin1 targets with consecutive 
proline residues.   
To our surprise, we detected weak but unambiguous exchange cross-peaks 
between the trans and the cis Q
634
-P
635
 conformations in the presence of Pin1 (Figure 
42).  No exchange cross-peaks were observed in the absence of Pin1 under identical 
experimental conditions.  Even though glutamine is not negatively charged, we think the 
non-specific catalysis herein is due to the similarity between the side-chains of 
glutamine and glutamate, which has been extensively used as a phosphorylation mimic 
for measuring Pin1 catalytic activity.
186
  These data also demonstrated the existence of 
an interaction between the isolated pTM and the PPIase domain.  The NOESY spectrum 
of the pTM peptide in the presence of the isolated PPIase domain is highly similar to that 
of the full-length Pin1, confirming that the non-specific catalysis towards the Q
634
-P
635
 
site is due to a direct weak pTM–PPIase domain interaction.  This weak interaction is 
probably what we observed for the Group 2 residues with a Kd larger than 3 mM (Figure 
40). Using 
1
H-
1
H EXSY experiments, we estimated the kEXSY of Pin1 catalyzed Q
634
-P
635
 
isomerization to be 4.05 ± 0.143 s
-1
.  The fitting results are shown in Table 11.  This 
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catalyzed exchange rate is slower than most other human Pin1 substrates ranging from 
10–87 s-1 tested under similar concentrations.170,183,187,188     
 
 
 
 
 
Figure 41. The amide region of TOCSY spectrum showing assignments of pTM 
peptide.  The four conformations of the pT
638
-P
639
-P
640
 motif are highlighted with red 
fonts and dashed lines showing connections.  The two Q
634
-P
635
 conformations are 
highlighted with green fonts. 
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Figure 42. Expansion of NOESY spectrum showing exchange cross-peaks for the 
non-specific Q
634
-P
635
 site on pTM peptide.  The spectrum colored in magenta was 
collected with a sample containing the catalytic amount (50μM) of full-length Pin1 
protein added to 2 mM pTM peptide.  As a control, the spectrum in black was 
collected with a sample containing only 2mM pTM peptide.  The four conformations 
of the pT
638
-P
639
-P
640
 motif are highlighted with red fonts.  The two Q
634
-P
635
 
conformations are highlighted with green fonts.  Cross-peak positions expected for 
chemical exchange are shown with dashed lines. 
 
 
 
 
 
Table 11. Pin1-catalysed cis to trans (kct) and trans to cis (ktc)  
isomerization rates of pTM peptide Q
634
-P
635
 site 
 
+ Pin1 (s
-1
) 
kct ktc kEXSY 
Itc/Icc     0.667 ± 0.0153 3.38 ± 0.142 4.05 ± 0.143 
 
 
 
In order to see if the proline residue at +1 position is the key to the inefficient 
catalysis observed, we tested a pTM-P640A peptide with an alanine substituting the +1 
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proline while keeping the rest of the pTM peptide identical.  Exchange cross-peaks were 
exhibited between the cis and trans conformations of the pT
638
-P
639
 bond of the pTM-
P640A peptide under identical experimental conditions (Figure 43).  The Q
634
-P
635
 
exchange cross-peaks originated from non-specific catalysis were still present for the 
pTM-P640A peptide.  However, the intensity ratio of the pT
638
-P
639
 bond exchange 
cross-peak versus diagonal Ict/Icc is 22-fold larger than that of Q
634
-P
635
 exchange cross-
peak, whereas the Itc/Itt is comparable for both.  This indicates a much more efficient 
catalysis for the pT
638
-P
639
 bond by Pin1 than the Q
634
-P
635
 bond in the pTM-P640A 
peptide.  Spectrum of the pTM-P640A peptide in the absence of Pin1 did not show any 
exchange cross-peak. 
 
Pin1 interaction with pV5 reveals specific binding mode 
After understanding how the isolated pTM and pHM interact with the two 
domains of Pin1, we went on and tested Pin1 interaction with a bisphosphorylated pV5 
peptide covering the amino acid sequence from residue 632–660 of V5 domain with both 
pTM and pHM sites included.  From the [
15
N-
1
H] HSQC spectral overlay with 
increasing concentrations of pV5 peptide (Figure 44), we observed distinct resonance 
shift patterns of the WW domain and PPIase domain residues within the full-length Pin1 
protein.  The WW domain residues shift upon interacting with pV5 with directions and 
amplitudes highly similar to the binding experiment with isolated pTM peptide 
(comparing Figure 37 with Figure 44).  On the contrary, the directions and amplitudes of 
the PPIase domain residues shifts are similar to the binding experiment with isolated 
pHM peptide (comparing Figure 33 with Figure 44).   
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Figure 43. Expansion of NOESY spectrum showing exchange cross-peaks for 
both the pT
638
-P
640
 and the non-specific Q
634
-P
635
 site on pTM-P640A peptide.  
The blue spectrum was collected with a sample containing a catalytic amount (50μM) 
of full-length Pin1 protein added to 2 mM pTM-P640A peptide.  As a control, the 
spectrum in black was collected with a sample containing only 2mM pTM-P640A 
peptide.  The four conformations of the pT
638
-P
639
-P
640
 motif are highlighted with red 
fonts.  Exchange peak for A
640
 is also shown in red fonts.  The two Q
634
-P
635
 
conformations are highlighted with green fonts.  Cross-peak positions expected for 
chemical exchanges are shown with dashed lines. 
 
 
 
In addition, we calculated CSP of Pin1 residues upon interacting with the pV5 
peptide as shown in Figure 44A.  The CSP plot pattern matches well when comparing to 
an overlay of the CSP plots from isolated pTM and pHM experiments (Figure 44B).  
From these data, we concluded that the interaction between full-length Pin1 and the pV5 
peptide is comprised of two unambiguous sub-interactions: pTM interacting with WW 
domain and pHM interacting with PPIase domain.   
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Figure 44. The pV5 peptide interacts with full-length Pin1 detected by NMR.  [
15
N-
1
H] HSQC spectra overlay of [U-
15
N] full-length Pin1 with an increasing pV5 concentration. The color coded legend shows the increasing concentrations. 
Residues are labeled blue and red corresponding to pTM–WW and pHM–PPIase sub-interactions, respectively.  
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Figure 45. Chemical shift perturbations reveal specific binding mode between 
full-length Pin1 and the pV5 peptide.  (A) Combined chemical shift perturbations 
(CSP) of full-length Pin1with 17-fold molar excess of pV5 peptide vs. no peptide are 
plotted against residue number.  (B) Overlay of CSP from the full-length Pin1 binding 
experiments with isolated pTM peptide (blue) and pHM peptide (red). CSP values are 
the same as in Figure 39C and Figure 35C, respectively. 
 
 
 
Most of the Pin1 resonances responding to pV5 interaction still displayed fast 
behavior on the NMR exchange timescale, with a few WW domain resonances 
exhibiting fast-to-intermediate exchange.  The only exceptions are that both the Trp34 
backbone N-H and side-chain Nε1-Hε1 resonances showed slow exchange behavior, 
which was the same in isolated pTM experiments.  Thus, we could extract accurate 
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dissociation constants Kd by fitting the binding curves for fast-exchanging WW domain 
and PPIase domain residues in the two groups, respectively (Figure 46).   
 
 
 
 
 
Figure 46. The pV5 peptide interacts with full-length Pin1 with avidity from the 
two binding sites.  Representative NMR-detected pV5 binding curves are shown for 
full-length Pin1 experiment with (A) the WW domain residues and (B) the PPIase 
domain residues. All solid lines are global fitting results. 
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Table 12. Dissociation constants extracted from NMR binding experiments 
Constructs 
Kd / μM 
WW residues PPIase residues 
pTM + WW      25.2 ± 0.215  
pTM + Pin1      35.4 ± 0.594 >3000 
pHM + WW   1006 ± 9.33  
pHM + Pin1     893 ± 13.7    772 ± 7.33 
pV5 + Pin1      11.1 ± 0.411   26.0 ± 1.02 
 
 
 
The globally fitted Kd for WW domain residues interacting with the pV5 peptide was 
11.1 ± 0.411 μM, which was a 3-fold decrease from the isolated pTM peptide 
experiment (35.4 ± 0.594 μM).  The globally fitted Kd for PPIase domain residues 
interacting with the pV5 peptide was 26.0 ± 1.02 μM, which was a strikingly 30-fold 
decrease from the isolated pHM peptide experiment (772 ± 7.33 μM).  All measured 
dissociation constants are listed in Table 12. 
 
Pin1 interaction with pV5 diminishes the weak interaction of PPIase domain with pTM  
With the highly specific interaction mode between full-length Pin1 and the pV5 
peptide (vide supra), we asked if the weak interaction accompanied by the non-specific 
catalysis towards the Q
634
-P
635
 site observed with the isolated pTM peptide would also 
exist for the pV5 peptide.  It order to test this, we first collected full set of 2D 
experiments (see Experimental procedures) and assigned the pV5 peptide resonances by 
comparing them to three sets of prior assignments: isolated pTM assignments, isolated 
pHM10 assignments (Chapter III) and dmV5α assignments (Chapter II).  In the NOESY 
spectrum of the pV5 peptide in the presence of Pin1, we did not observe any exchange 
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cross-peak from either the pT
638
-P
639
-P
640
 motif or the Q
634
-P
635
 site (Figure 47).  The 
weak interaction between the PPIase domain and the pTM site seemed to be diminished 
in the Pin1–pV5 complex.  We attribute this phenomenon to the PPIase–pHM interaction 
enhanced through the avidity effect in the Pin1–pV5 complex.  As a result, the PPIase 
substrate binding pocket is probably occupied by the pHM site, preventing the pTM site 
from another molecule of pV5 peptide to access the PPIase domain. 
 
 
 
Figure 47. Expansion of NOESY spectrum showing no detectable exchange 
cross-peaks with pV5 peptide in the presence of full-length Pin1.  The spectrum 
was collected with a sample containing catalytic amount (100μM) of full-length Pin1 
protein added to 1.53 mM pV5 peptide.  The three observed conformations of the 
pT
638
-P
639
-P
640
 motif are highlighted with red fonts.  The two Q
634
-P
635
 conformations 
are highlighted with green fonts.  Cross-peak positions expected for chemical 
exchange are shown with dashed lines. 
 
 
 
Discussion of results 
Peptidyl-prolyl isomerase Pin1 is a unique member of the PPIase family, due to 
the fact that it adds another layer of regulation on top of a kinase signaling cascade by 
recognizing pS/T-P motifs.  Our results indicate that Pin1 interacts directly with both 
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conserved phosphorylation motifs of the V5 domain from PKCα, supporting the 
previously suggested interaction between Pin1 and PKCα in the proteasome-dependent 
down-regulation process.
45
  We demonstrate that the non-canonical pHM site interacts 
with both domains of Pin1, and binds specifically to the PPIase domain when the pTM 
site is also present on the same polypeptide chain.  Here, we summarize and discuss our 
results of the Pin1–V5 interaction with highlights on the non-catalytic nature and avidity 
effect. 
 
WW domain selectivity towards the pTM motif with consecutive prolines 
Previous studies suggested that the pS/T-P-P Pin1 targets with consecutive 
prolines might interact exclusively with the WW domain,
173,174
 and function in a PPIase-
independent manner.
172,175,176
  Several roles have been proposed for this type of potential 
WW domain specific sites.  One proposition states that the pS/T-P-P site can function 
together with another pS/T-P site as a multivalent binder, such that the overall binding 
affinity is enhanced by the WW domain bound to the pS/T-P-P site, whereas the PPIase 
domain can target the pS/T-P with high specificity.
172
  This could increase the efficiency 
of binding by preventing the simultaneous binding of WW and PPIase domains to the 
same site, since the PPIase domain cannot bind to the pS/T-P-P site.  Since pS/T-P-P 
sites appear to be more prevalent in the cytosolic Pin1 targets, the other suggested role is 
that they could function as a reservoir (i.e., a buffer) for cytosolic Pin1 before entering 
the nucleus.
172
  However, it was difficult to test these theories further due to limited 
examples of Pin1 targets containing these sites in conjunction with another binding site 
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and sparse knowledge regarding detailed binding measurements or molecular 
mechanisms.  
Here in this chapter, we contribute a detailed analysis of a potential bivalent Pin1 
target containing a pS/T-P-P site with consecutive prolines: the pTM site from PKCα.  
Chemical shift perturbation analysis of the isolated pTM binding experiment with 
isolated WW domain and full-length Pin1 illustrated a strong preference for pTM to 
interact with the WW domain over the PPIase domain.  However, small but non-
negligible chemical shift changes together with the non-specific catalysis towards the 
Q
634
-P
635
 site in the presence of both Pin1 and isolated PPIase domain showed a weak 
direct interaction between pTM and the PPIase domain.  The non-specific catalysis is 
diminished when both pTM and pHM sites are present on the same polypeptide chain in 
the pV5 binding experiments, supporting the role of the  pS/T-P-P site in ensuring WW 
domain specific interaction in a multivalent system.   
Under our experimental conditions, we did not observe any exchange peak for 
the pT
638
-P
639
-P
640
 (pTM) site in the presence of full-length Pin1 or isolated PPIase 
domain by NMR EXSY experiments.  These data indicate that the pTM site is not an 
efficient catalytic substrate for the isomerase activity of Pin1.  This is supported by a 
recent NMR study of Pin1–Tau interaction regarding to a pT231-P-P-K-pS235-P site of 
Tau.
188
  They observed catalysis only for the pS
235
-P bond, but not the pT
231
-P-P bond.  
This could potentially be explained by a preferred binding geometry to place the pS
235
-P 
site at the catalytic pocket, but herein for the pTM sequence, the Q
634
-P
635
 site is N-
terminal to the pT
638
-P
639
-P
640
 site instead of C-terminal like the Tau site.  We attribute 
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the weak pTM-PPIase interaction observed here to the lack of an amide proton of the 
Pro640 residue, which prevents formation of an intramolecular hydrogen bond with the 
carbonyl oxygen of the pT638 residue.  The formation of this intramolecular hydrogen 
bond has been suggested to help stabilize the β-turn conformation as observed in the 
crystal structure of Pin1 bound to a peptide inhibitor.
177
  The lack of an efficient 
catalysis at the pTM site, on the other hand, could also be attributed to the lack of an 
amide proton of the P640 residue in the context of the twisted amide catalytic 
mechanism suggested for Pin1.
171
  The formation of a five-member ring including the 
amide proton of the +1 residue was proposed in this mechanism, supported by another 
Pin1 crystal structure bound to a reduced amide and kinetic isotope effect measurements.  
Our hypothesis is supported by the efficient catalysis of the pT
638
-P
639
 bond in the pTM-
P640A peptide with a single alanine substitution of the +1 proline residue.      
 
Potential interdomain communication upon pTM binding 
We observed in the isolated pTM binding experiment with a full-length Pin1 that 
a subset of PPIase domain residues localizes on the domain interface in the Pin1 crystal 
structure in response to pTM–WW binding event (Figure 40).  The binding curves of 
these residues fit to roughly the same Kd as pTM–WW binding residues (Table 10), but 
the scale of their chemical shift perturbations are much smaller than the pTM–WW 
binding residues (Figure 39).  This indicates that a direct binding to these residues is 
unlikely.  We speculate that these residues respond indirectly to the pTM–WW binding, 
 148 
 
through a potential interdomain communication network reflecting a change in 
interdomain orientations or domain interactions.   
Recent studies pointed out a potential negative allosteric regulation by 
interdomain contact in Pin1.
170
  One central piece of evidence was the I28A mutation on 
the WW domain, which is located at the domain interface of the Pin1 crystal structure 
(PDB ID 1PIN).  This mutant enhanced the isomerase activity towards the pCdc25C 
substrate when compared to wild-type Pin1.
189
  Our data here support a change on the 
domain interface indirectly through the binding of WW domain to a WW-specific 
substrate pS/T-P-P site.  The Group 1 residues we observed here (Figure 40) are not in 
direct contact with I28 in the crystal structure, but V150, M146 and E51 residues in this 
group are in the vicinity of I28.  K97 in this group is also located on the domain interface 
of the crystal structure.  We did not observe chemical shift changes in the Helix-4 region 
of PPIase domain, which was observed to be perturbed by the I28A mutation.
170
  This 
underlies a potential substrate-dependence on the interdomain communication.    
It is difficult to comment on the interdomain communication in the case of pV5 
binding, since the large chemical shift perturbations that occur upon direct binding of the 
pHM site to the PPIase domain could have masked the changes due to interdomain 
communication.  However, a noticeable change between the pTM induced CSP pattern 
and the pV5 induced CSP pattern was observed for residue G91, which was perturbed 
significantly in the pTM experiment but not perturbed in the pV5 experiment (Figure 
45).  Further characterization of the pTM and pV5 in complex with Pin1 will help to 
clarify the differences in interdomain communication.               
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Avidity from bivalent binding 
Since multiple binding sites were shown to co-exist on the same Pin1 target 
proteins, in principle, they could enhance the interaction with Pin1 through avidity.
190
  
Daum et al. suggested an optimal cooperativity at a five-proline linker length for 
designed bivalent Pin1 binders.
191
  To our knowledge there is only one characterization 
available regarding a bivalent Pin1 substrate with a large linker distance, which is 
comprised of 16 amino acids between the two phosphorylation sites.
174
  In that study, a 
mild cooperativity was observed in the bivalent pT
212
/pS
214
/pT
231
 Tau peptide.  This 
chapter presents a detailed analysis of a bivalent Pin1 substrate from the V5 domain of 
PKCα with 18 amino acids between the two phosphorylation sites.  Under the conditions 
tested, we found the binding affinities were clearly enhanced by bivalency 3- and 30-
fold for the pTM–WW binding and pHM–PPIase binding, respectively.  The 3-fold 
increase of pTM–WW binding affinity is similar to what was observed with the increase 
of the WW domain binding affinity in Smet et al. (2.3–5.4 fold), whereas the 30-fold 
increase of pHM–PPIase binding affinity is much more significant than the 4-fold 
increase observed in Smet et al.
174
  We conclude that the avidity effect of pTM and pHM 
sites from PKCα is quite drastic, given the large linker distance between the two sites.  A 
cause for this drastic avidity is yet to be determined.      
 
Non-catalytic function of Pin1 during down-regulation of conventional PKCs 
Using NMR experiments, we only observed a non-specific catalysis of the Q
634
-
P
635
 site when full-length Pin1 or isolated PPIase domain was added to the isolated pTM 
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peptide.  This non-specific catalysis is diminished when pV5 peptide is used, where the 
pHM site is present on the same polypeptide chain as pTM.  From these, we infer that 
Pin1 functions in a non-catalytic manner during the dephosphorylation/ubiquitination 
dependent down-regulation process of PKCα.  The PKCα–Pin1 interaction is potentially 
the strongest when both pTM and pHM sites are exposed, which is likely the case for 
fully activated, membrane-associated PKCα (Chapter III).  When only one of the two 
sites is exposed, Pin1 could still potentially interact weakly with V5.  The structures of 
inactive, cytosolic and fully activated, membrane-associated forms of PKCα are still 
largely unknown.  But based on the potential role of a pHM site in stabilizing the N-lobe 
of the kinase domain, which is conserved throughout AGC kinases,
192
 the PKCα–Pin1 
complex could have a drastically decreased kinase activity since the pHM site is 
associated with the PPIase domain of Pin1.  This could potentially function as an acute 
shut-down of kinase activity as a first step of down-regulation.   
Our proposed model for PKCα might also be true for PKCβII and γ, since these 
isoenzymes both have consecutive prolines following the phosphorylated threonine 
residue like PKCα.  PKCβI, however, has a pT642-P-T sequence for its turn motif.  It is 
difficult to make further inferences since only PKCα and PKCβII were tested to be 
regulated by Pin1 in Abrahamsen et al.
45
  Further binding characterization of pTM from 
PKCβI as well as biological investigations of βI and γ down regulations are required to 
clarify this.   
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CHAPTER V  
DISCREPANCIES OF FUNCTION AND THE TERMINAL REGION OF C2 
DOMAIN IN CD(II) AND CA(II) INTERACTIONS
*
  
 
Background 
Ca
2+
 is the physiological signaling messenger for the activation of conventional 
PKCs, through interactions with C2 domain.  As discussed in Chapter III, C2 domain is 
a conditional peripheral membrane protein (CPMP) domain that undergoes membrane 
association in a Ca
2+
-dependent manner, with specificity towards negatively charged 
phospholipids, such as phosphatidylserine (PtdSer).  Although Ca
2+
 functions through 
changing the structure in various other calcium binding proteins (CBPs) 
193-195
, the 
crystal structures of apo and Ca
2+
 bound C2 domain from PKCα reveal minimal 
structural changes upon Ca
2+
 association (Figure 48A).  This has prompted us to 
consider alternative mechanisms of Ca
2+
 binding in triggering C2-membrane association 
from conventional PKCs.  In this chapter, we seek to understand the detailed molecular 
mechanism pertaining to the metal-dependent membrane association of C2 domain with 
a collection of NMR probes.   
Previously there were two views on the role of Ca
2+
-mediating protein-membrane 
interactions.  One view is that Ca
2+
 increases the electrostatic potential of the membrane-
                                                 
*
 Portions of this chapter have been reproduced with permission from: Krystal A. Morales, Yuan 
Yang, Zheng Long, Pingwei Li, Alexander B. Taylor, P. John Hart, and Tatyana I. Igumenova. 
Cd2+ as a Ca2+ surrogate in protein-membrane interactions: isostructural but not isofunctional. 
Journal of the American Chemical Society 2013, 135 (35), 12980-12983.  Copyright 2013 © by 
the American Chemical Society.   
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binding regions of the protein, and acts as a nonspecific “electrostatic switch” which 
favors the negatively charged phospholipid surface.  The other view is that Ca
2+
 
specifically recognizes PtdSer headgroup through the formation of coordination bonds 
with the carboxyl and/or phosphoryl oxygens.   
 
 
 
 
Figure 48. C2 domain from PKCα has minimal structural change upon binding 
Ca
2+
 and can bind two or three Ca
2+
 ions.  (A) Overlay of three crystal structures of 
isolated C2 domain from PKCα, where PDB ID 3RDJ corresponds to apo C2 (gray), 
1DSY is C2 associated with two Ca
2+
 ions and PSF molecule (orange), and 3GPE is 
C2 associated with three Ca
2+
 ions (blue).  The PSF molecule is colored light blue 
with the oxygen and phosphorus atoms highlighted.  (B) The coordination geometry 
of two Ca
2+
 ions from PDB ID 1DSY.  All coordinating atoms are oxygens.  (C) The 
coordination geometry of three Ca
2+
 ions from PDB ID 3GPE. Atoms that coordinate 
the third Ca
2+
 are colored blue. 
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The latter mechanism implies that the coordination sphere of protein-bound Ca
2+
 is 
dynamic: the labile water molecules coordinated by protein-bound Ca
2+
 are replaced by 
the lipid headgroup upon membrane association.   
To test the above two mechanisms, we started out by selecting Cd
2+
 as a Ca
2+
 
surrogate, due to the similarity in ionic radii (Ca
2+
 = 0.99 Å, Cd
2+
 = 0.97 Å) and the 
favorable NMR spectroscopic property for 
113
Cd
2+
 (Spin I = 1/2).  In this chapter, we 
compared the interactions of C2α with Ca2+ and Cd2+ with respect to the (i) structure, (ii) 
metal coordination geometry, (iii) affinity, (iv) metal-dependent membrane interaction, 
and (v) terminal region responses.  We found unexpectedly that despite high affinity of 
Cd
2+
 to C2α and the similar coordination geometry of protein-bound Cd2+ and Ca2+, Cd2+ 
is unable to support the membrane association of the protein domain.  This is in sharp 
contrast with Pb
2+
studied previously in our lab
72
, which has different coordination 
geometry than Ca
2+, yet drives the C2α-membrane binding  almost as well as Ca2+.   
From the perspective of the full-length enzymes of conventional PKCs, it is 
shown that a large conformational change occurs upon Ca
2+
 signaling.
69,196,197
  During 
this conformational change, one
198
 or two
155,156
 C1 domains synergizes the membrane 
association together with C2 domain.  Ca
2+
 binding to C2 is proposed to be in the first 
step for activation
33,69
, and Ca
2+
-dependent C2-membrane interaction is proposed to 
disrupt the intramolecular interactions between the C1 and C2 domains.
66
  Since the 
structure of C2α remains identical between apo and Ca2+ bound states, it is thus through 
alternative mechanisms for C2 to propagate the signaling event to other domains.  One 
potential mechanism is the changes in the conformational dynamics of C2 domain upon 
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Ca
2+
 binding.  Conformational dynamics of proteins has been implicated to involve in a 
broad range of ligand binding events and enzymatic kinetics.
199,200
  However, our 
knowledge about PKC regulation is still largely focused on the global structural change, 
with very little understanding on the local conformational dynamics of individual 
domains. We think it is possible that the ligand binding events are correlated to the 
global structural change through fine-tunings of local dynamics.  
In order to answer this question, an important detail regarding C2 function is the 
stoichiometry of Ca
2+
 ions bound per protein molecule during a signaling event.
201,202
  In 
the available crystal structures of C2 domain from PKCα and PKCβII, each C2 molecule 
was able to bind two or three equivalents of Ca
2+
 ions.  The first two Ca
2+
 sites have 
more complete coordination geometry with six protein ligands coordinating each Ca
2+
, 
comparing to the third Ca
2+
 site having five protein ligands (Figure 48B, C).  We have 
previously shown that the first two Ca
2+
 ions bind C2 with equivalent affinities, whereas 
the third Ca
2+
 bind C2 with a much lower affinity.
72
  Despite the apparent weak affinity 
for the isolated C2 domain, it was previously implicated that the third Ca
2+
 binding site 
can be differentially occupied in the protein-membrane complex for C2 domains from 
conventional PKCs.
203
  The existence of a high affinity event at the membrane illustrated 
by isolated C2 domain indicated a potential role of the third Ca
2+
 site.
202
  It is not clear 
yet as to a detailed understanding regarding to the effect of the third Ca
2+
 site on C2 
domain.  In this work, we characterized the μs-ms dynamics of isolated C2 domain as a 
function of Ca
2+
 with an emphasis on the third Ca
2+
 binding event.  A R159G mutant 
which was shown in the lab to alter the exchange processes of isolated C2 was also used 
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as a comparison.  The information acquired here together with our previous work 
supported a mechanism by which the third Ca
2+
 binding directly affects the 
conformational dynamics of the N- and C-termini regions of C2 domain.  This could 
further assist in the destabilization of the closed kinase conformation at plasma 
membrane during the final stages of cPKC activation. 
 
Experimental procedures 
Materials 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3- phospho-L-serine (POPS) were obtained from Avanti Polar Lipids 
(Alabaster, AL).  
 
Sample preparation 
Natural abundance, uniformly 
15
N-enriched, uniformly 
2
H
13
C
15
N-enriched ([U-
13
C, 
15
N] and ~70% 
2
H incorporation) and uniformly 
2
H
15
N-enriched ([U-
15
N] and ~70% 
2
H incorporation) C2 domain (residues 155-293 of Protein Kinase C from R. 
norvegicus) was over-expressed and purified to homogeneity as previously described.
72
  
The R159G mutant of C2α was generated previously in the lab from wild type (WT) 
C2α using QuickChangeTM site-directed mutagenesis.  The expression and purification 
processes were identical to that of WT C2α. All buffers used in this study were treated 
with Chelex 100 resin (Sigma-Aldrich) to remove residual divalent metal ions.  
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NMR spectroscopy 
For Cd
2+
 binding to C2 detected by NMR spectroscopy, The protein solution 
was prepared at the concentration of 110 M in NMR buffer containing 10 mM 2-(N-
morpholino) ethanesulfonic acid (MES) at pH = 6.0, 8% D2O, and 0.02% NaN3.  The 
stock solutions of Cd(II) nitrate were prepared in the same buffer.  Aliquots of Cd(II) 
nitrate stock solution were added stepwise to the uniformly 
15
N-enriched C2α.  The 
Cd
2+
-binding and assignment experiments were conducted on a Varian Inova 
spectrometer operating at the Larmor 
1
H frequencies of 500 and 600 MHz, respectively.  
The temperature in the NMR experiments was maintained at 25 C.  The resonances of 
Cd
2+
-complexed C2α were assigned using: (i) 3D HNCACB experiment with 2H 
decoupling
93,204
 that was carried out on fractionally deuterated, [U-
13
C,
15
N] enriched 
C2α in the presence of 15-fold molar excess of Cd2+, (ii) the titration behavior of the 
individual cross-peaks, and (iii) the previously obtained assignments of apo C2α.72 
For the chemical shift perturbation (CSP) analysis, the overall change in 
chemical shift  was calculated between a pair of protein states as:96 
 ∆= √(∆𝛿𝐻)2 + (0.152 × ∆𝛿𝑁)2 5.1 
where H and N are the differences between the 
1
HN and 
15
N chemical shifts of the 
two states being compared. 
For R2-HE relaxation experiments
205,206
 and R159G mutant HSQCs, uniformly 
2
H
15
N-enriched C2α samples of 0.35mM and 0.16mM concentration were prepared, 
respectively.  NMR experiments were carried out at 25°C on Bruker AvanceIII 
spectrometer operating at a 
1
H Larmor frequency of 600MHz (14.1T) equipped with 
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cryogenic probe.  Temperature was calibrated using d4-methanol.  The R2
HE
 values were 
extracted by fitting to the following equation: 
 𝐼𝑇 = 𝐼0exp (−𝑅2
𝐻𝐸𝑇)  5.2 
where IT and I0 are peak heights with or without the delay T, which was 48.27ms.  The 
errors are sample standard deviation from four repeating measurements.  For Arg-HSQC 
one experiment was carried out at 10°C, with temperature calibrated with d4-methanol.  
 
Fluorescence spectroscopy 
Cd
2+
 binding to C2α was monitored using intrinsic tryptophan fluorescence of 
C2α.  The experiments were conducted at 25C using an ISS Phoenix 
spectrofluorometer.  The excitation and emission slit widths were set to 4 and 8 nm, 
respectively.  The fluorescence emission spectra were obtained in the range from 310 to 
530 nm, with the excitation wavelength of 295 nm.  10 mm quartz cuvettes were coated 
with Sigmacote (Sigma-Aldrich) to decrease the protein adsorption on cuvette walls. 
Concentrated stock solutions of Cd(II) nitrate were prepared in HPLC-grade 
water and titrated into the sample cuvette containing 0.5 μM C2α in 20 mM HEPES (pH 
7.4) and 100 mM KCl.  Prior to the start of the experiments, the buffer was treated with 
Chelex 100 (Sigma-Aldrich) to remove residual divalent metal ions.  The reference 
cuvette contained 0.5 μM C2α in the same buffer.  Instead of the metal ion solution, an 
equivalent volume of HPLC-grade water was added to the reference cuvette.  The 
changes in tryptophan fluorescence emission upon Cd
2+
 binding were evident in the 
difference between the sample and reference spectra.  Both the change in the emission 
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intensity and the shift of the emission maximum were observed over the course of the 
titration experiment.  To quantify the Cd
2+
 binding process, we calculated the spectral 
center of mass (CM)
207
 of the emission spectra at each metal ion concentration.  The 
change in CM divided by the maximum observed change upon Cd
2+
 saturation of CMBL 
sites is proportional to the fraction of the Cd
2+
-complexed C2α, FCd.  The data were fitted 
with the Hill equation: 
 
FCd=
[M2+]
H
[M2+]
1/2
H
+[M2+]
H 5.3 
where H is the Hill coefficient, and [M
2+
]1/2 is the Cd
2+
 concentration required to yield 
the half-maximal CM change.  The fit produced the following parameters: H=2.9 ± 0.3 
and [M
2+
]1/2 =1.1 ± 0.1 M.  The low-affinity Cd
2+
 site is not appreciably populated at 
the 0.5 M C2α concentration used in the fluorescence experiments. 
 
Ultracentrifugation lipid-binding assays 
The sucrose-loaded LUVs were prepared and the assays were carried out as 
previously described
72
, at a total lipid concentration of 1.5 mM and C2α concentration of 
5 M.  The composition of LUVs was either POPC/POPS (70:30) or POPC/POPS 
(80:20).  An additional EDTA wash was performed to remove divalent metal ions from 
the LUVs, and EDTA was subsequently removed by four buffer exchanges with G-25 
buffer exchange columns into final buffer of 10mM MES pH6.0 and 100mM KCl.  
 
 
 159 
 
Results 
Two types of Cd
2+
 binding sites in C2α 
The Cd
2+
 binding sites in C2α were identified by solution NMR.  The response of 
individual cross-peaks, each of which correspond to one protein backbone amide group, 
to increasing Cd
2+
 concentration was monitored by a series of 
15
N-
1
H HSQC spectra.  
We observed two groups of residues that respond differently to Cd
2+
 binding, as 
demonstrated with selected subsets in Figure 49.  Group 1 residues fall into the slow-to-
intermediate exchange regime on the NMR chemical-shift timescale, where the cross-
peaks of the apo protein species disappear, and the metal-complexed protein species 
appear at their final positions and gradually build up upon Cd
2+
 saturation.  Group 2 
residues show fast-exchange behavior, where the cross-peak positions change smoothly 
upon increasing Cd
2+
 concentration.  These data indicate that there are two 
distinguishable types of Cd
2+
 binding sites in C2α, with different binding kinetics of 
Cd
2+
 ions.  The apparent Cd
2+
 affinities are also quite different, with group 1 and group 2 
residues saturating at ~300 μM and ~4 mM Cd2+, respectively. 
To map the Cd
2+
 binding sites onto the structural elements of C2α, we exploited 
their differential Cd
2+
 affinities and conducted the chemical shift perturbation (CSP) 
analysis for two pairs of Cd
2+
 concentration points: 0 and 240 μM; and 240 and 4160 
μM.  Site 1 is mostly formed by the Ca2+- and membrane-binding loops, or CMBLs 
(Figure 50A, shaded regions).  According to the crystal structure of Ca
2+
-complexed 
C2α, CMBLs provide all ligands for the binuclear Ca2+ site and the third Ca2+ site except 
from water molecules and external ligands (Figure 48).  The CSP pattern in the low-
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concentration Cd
2+
 regime is very similar to that observed previously for the binding of 
two Ca
2+
 ions to C2α.72  This suggests that no less than two Cd2+ ions with similar 
affinities bind to the loop region.  We used the fluorescence emission spectra of native 
tryptophan residues in C2α to estimate the affinity of Cd2+ to the high-affinity CMBL 
site.  The shape of the binding curve indicates a significant degree of cooperativity, 
consistent with NMR CSP data that there are more than one metal binding for the loop 
region (Figure 50B).   
 
 
 
 
Figure 49.  Two types of Cd
2+
 binding sites in C2α.  Expansions of the 15N-1H 
HSQC spectra show the chemical shift changes of 110 μM C2α in response to 
increasing Cd
2+
 concentration.  The residues of groups 1 and 2 are shown in boldface 
and italics, respectively.  The asterisk marks the position of the apo C2α T251 cross 
peak, which overlaps with F261. 
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Figure 50.  Cd
2+
 binds to two distinct C2α regions: CMBLs and the N-terminal 
/Helix3 region.  (A) Chemical shift perturbation for the low- (yellow) and high-
concentration (black) Cd
2+
 regimes, demonstrating the presence of two types of sites.  
The inset shows values for the indole N-H groups of Trp side-chains.  (B) Fraction of 
the Cd
2+
-complexed C2α, FCd, calculated using the change in the spectral center of 
mass of the Trp fluorescence emission spectra, plotted against Cd
2+
 concentration.  
(C) Representative NMR-detected Cd
2+
 binding curves for the N-terminal/Helix3 
region.  (D) Crystal structure of the Cd
2+
-complexed C2α (PDB ID 4L1L).  Residues 
that show intermediate-to-slow and fast exchange regimes upon Cd
2+
 binding are 
highlighted in orange and blue, respectively.  Pro and residues with no data are in 
dark grey. 
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The concentration of Cd
2+
 required to achieve half-maximal binding is 1.1 ± 0.1 μM.  
This value can be used as an upper limit for the apparent dissociation constant Kd, given 
that the total concentration of C2α is comparable (0.5 μM). 
The N-terminal/Helix3 region of C2α forms the low-affinity Cd2+ site (Figure 
50A).  This behavior is unique for Cd
2+
, as the binding of Ca
2+
 to this region of C2α has 
not been observed.  The binding curves were constructed by plotting a combined change 
in 
1
HN and 
15
N chemical shifts  against total Cd2+ concentration.  All curves have a 
slight lag period because the higher-affinity CMBL sites get populated first.  This and 
the changes in the millisecond-timescale dynamics of the protein upon binding metal 
ions (K. A. Morales and T.I. Igumenova, unpublished data) make it difficult to construct 
an analytical function that accurately describes the binding process.  To estimate the 
binding affinity, we simply fit the residue-specific curves individually with the Hill 
equation, corrected for the free ligand concentration, as described for the C2 domain of 
rabphilin-3A.
134
  The range of apparent Kd values is 270-1100 μM, with the mean of 540 
μM, which is similar to the global fitting result of 523 μM (Figure 50C).  Individual 
fitting of all residues in the low-affinity group are shown in Figure 51. Note that the 
separation of the Cd
2+
 binding sites was possible, due to the different total protein 
concentration regimes used for the fluorescence (0.5 μM) and NMR (110 μM) 
experiments.   
The high-affinity binding event consisting of at least two metal ions and the low-
affinity binding event affecting the N-terminal/Helix3 region are in excellent agreement 
with the crystal structure of Cd
2+
-complexed C2α (PDB ID 4L1L) we went on and 
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solved. Out of six Cd
2+
 ions bound to C2α, only three have four or more protein ligands 
and significant occupancy: the binuclear Cd
2+
 cluster in the CMBL region, with 
occupancies of 1.0 (Cd1) and 0.74 (Cd2); and Cd3 located between the N- terminal 
 
 
 
Figure 51.  NMR-detected Cd
2+
-binding curves of C2α.  The solid lines represent 
the fits to Eq. (3) of Montaville et al..
134
  Missing data points at certain Cd
2+
 
concentrations indicate that the corresponding cross peak is not resolved in the HSQC 
spectrum. 
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region and Helix3, with an occupancy of 0.41 (Figure 50D and Table 13). We concluded 
that Cd1 and Cd2 correspond to the high-affinity sites located at CMBLs, exhibiting 
slow-to-intermediate exchange behavior; whereas Cd3 corresponds to the low-affinity 
site located at N-terminal/Helix3 region, with fast exchange behavior in NMR binding 
experiments.   
 
Cd
2+
 does not support PtdSer-containing membrane association of C2α 
We then seek to understand if Cd
2+
 could support membrane association of C2α 
with PtdSer-containing LUVs. Two types of experimental approaches were used for this 
purpose. One is Förster Resonance Energy Transfer (FRET) based experiments 
monitoring the membrane binding event with intrinsic Trp of C2α as donor of the FRET 
pair and dansyl-PE incorporated in LUVs as the acceptor. The other type of experiment 
is ultracentrifugation experiments with sucrose-loaded LUVs. The results of the FRET 
based membrane-binding assays (as demonstrated in Figure 3 of Morales and Yang et 
al.
208
) and the ultracentrifugation assays (Figure 52) both revealed that there is minimal 
membrane-association when Cd
2+
 is added. This is in opposite situation when comparing 
to Pb
2+, which also binds with high affinities to CMBLs of C2α but drives membrane 
association also as efficient as Ca
2+
.  Cd
2+
 alone neither quenches dansyl fluorescence 
nor associates appreciably with the PtdSer component of the LUVs under the conditions 
of our experiments (as described in the SI of Morales and Yang et al.
208
).  We conclude 
that Cd
2+
 is unable to mediate the association of C2α with membranes due to the intrinsic 
differences of the divalent metal ion from Ca
2+
 and Pb
2+
.   
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Figure 52. Fractional population of membrane-bound C2α obtained in 
ultracentrifugation binding assays with LUVs having 30% PtdSer component.  
Total concentration of metal ions was 175 M, except for the Cu2+/Ca2+ displacement 
experiments that were carried out at 12.5/175 M (Bar 1) and 175/2450 M (Bar 2).   
 
 
 
The ability of metal ions to mediate membrane association does not correlate with their 
radii or coordination geometry when complexed to C2α 
The results that Cd
2+
 cannot support C2α-membrane binding were surprising to 
us in two different aspects. On one hand, Pb
2+
 binds CMBLs of C2α with high affinity 
just like Cd
2+
, whereas the coordination geometry of the second Pb
2+
 differs from Ca
2+
 
or Cd
2+
 (Figure 53). On the other hand, Cd
2+
 (0.97Å) has a very similar radius as Ca
2+
 
(0.99Å), whereas Pb
2+
 has a larger radius (1.33Å).  Despite all these, Pb
2+
 drives C2α-
membrane association almost as efficient as the native ligand Ca
2+
.   
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We attribute this behavior to the coordination preferences of metal ions.  Cd
2+
 is 
a soft Lewis acid
209
, with preference towards soft ligands, such as thiol groups of 
cysteine residues.
210
  Its most frequently encountered coordination number (CN) in 
proteins is either 4 or 6.
211
  The crystal structures of Ca
2+
-bound C2α68 and annexin V212 
in complex with PtdSer analogs suggest that a Ca
2+
-coordinated water molecule is 
replaced by either phosphoryl and/or carboxyl oxygen(s) of PtdSer upon membrane 
association.  This may be accompanied by an expansion of the metal ion coordination 
sphere, as shown for Ca
2+
-bound C2α in Figure 53.  While Cd2+ can adopt a hepta-
coordinated state when bound to C2α, the rearrangement and possible expansion of its 
all-oxygen coordination sphere required for PtdSer interactions may be unfavorable.  In 
contrast, Ca
2+
 is a hard Lewis acid that favors all-oxygen coordination environment with 
CNs of 6-8.
213
  Pb
2+
 is a borderline Lewis acid that interacts readily with oxygen-
containing ligands and can adopt CNs up to 9 in proteins.
214
 
This explanation correlating the ability to expand coordination sphere with 
membrane binding was further tested with a fourth metal ion: Cu
2+
. Similar to Pb
2+
, Cu
2+
 
is a borderline Lewis acid, albeit with a well-documented preference for CN=4 in 
proteins.
211
  In addition, Cd
2+
 and Cu
2+
 have been used with success as a diamagnetic-
paramagnetic pair in structural studies.
215
  According to elegantly measured 
paramagnetic relaxation enhancement effects (described in Figure 4 of Morales and 
Yang et al.
208
), Cu
2+
 also binds to both CMBLs and N-terminal/Helix3 region similar to 
Cd
2+
.  However,the N-terminal/Helix3 site populates Cu
2+
 prior to CMBLs, indicating a 
higher affinity of Cu
2+
 to the N-terminal/Helix3 region than the CMBLs which is with 
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opposite preferences to Cd
2+
.  The lipid-binding assays show that like Cd
2+
, Cu
2+
 is not 
an effective mediator of protein-membrane interactions: only ~20% of Cu
2+
-complexed 
C2α is membrane-bound (Figure 52).  Reducing the concentration of PtdSer from 30% 
to 20% eliminates the membrane binding of C2α in the presence of Cu2+ (see Figure S10 
of Morales and Yang et al.
208
).  
 
 
 
Figure 53.  Comparison of the coordination geometry of Cd
2+
, Ca
2+
 and Pb
2+
 
complexed to the C2 domain from PKCα.  The crystal structures used are PDB ID 
4L1L, 3DSY and 3TWY, respectively.  All coordinating oxygen atoms are colored 
black. 
 
 
 
More interestingly, Cu
2+
 at the weaker CMBLs site could be replaced by 
excessive Ca
2+
, but not the N-terminal/Helix3 site.  The generated mixed species has 
Ca
2+
 bound to CMBLs while Cu
2+
 remained associated with the N-terminal/Helix3 site.  
The mixed metal-bound species associates with membrane as efficient as the Ca
2+
-bound 
C2α (Figure 52).   This demonstrates nicely that having a divalent metal ion bound to the 
N-terminal/Helix3 site does not negatively affect the C2α membrane-binding properties. 
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Table 13.  Cd-O distances and occupancy for Cd1-3 in Cd
2+
-complexed C2α structure 
Cd1 
CN
a
=7 
Bond length 
(Å) 
Cd2 
CN=7 
Bond length 
(Å) 
Cd3 
CN=6 
Bond length 
(Å) 
D187 (Oδ1) 2.57 D187 (Oδ1) 2.45 E157 (Oε2) 2.62 
D187 (Oδ2) 2.52 D248 (Oδ2) 2.67 E282 (Oε2) 2.67 
D193 (Oδ2) 2.35 D248 (Oδ1) 2.55 E282 (Oε1) 2.59 
D248 (Oδ1) 2.40 D254 (Oδ2) 2.45 N279 (Oδ1) 3.04 
D246 (Oδ1) 2.35 D246 (Oδ2) 2.34 H2O (141) 2.84 
W247 (O) 2.36 M186 (O) 2.53 H2O (142) 2.20 
H2O (10) 2.46 H2O (43) 2.54   
Average  2.43±0.09  2.50±0.10  2.66±0.28 
Occupancy 1.00  0.74  0.41 
a
CN stands for coordination number 
 
 
 
 
Table 14.  Cd-O distances and occupancy for Cd4-6 in Cd
2+
-complexed C2α structure 
Cd4 
CN=5 
Bond length 
(Å) 
Cd5 
CN=4 
Bond length 
(Å) 
Cd6 
CN=5 
Bond length 
(Å) 
D193 (Oδ1) 2.47 D254 (Oδ1) 2.75 E265 (Oε2) 2.38 
D193 (Oδ2) 2.57 T251 (Oγ1) 2.76 E265 (Oε1) 2.92 
H2O (408) 2.37 D248 (Oδ2) 2.84 H2O (511) 2.22 
H2O (419) 2.43 R252 (O) 2.86 H2O (501) 2.58 
H2O (522) 2.69   H2O (420) 2.92 
Average  2.51±0.13  2.80±0.06  2.60±0.32 
Occupancy 0.29  0.35  0.27 
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Weak Cd
2+
 sites of C2α observed in crystal structure 
We were able to observe a total of six Cd
2+
 ions bound to the protein from the 
crystal structure of Cd
2+
-complexed C2α.  Tables summarizing all six Cd2+ ions are 
shown in Table 13 for the Cd1-3 and Table 14 for the Cd4-6, respectively.  From the 
tables, it is apparent that Cd1-3 have significant occupancies, four or more protein 
ligands and six or more total coordination numbers, as comparing to Cd4-6.  This is in 
full consistency with our solution Cd
2+
 binding studies by NMR (vide supra).  It is worth 
to note that Cd4 and Cd5 both locate at the CMBLs region to form a Cd “string” via the 
formation of O-M-O bridges (Figure 54).   
 
 
  
 
 
Figure 54. Cd “string” formed by Cd1, Cd2, Cd4 and Cd5 at the CMBLs region.  
Not all coordinating residues are shown. CMBL1 and CMBL3 are indicated.  
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On the other hand, Cd5 binds to the same location as the Ca3 site observed in the 
PDB ID 3GPE.  Detailed analysis of the coordinating residues reveals that Cd5 forms the 
same coordination bonds as the Ca3 site (Table 13, Figure 48, Figure 53 and Figure 54), 
except from Cd5 having one less ligand than Ca3 (D254 Oδ2).  This is again consistent 
with that Cd(II) and Ca(II) are isostructural, but have slightly different ligand 
preferences and coordination numbers.   
 
Third Ca
2+
 binding induces μs-ms dynamics changes in C2α 
 After acquiring insights into the mechanism of Ca
2+
-mediated membrane 
binding, the next step was to investigate the role of the third Ca
2+
 site on C2α that could 
relate metal-binding to the final conformational change of full-length PKC.  We 
hypothesize that the third Ca
2+
 binding alters the conformational dynamics instead of 
structure.  We measured amide 
15
N R2 values with the Hahn Echo experiments 
containing a single 
15
N refocusing pulse.  The R2
HE
 values extracted from these 
experiments contain both spin-lattice relaxation rate R2
0
 and any existing chemical 
exchange rate Rex on the μs-ms time scale.   
Figure 55A shows the results of R2 relaxation measurements of C2α with 
different concentrations of Ca
2+
.  From previous NMR studies
72
 we knew that C2α 
associates with the first two Ca
2+
 ions with equivalent affinity of ~270μM.  This allows 
us to estimate a saturating point for the first two Ca
2+
 ions at the protein concentration 
we used in the relaxation sample described in this chapter.  According to the estimation, 
95% of C2α is bound with the first two Ca2+ ions at [Ca2+] of 1.75mM.  Therefore, only 
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data from high concentrations of [Ca
2+] ≥ 1.75 mM are shown here in order to represent 
the third Ca
2+
 binding event.  From the array of R2
HE
 values (Figure 55A), it is apparent 
that the value of residue R159 increases dramatically upon increasing third Ca
2+
 binding.  
The total increase of R2
HE
 for R159 is 9.70 ± 1.11 s
-1
 between the first and last Ca
2+
 
points (1.75 mM and 87.5 mM).   
 
 
 
 
Figure 55. Third Ca
2+
 binding induces μs-ms dynamics changes in C2α.  (A) 
Increased R2
HE
 values of the N-terminal region by the third Ca
2+
 binding.  The values 
plotted against residue number at increasing Ca
2+
 concentration are colored as 
indicated.  (B) Hydrogen bond between R159 side-chain and the backbone carboxyl 
oxygen of M256 observed in crystal structure 3RDJ.  The distance between nitrogen 
and oxygen atoms in the hydrogen bond is 2.584 Å.  The locations of the Ca
2+
 are 
indicated by an overlay with crystal structure 3GPE. 
 
 
 
This indicates an increased motion of R159 at μs-ms time scale.  The change of R2
HE
 at 
Helix3 is not as pronounced.  On the contrary, CMBL1 and CMBL3 residues have 
decreased R2
HE
 upon third Ca
2+
 binding.  This is consistent with reduced backbone 
motions of CMBL1/3 residues upon formation of coordination bonds with the third Ca
2+
.   
The dramatic increase of R159 motion upon addition of Ca
2+
 is not likely due to a direct 
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association of Ca
2+
 to the N-terminal/Helix3 region, due to two aspects: 1) we did not 
observe large chemical shift perturbations for the region which is the case for Cd
2+
; 2) 
Ca
2+
 coordinating to this region has never been observed previously despite multiple 
Ca
2+
-bound structures available in the Protein Data Bank.  
In order to understand the basis of the increased motion for R159, we carefully 
inspected the existing crystal structures of C2α to look for potential interactions 
involving this residue.  In all available crystal structures we analyzed, there is a 
hydrogen bond between the side-chain Nη1 of R159 and the backbone carbonyl oxygen 
of M256.  This hydrogen bond is shown in Figure 55B and all bond distances analyzed 
are summarized in Table 15.  Although crystal structures do not necessarily report on the 
solution state, they likely represent a thermodynamically stable conformation on the 
energy landscape in solution.  To probe the existence of this hydrogen bond in solution, 
we collected 
1
H-
15
N HSQC spectra of wild-type and a R159G mutant of C2α with the 
15
N carrier placed at an optimal frequency for Arg side-chain nitrogen atoms.  From the 
spectra comparisons between wild-type and mutant (Figure 56), it is immediately 
apparent that there is a resonance corresponding to R159 Nη-Hη (71.6, 6.7) with a 
down-field shift on 
1
H dimension comparing the other Arg Nη-Hη (71.5, 5.9).  This 
down-field shifted resonance is not in the R159G mutant spectrum, which assisted in 
assigning the identity in the wild-type spectrum.  At the same time, the down-field shift 
is consistent with a hydrogen-bonded species.      
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Figure 56.  Arg 
15
N-
1
H HSQC spectral overlay of wild-type C2α and R159G 
mutant reveals a hydrogen-bonded species of residue R159 in the wild-type 
protein.  The color coding of each spectrum is illustrated on the right part of the 
spectra, with wild-type protein spectra colored cyan (25°C) and blue (10°C), R159G 
mutant spectra colored magenta (25°C) and black (10°C), respectively.  Resonance 1 
is the hydrogen bonded species of R159, whereas Resonance 2 corresponds to all 
other Arg Nη-Hη and R159 species that is not hydrogen bonded.  The volume 
percentage (Vol%) is calculated by the ratio of the peak volumes of  Resonance 1 
versus the sum of Resonance 1 and 2. 
 
 
 
                         Table 15. Distances between R159 Nη1 and M256 O atoms 
PDB ID distance (Å) Ligand 
3RDJ 2.584 apo 
1DSY 3.005 2Ca
2+
 
3GPE 2.870 3Ca
2+
 
3TWY 2.895 2Pb
2+
 
4L1L 2.969 6Cd
2+
 
4DNL 3.196 1Na
+
 
Average 2.920 ± 0.201 
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The population ratio of this down-field shifted resonance also increases at 10°C than at 
25°C, further confirming that this resonance corresponds to a hydrogen-bonded species 
which is stabilized at lower temperature. 
Based on the above evidence, we infer that the increased motion of R159 residue 
upon third Ca
2+
 binding is related to a change in the equilibrium between hydrogen-
bonded and not hydrogen-bonded species.  If true, this indicates a potential role of the 
third Ca
2+
 binding in modulation of μs-ms motion at the slightly remoted N-terminus of 
C2α (Figure 55B).  Given that the linker between C2 domain and the preceding C1B 
domain in the host enzyme PKCα is short (7 aa), the increased motion of residue R159 
will potentially have an effect on the degree of freedom of the preceding C1B domain.     
There is a minor R2
HE
 decrease of the baseline residues excluding residues of regions N-
terminal/Helix3 and CMBL1/3.  The baseline decrease is an average of 2.67 ± 0.56 s
-1
 
between the first and the last Ca
2+
 points shown in Figure 55A.  This minor baseline 
decrease is a potential result of a change in overall molecular tumbling, caused by either 
a change in the molecular shape or oligomerization state.  The crystal structure of C2α 
remains identical between the two-Ca
2+
 bound state and the three-Ca
2+
 bound state 
(Figure 48). Therefore, we think it is more likely to be due to reduced oligomerization at 
lower protein concentrations for the higher [Ca
2+
] points, as a result of dilution.  The 
ability for C2 domain to oligomerize is further supported by the crystal structure of C2 
domain from PKCβII, where the adjacent molecules form a dimer (Figure 57).    
 
 
 175 
 
 
Figure 57. Homo dimer observed in crystal structure of C2 domain from 
PKCβII.  The PDB ID is 1A25, and the two chains forming a dimer are colored cyan 
and grey, respectively.  R159 and P185 residues forming hydrogen bonds on the 
dimer interface is illustrated. The Nη2-O distances are 2.401 Å and 2.428 Å for the 
top and bottom bonds, respectively. 
   
 
 
R159G mutantion alters the third Ca
2+
 binding affinity 
The third Ca
2+
 binding is also investigated in the R159G mutant as comparing to 
the wild-type C2α.  Figure 58 and Figure 59 display the spectral overlay of wild-type 
and R159G C2α with increasing concentration of Ca2+.  Both constructs display a linear 
trajectory of resonance shifts upon populating the third Ca
2+
 bound species.  The 
constructed binding curves fit very well with the single-site binding equation.
134
  Figure 
60 displays the binding curves of both wild-type and R159G mutant upon binding the 
third Ca
2+
 site.  All solid lines displayed are global fitting results to a single-binding site 
equation
134
, which yielded Kds of 26.5 ± 0.8 mM for the wild-type C2α and 57.9 ± 3.3 
mM for R159G mutant.  This about 2-fold decrease in binding affinity indicates a role of 
the R159 residue in the third Ca
2+
 binding through modulating the μs-ms dynamics of 
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C2α.  Together with the R2
HE
 increase of R159 upon binding third Ca
2+
 (vide supra), we 
conclude that the third Ca
2+
 binding and the μs-ms dynamics of the N-terminal/Helix3 
region is interconnected.  This effect is likely mediated by the hydrogen-bonding 
network at the N-terminal/Helix3 region especially for the R159-M256 hydrogen bond.   
 
 
 
 
Figure 58. Spectral overlay of the wild-type C2α R2-HE experiments without the 
delay T.  These are essentially the same as 
1
H-
15
N HSQC experiments, and are used to 
extract the third Ca
2+
 binding affinity.  Color coding of each spectrum is indicated at 
the left top corner.  Only resonances with significant chemical shift perturbations are 
shown, with arrows indicating the direction of shifts. 
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Figure 59. [
15
N-
1
H] HSQC pectral overlay of the R159G mutant C2α upon binding 
third Ca
2+
.  These are used to extract the third Ca
2+
 binding affinity.  Color coding of 
each spectrum is indicated at the left top corner.  Only resonances with significant 
chemical shift perturbations are shown, with arrows indicating the direction of shifts. 
 
 
 
It is worth to mention that the effect of R159G mutation on the binding of the 
first two Ca
2+
 ions is not as pronounced as the third Ca
2+
.  The median of Kd for wild-
type C2α binding to the first two Ca2+ is ~270 μM, whereas for R159G mutant the 
median Kd is ~301 μM.  There are variations of Kd and cooperativity if individual 
residues are compared, reflecting a potential change in overall dynamics across the 
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protein by the mutation without altering the overall binding affinity for the first two 
Ca
2+
. 
 
Discussion of results 
The work in this chapter provides valuable insights into the metal-dependent 
membrane association of C2 domain from PKCα, with specific case studies involving 
divalent metal ions Cd
2+
 and Ca
2+
.  Regarding to the mechanism of metal-dependent 
membrane association, our data clearly demonstrate that Cd
2+
, along with two other non-
native metal ions: Cu
2+
 and Pb
2+, can act as a general electrostatic “switch” by 
associating with the aspartate-rich CMBL region of C2α and neutralizing the negative 
charges.  However, the formation of metal ion-protein complex is not sufficient to 
promote protein-membrane association, as demonstrated for Cd
2+
 and Cu
2+
.  We 
conclude that bridging interactions between a divalent metal ion and PtdSer groups are 
required for productive protein-membrane interactions.   
Favorable spectroscopic properties and the nearly identical ionic radius have 
made Cd
2+
 a popular substituent of Ca
2+
.
216
  Our results show that the preferred 
coordination geometry of metal ions, their ability to expand the coordination sphere, and 
the chemical identity of protein ligands need to be taken into account when designing 
metal substitution studies.  This is particularly important for proteins that rely on metal 
ions to carry out a specific function.  A case in point is the C2 domains, which are the 
second most abundant lipid-binding domain behind the PH domains:
217
 a UniProt
218
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search  produced >140 different human C2-containing proteins whose function includes 
signal transduction and membrane trafficking. 
 
 
 
 
Figure 60. R159G mutation reduces the binding affinity for the third Ca
2+
 site.  
The binding curves for both wild-type C2α (closed symbols) and R159G mutant 
(open symbols) are shown in overlay.  All fits are global fitting results to a single 
binding site equation.
134
  Residue identities are shown on each graph.  W245sc and 
W247sc refer to the imidazole side-chain Nε1-Hε1 resonances of the two trp residues 
on CMBL3.  
 
 
Cd
2+
 is a toxic metal ion with no safe limit of exposure.
219
  In our study, the 
affinity of Cd
2+
 to the CMBL region far exceeds the previously reported Ca
2+
 value
203
 
for > 30-fold.  It is plausible that bioavailable Cd
2+
 can influence the function of C2-
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domain containing proteins through a direct competition with Ca
2+
 for the CMBL 
regions.  Our results demonstrate that toxic metal ions such as Cd
2+
 and Pb
2+
 can elicit 
very different functional responses with respect to the in vitro membrane binding: Pb
2+
 
promotes membrane association of C2α, whereas Cd2+ does not.  Either scenario, if 
occurring in the cell, would lead to the aberration in the Ca
2+
 signaling response. 
We further observed a difference between the two metal ions, Cd
2+
 and Ca
2+
, in 
their weak interactions with C2α beyond the first two sites.  After populating the first 
two sites with high affinity at the CMBLs, Cd
2+
 populates a significant third binding site 
on the N-terminal/Helix3 region of the protein, which is absent in the case of Ca
2+
.  
However, the third Ca
2+
 binding to CMBLs of C2α modulates the μs-ms dynamics of the 
slightly remote N-terminal/Helix3 motion potentially through a hydrogen-bonding 
network involving residue R159.  This is further demonstrated by a 2-fold reduce in the 
affinity for the third Ca
2+
 by the R159G mutation which disrupts the R159-M256 
hydrogen bond.  These data highlight a connection between the third Ca
2+
 binding event 
and the μs-ms dynamics at the N-terminal/Helix3 region of C2α.  The third Ca2+ binding 
was shown to be present in the PtdIns(4,5)P2 liganded C2α structure
62
, and was indicated 
to exist in the membrane-bound C2 domains from all conventional PKCs.
203
  Given that 
the N-terminus of C2 domain connects to the preceding C1B domain through a short 
linker, we infer that third Ca
2+
 binding to C2 domain could trigger a more open 
conformation of conventional PKCs through potential alteration of the linker μs-ms 
motions.  On the other hand, since Cd
2+
 populates a binding site at the N-terminal/Helix3 
region with residues E157, E282 and N279, Cd
2+
 could also affect the motions of the 
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C1B-C2 linker through direct weak binding.  Further studies including the interactions 
between the C1B-C2 two-domain construct and full-length PKC constructs with Cd
2+
 
and Ca
2+
 are required to provide a more complete understanding on this subject.  
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CHAPTER VI 
SUMMARY AND FUTURE DIRECTIONS  
 
Summary and perspectives 
Protein kinase C (PKC) isoenzymes have been identified as promising treatment 
targets for numerous human diseases, due to their central role in a broad range of cellular 
signaling pathways.
12
  However, the current understanding of PKC regulation is not 
sufficient to achieve isoenzyme specific modulations by therapeutic agents.  One of the 
main challenges in the field is to acquire atomic level information that could serve as a 
foundation to better understand the molecular mechanisms of PKC function and to 
address the fine differences between isoenzymes within PKC family.  Towards this goal, 
the work conducted in this dissertation focuses the C-terminal V5 domain, a critical 
regulator for PKC function and isoenzyme-specific cellular localization, of which 
structural information was largely missing.   
Chapter I provided the first successful expression and purification of the isolated 
V5 domain from PKCα with sufficient quantity for structural studies.  We showed by 
combined spectroscopic methods that V5 domain is intrinsically disordered, with minor 
secondary structural propensities.  This immediately explains the missing structural 
information prior to this study, since disordered proteins and protein domains generally 
exhibit large flexibility which prevents them to be visualized by crystallography and 
other structural approaches.  On the other hand, the intrinsically disordered properties of 
V5 domain potentially allow highly adaptive protein-protein interactions with multiple 
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targets, which is one of the commonly suggested functions for disordered proteins and 
protein domains during cell signaling.
112,220
  This is consistent with the large number of 
intermolecular domains, upstream kinases, scaffold proteins, molecular chaperone and 
other regulating proteins proposed to bind V5.  In addition, the phosphorylation mimetic 
mutant was found to not affect the structural properties of V5 domain, suggesting 
alternative mechanisms for the PKC conformational change upon the phosphorylation 
events other than a change of V5 structure during the kinase maturation process. 
The propensities of the isolated V5 domain from PKCα to interact and partition 
into hydrophobic environments were also unveiled in this work using detergent micelles 
as a membrane mimetic.  We further tested this propensity with bilayer membrane 
mimetic LUVs.  The interaction seems to be weaker with bilayer membrane as compared 
to micelles, consistent with the overall weak affinity of endogenous newly synthesized 
PKC to membranes.  Using sensitive paramagnetic relaxation enhancement techniques, 
we observed similar regions of V5 interacting with bilayer membrane mimetic LUVs to 
those observed in micelle experiments.  A slowly built-up species of V5 in the presence 
of LUVs over a time course of days suggested an additional interaction mode between 
V5 and bilayer membrane.        
Chapter III and IV investigated the intramolecular and intermolecular 
interactions of PKC involving the V5 domain as implicated in previous functional 
studies.  In Chapter III, direct evidence of the intramolecular C2–V5 interaction from 
PKCα was presented.  This same interaction was shown to enhance the calcium binding 
affinity of the C2 regulatory domain, which would potentially decrease the concentration 
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of calcium needed to activate PKCα in cells.  We determined the ternary C2•Ca2+•V5-
pHM complex structural model in solution, which showed overlapping binding sites 
between V5-pHM and PtdIns(4,5)P2 on the C2 regulatory domain.  Guided by the 
structure, mutations were designed to disrupt the observed C2–V5 interface in full-
length PKCα construct.  These mutations were shown to affect both autoinhibited 
conformation of the latent full-length PKCα and the membrane translocation kinetics 
upon phorbol ester PDBu stimulus in live cells.  These data together with other studies 
suggested a potential conformational plasticity in the intramolecular binding site of the 
C2 domain.  A fine-tuning and intricate regulation mechanism through the 
phosphorylated hydrophobic motif of V5 domain was described to be both 
autoinhibitory and activating at the same time.  
Chapter IV provided a detailed analysis of V5 domain from PKCα as a bivalent 
binder for the peptidyl-prolyl isomerase Pin1.  Several novel insights were contributed to 
both PKC field and Pin1 field.  As a non-canonical Pin1 site, the hydrophobic motif of 
V5 domain was observed to interact with both domains of Pin1.  On the other hand, the 
turn motif was found to be a WW domain specific interaction site and an inefficient 
substrate for Pin1 catalysis of peptidyl-prolyl bond cis-trans isomerization.  When both 
turn and hydrophobic motifs are present on the same polypeptide chain, the interaction 
mode between Pin1 and bisphosphorylated V5 is highly specific: the turn motif interacts 
with the WW domain and the hydrophobic motif interacts with the PPIase domain.  The 
binding affinities were shown to be enhanced significantly in the bivalent binding when 
comparing to the isolated motifs.  These data illustrated a mechanism of Pin1–V5 
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interaction during the dephosphorylated/ubiquination dependent down-regulation 
process of conventional PKCs (with a potential exception for PKCβ). 
We further investigated the reason why the phosphorylated turn motif is not an 
efficient substrate or interaction site for the PPIase domain.  An unexpected non-specific 
catalysis was observed for the Q
634
-P
635
 site in the presence of full-length Pin1 or the 
isolated PPIase domain.  We demonstrated that this non-specific catalysis is due to a 
direct weak interaction between the phosphorylated turn motif and the substrate binding 
pocket of the PPIase domain.  We attributed this phenomenon to the similarity between 
Gln and Glu residue, which is an effective phosphorylation mimic for Pin1.  On the other 
hand, we hypothesized that the lack of amide proton for the +1 proline is the key to the 
lack of catalysis or binding.  Indeed, a peptide with an alanine substitution at the +1 
proline position while keeping the rest of the phosphorylated turn motif peptide identical 
exhibited efficient catalysis by Pin1 under the same experimental conditions.    
Although the non-specific catalysis towards Q
634
-P
635
 site still existed in the 
alanine substituted peptide, the full pV5 peptide did not display any efficient catalysis.  
This indicates that the nature of Pin1–V5 interaction during down-regulation of 
conventional PKC isoenzymes (α, βII and γ) is non-catalytic.  In addition, we observed 
potential interdomain communication upon Pin1 interacting with the isolated 
phosphorylated turn motif.  This could contribute in part to the significant avidity for the 
bivalent binding between full-length Pin1 and the bisphosphorylated V5 domain.   
In Chapter V, we dissected the roles of divalent metal ion during the metal-
dependent membrane interaction of the C2 regulatory domain.  Specifically, cadmium 
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was used as a calcium structural surrogate.  The coordination geometries of cadmium at 
the calcium membrane binding loops of C2 domain were shown to be identical to 
calcium.  However, cadmium was not able to support C2–membrane interaction.  This 
was further compared with lead and copper.  Divalent lead has a much larger ionic 
radius than calcium, and was shown previously in the lab to have a different 
coordination geometry at the second metal-binding site from calcium.
72
  Despite of that, 
lead was shown to support C2–membrane interaction almost as efficient as calcium.  
Divalent copper is similar to cadmium regarding to their limited coordination numbers 
generally observed, and could not support C2–membrane binding just like cadmium in 
this study. Taken together, we attributed the ability of divalent metal ions to support 
membrane association to the ability to expand their coordination sphere to oxygen atoms 
of phospholipids on top of the protein ligands, rather than the radius or protein-ligated 
coordination geometry.  This is the first time to our knowledge where a “bridging” 
mechanism is verified directly through combined bioinorganic and membrane binding 
analysis. 
A third binding site at the N-terminus/Helix3 region was observed for cadmium 
and copper.  However, the third calcium binding site is located at the loop region of C2 
from PKCα.  Although not directly interacting, we observed a change of dynamics at the 
N-terminus/Helix3 region on the microsecond to millisecond timescale in response to the 
third calcium binding.  This effect was attributed to the hydrogen bond network at the N-
terminus/Helix3 region as shown by disrupting one hydrogen bond with the R159G 
mutation.  This mutation did not significantly affect the first two calcium binding 
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affinities, but reduced the cooperativity slightly between the first two calcium binding 
events and reduced the binding affinity of the third calcium binding by two fold.  Given 
the short linker length between C2 domain and the preceding C1B domain, as well as 
previously indicated increased third calcium binding by association with negatively 
charged membrane, these findings suggest a potential connection between the third 
calcium binding to the conformational change of full-length cPKCs upon membrane 
binding.   
 
Future directions 
This dissertation provided characterization and direct evidence for the multi-
functional properties of the intrinsically disordered C-terminal V5 domain from 
conventional PKCs.  The intramolecular and intermolecular interactions described here 
of V5 domain with both C2 regulatory domain and peptidyl-prolyl isomerase Pin1 
illustrated the critical roles of V5 domain at all stages of PKC regulation with atomic 
level details.  However, this is only the first step towards acquiring a full understanding 
of how V5 domain controls PKC life cycle.  Many questions remain to be answered.  We 
now know that the isolated V5 domain is intrinsically disordered and presents large 
conformational flexibility wrapping around the N-lobe of the catalytic domain in crystal 
structures.  This property may be changed under different regulation stages.  For 
example, the two phosphorylation sites on V5 domain were suggested to be 
autophosphorylation sites for conventional PKCs.  In order for this to happen, the two 
unphosphorylated motifs may be interacting with the active site located between the N- 
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and C-lobes of the kinase core.  The phosphorylation events are then concerted with 
intramolecular interactions in an unknown order resulting in a closed conformation of 
the mature kinase.   
The Pin1 mediated down-regulation of PKC is shown in this dissertation to be 
non-catalytic with avidity from bivalent binding for at least three out of four isoenzymes 
in the conventional PKC subfamily.  The source of the observed avidity will be 
determined by future experiments.  A structural model is yet to be determined for this 
bivalent Pin1–V5 complex.  The effect of dephosphorylation for both V5 motifs on the 
Pin1–V5 binding is still not clear.  Future experiments with full-length enzyme could 
test the sequence of action to see which V5 motif interacts first with Pin1, and what kind 
of initial changes could occur to Pin1.  Since the cis-trans isomerizations of V5 are not 
altered by Pin1 for these PKC isoenzymes, another conformational change may occur to 
the full-length PKC upon Pin1 interaction that will eventually lead to dephosphorylation 
and ubuiquitination of PKC.  Perhaps the non-catalytic V5–Pin1 interaction mediates 
other protein-protein interactions with phosphatases or ubiquitination pathway proteins.  
Since the turn motif of PKCβI is potentially an efficient substrate for Pin1 catalysis, it 
could be regulated by Pin1 through a different mechanism.  It also remains to be 
investigated if other Pin1 targets in the cell containing non-catalytic or non-canonical 
sites would share a common mechanism as observed in this study.    
Finally, other functional elements of the C-terminal V5 domain remain to be 
studied.  The propensities of V5 domain from PKCα to interact with hydrophobic 
environment could relate to PDZ-domain interaction via the C-terminal QSAV motif , 
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which is unique for PKCα.  This could be further investigated to test α-isoform specific 
regulations.  Functions of the highly conserved NFD motif and the N-terminal PPXXP 
sites of V5 domain are still largely unexplored.  Since interpretations of functional 
studies through mutagenesis are currently limited by the lack of full-length PKC 
structures, biophysical studies with individual V5 elements will provide valuable 
insights for understanding regulation mechanisms of PKC. 
Protein kinase C has been a significant cell regulator and a challenging kinase 
system since its discovery almost forty years ago.  However, the functional significance 
of intrinsically disordered proteins and protein domains in eukaryotes only emerged 
within the past twenty years.  We hope the results and approaches in this dissertation 
would assist in future understanding of regulations not only for PKC, but also the 
abundance of eukaryotic proteome containing disordered regions.   
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